Synthesis and applications of novel azolium salts by Dallas, Andrea
Thesis for the degree of Doctor of Philosophy
Synthesis and Applications of Novel Azolium 
Salts
Andrea Dallas B.Sc.
Dublin City University  
School o f Chem ical Sciences
DCU
September 2003
Supervisor: Dr. Kieran Nolan
D eclaration
I hereby certify that this material, which I now submit for assessment on the 
programme of study leading to the award o f Doctor of Philosophy is entirely my own 
work and has not been taken from the work of others save and to the extent that such 
work has been cited and acknowledged within the text o f my work.
Signed: Ç )  . Q C \J lV <0 ID No.: ^ *1 H
Andrea Dallas
Date: | £ / f j ,  / o 3
ii
Abbrevations
ATP Adenosine triphosphate
BuLi «-Butyl lithium
Bu Butyl
Bzim Benzimidazo^enzimidazolium
«-Bu normal-Butyl
cat. Catalyst
Cp Cyclopentadiene
CV Cyclic voltammetry
DAB 1,4-Diazobutadiene
DCM Dichloromethane
dba Dibenzyl ideneacetone
DME Dimethoxyethane
DMF N,A/'-Dimethylformamide
DMSO Dimethyl sulfoxide
DNA Deoxyribonucleic acid
dpim l-Methylimidazol-2-yldiphenylphosphine
dppf Bis(diphenylphosphino)ferrocene
ee Enantiomeric excess
E t E thyl
Fc Ferrocene
fc 1,1'-Disubstituted ferrocene
Fc-DAB Af,A',-Diferrocenyl-l,4-diaza- 1,3-butadiene
HCN W-Heterocyclic carbene
Im Imidazole/imidazolium
IR Infrared
Me Methyl
MeCN Acetonitrile
MeOH Methanol
m.p. Melting point
NMR Nuclear magnetic resonance
PBP Phosphate binding protein
PET Photoinduced electron transfer
PPFA /^Sp-N.jV-Dimethyl-1 -[(2-diphenylphosph
Ph Phenyl
Pr Propyl
RT Room temperature
SCE Saturated calomel electrode
THF Tetrahydrofuran
t.l.c. Thin layer chromatography
TMEDA N,Af,A,',yV’-Tetramethyl-1,2-ethanediamine
VOC Volatile organic compounds
Publications
The following paper was published as part of the work contained within this thesis:
[1] J. Howarth, A. Dallas, Molecules, 5 (2000) 851.
The following presentations were presented as part of the work contained within this 
thesis:
[1] A. Dallas, J. Howarth, ‘Synthesis o f Novel Ferrocenyl-azole Compounds’, 
13th International Conference on Organic Synthesis (ICOS-13), Warsaw, 
Poland, 1-5 July, 2000. Poster.
[2] A. Dallas, J. Howarth, ‘ (1 -Methylferrocenyl)imidazolium Iodide Salts: 
Synthesis and Characterisation’, 51th Irish Chemistry Colloquium, Cork, 
Republic of Ireland, 14-15 May, 2001. Presentation.
A b stract
The application o f azole and azolium compounds is o f  widespread interest both 
industrially and academically. There are many lively and diverse research areas employing 
these compounds, including organometallic processes, molecular recognition and biological 
research. Thus, the objective o f this research was the preparation novel azolium salts and their 
application in some o f these areas. Ferrocenyl-im idazole and ferrocenyl-benzimidazole 
compounds and their respective salts were prepared and their catalytic, chemoreceptor and 
biological properties studied.
M onosubstituted ferrocenyl-azolium  salts (l-ferrocenylmethy-3-alkylazolium 
halides), acyclic bisazolium -ferrocenyl salts {l-[(l-ferrocenylm ethyl-3-butyl)azolium ]-3- 
ferrocenylmethylazolium diiodides and l,l'-bis(l-m ethyl-3-m ethylbenzim idazolium )
ferrocenyl iodides} were synthesised. In addition, a very interesting macrocyclic 
benzim idazolium -ferrocenyl cyclophane was prepared -  b is{l-[(l,r-ferrocenylm ethyl-3-
butyl)benzimidazolium]-3-ferrocenylmethyl}benzimidazolium tetraiodide.
The action o f  these ferrocenyl-azolium  salts as highly effective auxiliary ligands in 
transition metal-mediated catalysis was shown through catalytic studies using the Heck 
reaction. Furthermore, different catalytic efficiencies o f benzimidazolium vs. imidazolium 
salts in the Heck reaction depending on the system was demonstrated in a comparitive study. 
In addition, l-butyl-3-methylimidazollium hexafluorophosphate was successfully employed 
as a recyclable, highly efficient solvent in the Heck reaction compared to DMF.
Potential biological applications of these compounds include molecular recognition 
and antimicrobial studies. Coupling the redox active ferrocenyl unit with the cationic azolium 
nucleus allowed them to be realised as ionophores. Acyclic ferrocenyl-azolium  salts 
dem onstrated evidence o f anion co-ordination in ‘H NMR anion titration experiments. Also 
screening o f a range o f  ferrocenyl-azole/azolium  compounds against P. aeruginosa and C. 
albicans showed that azolium compounds with two ferrocene units in their structure had 
highly effective antifungal properties.
Furthermore, a second co-ordination functionality was introduced into the 
ferrocenyl-azolium  system. Thus, the preparation o f a 1,1 '-disubstituted ferrocenyl salt 
system  w ith an imidazolium nucleus on one Cp ring and a diphenyl(sulphido)phosphine entity 
on the second Cp ring and a series o f 1-ferrocenylmethylazole-diphenylphosphine 
functionalised compounds was carried out. Thus, developing a range o f compounds that show 
great potential as ligands.
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Chapter 1
Azole Derivatives and Their Applications in 
Catalysis and Anion Recognition
i
1.1 Azoles -  an introduction
The azole system arguably represents one of the most ubiquitous classes of 
heterocyclic species. Their many wide-ranging applications vary from medicinal use 
as pharmaceuticals to actually being some of the building blocks necessary for life. 
They are also used in numerous more technical applications, such as electrolytes, 
components in supramolecular structures and in polymers [1 ],
The azoles can be defined as five-membered heterocycles with more than one 
heteroatom that are formally derived from pyrrole (1), fiiran (2) and thiophene (3), 
where a CH unit is replaced with an sp2 hydribised nitrogen atom. O f the nitrogen 
containing azoles, the preferred nomenclature gives them names ending in -azole. 
There are two classes of diazoles -  pyrazole (4) and imidazole (5); two classes of 
triazoles -  1,2,3-triazole (6 ) and 1,2,4-triazole (7) and one tetrazole (8).
The azoles also have benzo-analogues, where a benzene ring is fused to the azole ring, 
sharing a double bond. The parent compound for the nitrogen-based benzoazoles is 
indole (9), from which indazole (10), benzimidazole (11) and benzotriazole (12) are 
derived. The parent compounds and resulting nitrogen azoles are shown in Figure 1.1.
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Figure 1.1. (a)The five-membered parent compounds o f  the azoles, (b) the five- 
membered nitrogen-based azoles and (c) their benzo-analogues.
The azoles have a wide variety of applications with the emphasis being on their roles 
in agriculture and medicine, as they have been shown to have a wide-range of 
biologically active properties, including being bacteriostats, bacteriocides, 
insecticides, fungicides, sedatives, anticarcinogens and psychopharmacological 
agents.
Here is a brief illustration of the great diversity of properties and applications that the 
azoles have been used for: Pyrroles have traditionally been employed for drug, dye 
and anaesthetic uses, with growing interest in applying reduced pyrroles (pyrazolines) 
as chemical bleaching agents and luminescent and fluorescent substances. The 
imidazole moiety has been found in a number of naturally occurring compounds, such 
as histamine (13) [the decarboxylation product of the essential amino acid histidine
(14)], allantoin (15) [the end product of the nitrogen metabolism in some animals] and 
pilocarpine (16) [an imidazole alkaloid] (see Figure 1.2). The triazoles have been 
employed as light-stabilisers, optical brightening agents, herbicides, adhesives and as 
precursors of other biologically active agents, such as azapurines, while the tetrazoles 
have also found applications as antibacterial agents.
NH,'2
-O 0
n h 2 h2n  c °2 H s :  j— n r
n o  2
H
\ ■ \ 
HN N HN N
N
f = \
N, ,,-N i
HN NH
H2N ^  | f
o
(13) (14) (15) (16)
Figure 1.2. Some naturally occurring compounds where the imidazole nucleus has 
been found.
Imidazole is a 1,3-diazole, and can be essentially thought of as being a pyrrole 
structure with a pyridine-like nitrogen replacing a CH group at the 3-position (Figure 
1.3a). The ‘pyrrole’ nitrogen has two ^-electrons delocalised in the aromatic sextet, 
while the ‘pyridine’ nitrogen is holding its lone pair o f electrons in an sp2 orbital 
outside the ring. This addition of a pyridine nitrogen drastically affects the properties 
of the pyrrole-derived compound. Imidazole has an aromatic character, as evidenced 
by its *H NMR spectrum. The protons are not all equivalent as in benzene, but 
resonate in the aromatic region of the spectrum, showing that a ring current must be 
present. However, it also has some interesting different characteristics from its two 
parent compounds, such as increased hydrogen bonding and amphoteric properties.
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The parent compound o f  benzimidazole is indole, where again the 3-CH has been 
replaced with a nitrogen. It is a ten ^--electron aromatic system that holds a lone pair 
o f  electrons outside the ring on the nitrogen and shows aromaticity with a ring 
current, as illustrated by its *H NMR resonances. Figure 1.3 shows the electron 
density and resulting 'H NMR shifts in both compounds.
(a)
pyrrole-like w  pyridine-like pyTrole-like W  pyridine-like
nitrogen nitrogen nitrogen nitrogen
(c) 7.25 ppm 7.25 ppm
H H
HN,
' \  v
2 
H
7.86 ppm
Figure 1.3. The distribution o f  electron density in the unsubstituted (a) imidazole and 
(b) benzimidazole rings. ‘H N M R  chemical shifts fo r  (c) imidazole (CDCI3) 
and (d) benzimidazole (DMSO-dt), demonstrating aromaticity.
1.2 Applications of azoles
1.2.1 Biological applications
Imidazole and benzimidazole show hydrogen-bonding properties not seen in other 
azoles, display amphoteric properties and in general have varied chemical properties, 
hence leading to their many different applications. As it is such a large o f  class o f
5
compounds, this review will focus on the imidazole/imidazolium systems together 
with their benzo-analogues.
The imidazole/imidazolium systems have been of interest as potential therapeutic 
agents due to their biological activities. Imidazole, in particular, is found a great deal 
in nature. Its amphoteric, nucleophilic, electrophilic and solubility properties means 
that it can perform a variety of different functions in various biological pathways, 
hence it is used in enzyme reactions and other various biological processes. An 
example of this is histidine, which is found at the active sites of ribonuclease and 
several other enzymes. At physiological pH (-7.4), it is present in both its protonated 
and deprotonated forms, and as such in some enzymes its function is for proton 
transfer catalysis. For benzimidazole, indole is within the skeleton of the amino acid 
tryptophan and the indole alkaloids (biologically active compounds from plants, such 
as strychnine and LSD). Therefore, imidazoles and benzimidazoles have been the 
starting point for many therapeutic and biologically active compounds.
1.2.2 The use of azoles in transition metal catalysis
One particular area where the application of azoles -  in particular imidazoles -  has 
been expanding is that of transition metal catalysis. Transition metal-catalysed cross­
coupling processes have become some of the most important tools in organic 
synthesis. Carbon-carbon bond formation is arguably one of the most important 
synthetic procedures in organic chemistry, as it is often one of the key steps in the 
building o f complex carbon skeletons. While in the past 50-100 years, chemists had 
an array of techniques for the building of C-C bonds between saturated sp3 carbons, 
direct methods for the coupling together of unsaturated sp or sp carbons were very
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rare. However, in the 1970s transition metal-mediated cross-coupling reactions were 
discovered, and since then a wide variety of methodologies have been developed to 
the point where these transition metal catalysed cross-coupling is one of the most 
essential techniques in modem synthesis.
There is one generalised pathway for transition metal-mediated catalytic cycles -  that 
of oxidative addition/reductive elimination, which is obviously subject to minor 
variations depending on the reaction. All cross-coupling reactions have a metal 
nucleus that is able to vary its oxidation state, co-ordination numbers, reaction 
partners (an electrophile and a nucleophile) and ligands co-ordinated to the metal 
centre. The catalysts work by co-ordination of the reaction partners with the metal 
centre, and thus can accelerate the reaction in one or more o f the following ways: 
bringing the reaction partners into close proximity, activating a reaction partner and/or 
facilitating nucleophilic attack. The simplified catalytic cycle of a transition metal- 
mediated reaction is outlined in Scheme 1.1.
Reaction E+
Kumada RMgX
Negishi RZnX
Negishi RZr
Suzkui-Miyaura RBX,
Stille RSnR3
Buchwald-Hartwig R2NH 
Buchwald-Hartwig ROH 
Buchwald-Hartwig RSH 
Heck RC=CR
Ligand
substitution
Scheme 1.1. Generalised catalytic cycle fo r  transition metal-mediated reactions.
R Nu v
L„M(0)
R— X
Reductive
elimination
Oxidative
addition
L m :
n 'Nu
7
Here the metal centre enters the cycle in an oxidation state of 0 [stabilised by 
ligand(s)], whereupon oxidative addition o f the electrophile into the complex causes 
the oxidation state to increase to +2. The electrophile is nearly always an 
organohalide or triflate. Aryl, vinyl, allyl and benzyl groups can all be used as 
substrates. The ligand substitution/transmetallation/migration steps are unique to each 
reaction but generally the nucleophile will enter the cycle with some change in the 
geometry of the intermediate complex and replacement of the halide/triflate. On 
reductive elimination, the two organo species are coupled together (therefore they 
must be cis in the intermediate complex) allowing the release of the product and 
regeneration of the catalyst in the 0 oxidation state.
The metal centre must be able to exist in a variety of oxidative states, especially a co-
— 8 10ordinatively unsaturated state. The late transition metals (d , d  ) show a greater
ability to do this. Therefore, Ru, Co, Ni, Pd and Pt are the most important metal
centres used in cross-coupling catalysis, with palladium and nickel being the most
commonly used.
However, it is the ligand that aids the metal in its co-ordination properties and, thus, 
really determines the catalytic efficiency of the complex. Through ligand variation, a 
high specificity of the metal centre towards the incoming reaction partners can be 
tailored. Furthermore, the ligand should be able to stabilise the different co-ordination 
states and activate the zerovalent metal centre towards the oxidative addition of the 
electrophile. Therefore, control of product selectivity can be achieved by careful 
selection of the ligand.
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Traditionally triarylphosphines have been used as ligands. These ligands are both 
electron rich and sterically demanding. It has been shown that the electron-donating 
ability o f the phosphines, together with their bulk increases their catalytic efficiency 
[2,3]. The combination of these electronic and steric effects has made the phosphines 
the most popular choice for organometallic catalysis. They are able to stabilise the 
zerovalent metal centres, while allowing competing ligands to co-ordinate to the metal
However, the alkylphosphines have certain drawbacks: they can be expensive and 
time-consuming to prepare, they require air and moisture free environments to prevent 
ligand oxidation and, most importantly, they suffer from P-C  bond degradation at 
elevated temperatures, leading to deactivation of the catalyst. Thus, work is ongoing 
in the design of cheaper, air-stable ligands, of which carbene ligands are proving to be 
the most promising.
1.2.2.1 Azoles as N-Heterocyclic carbene ligands in co-ordination compounds
Carbenes are defined as neutral organic species where the carbon atom has only six 
electrons in its valence shell and has a valence of two. In organic chemistry, carbenes 
are highly reactive electrophilic transient intermediates that are very rarely isolated 
due to their electron deficiency. However, it was realised in the early 1960s by 
Wanzlick [5-11] that if electron-donating substituents were placed adjacent to the 
carbene centre then the species maybe stabilised. This led to the development of 
azolylidene units as carbene ligands in co-ordination chemistry. For example, 
complexes (17) and (18) were reported, which were obtained from imidazolium salts
9
and metal compounds containing ligands o f sufficient basicity to deprotonate the 
imidazolium 2-CH and produce the carbene in situ (Scheme 1.2).
r CH [HCr(CO)s] CH,
CH,
-H,
-Cr<CO)6
CH,
(17)
Ph
N
+ I
! ^ N
Ph
[C IO J - Ph Ph
Hg(OAc)2 N
------- ^ I \  /  |
-2AcOH -H g -
N N
Ph Ph
2PO,:
(18)
Scheme 1.2. Examples o f the first N-heterocyclic ligands prepared by Wanzlick.
It was not until the early 1990s, though, that the first free ,'V-heterocyclic carbenes 
using imidazolium precursors were characterised. Ardunego et al. [12] in 1991 
successfully prepared and isolated l,3-di-l-adamantylimidazolylidene (19) (Scheme 
1.3). Its characterisation led to a renaissance in the preparation o f N-heterocyclic 
carbenes with the imidazolium salt systems being the foremost investigated.
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Scheme 1.3. The first isolated imidazolylidene carbene prepared by Ardunego et al.
In these nucleophilic carbene systems, the two non-bonded electrons may either be 
paired (singlet state) or unpaired (triplet state). The singlet carbenes have a filled and 
a vacant orbital, whereas the triplet carbene has two singly occupied orbitals and is 
regarded as a diradical (Figure 1,4a). If  the groups adjacent to the carbene centre are 
electron-donating, they can interact with the vacant /^-orbital of the singlet state via 
electronic mesomeric effects and stabilise the singlet state with respect to the triplet 
state. Also the /V-heterocyclic carbenes possess an electron-withdrawing inductive 
effect, yielding a ‘push-pull’ effect [13,14] that ensures that all ¿V-heterocyclic 
carbenes are nucleophilic singlet carbenes. Thus, the azole moieties make very good 
precursors for carbenes due to their electronic structures.
The chemical properties o f these nucleophilic ligands have been investigated by many 
researchers, the most prominent of which include Herrmann et al. [15 and Refs, 
therein], Ofele et al. [16], Kuhn et al. [17-21], Enders et al. [22-25], Teles et al. [26] 
and others [27-32]. These studies have focused on using the ALheterocyclic carbenes 
as ligands in co-ordination complexes and their application in transition metal 
catalysis. Furthermore, studies on their stability and electronic structure have also 
been reported [33-36]. The /^-heterocyclic azole carbenes that have been prepared 
and employed as ligands for transition metals are shown in Figure 1.4.
(a)
O
Singlet state carbene
\ } C  
—  c — 
, " I A
Triplet state catbene
(b)
N N N N N N
(20)
r " N\
N N 
R R
(21) (22)
R
\
L N
\
- M -
(23) (24)
Figure 1.4. (a) Singlet and triplet state carbenes. (b) Free azole carbenes:
imidazolylidenes (20), imidazolinylidenes (21), benzimidazolylidenes
(22) and triazolylidenes (23). A typical azolylidene complex (24).
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The method for generating these carbenes involves deprotonation o f the 
dialkylazolium salt usually using potassium i-butoxide in tetrahydrofiiran (THF) 
(Scheme 1.4).
Mes Mes
N
+
N
KO'Bu
------- a
THF
C:
N
Me
Mes =
Me
Mes Mes Me
Scheme 1.4. Typical formation o f  an imidazolylidene carhene from  a 1,3- 
dialklyim idazolium salt.
However, apart from physical studies on the imidazolylidenes, these free carbenes are 
very rarely generated and isolated, instead they are usually converted directly into the 
desired complex. This is achieved in two ways. The first involves the generation of 
the carbene using potassium /-butoxide in the presence of a metal complex (it has 
been found that free carbenes can easily replace several different types of ligands, e.g. 
halides, alkenes, carbonyls, arenes and phosphines [37]) (Scheme 1.5a). The second 
involves reaction of the precursor azolium salt with a metal complex containing basic 
ligands, e.g. the acetate anion (Scheme 1.5b).
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(a)
N '-R
Cl
(b)
*R !
(i) LiO'Bu, (ii) [Rh(COD)CI2] 
THF, 25°C, 16 h
(iii) TIPF0
21
\ ♦
.N.
Pd(OAc)2
DMSO, 140°C
V .  '>  Rh \
\ 1
PF„
N-
r- • \
N N 
I — Pd— I 
N
Scheme 1.5. Formation o f N-heterocyclic carbene ligands.
As expected these carbenes act as neutral two electron donor ligands. They exhibit 
strong cr-bonding tendencies with no significant /r-backbonding. Thus, it has been 
found that they are better electron donors than the phosphine ligands [38-40], It was 
perceived that they could not only act as phosphine mimics but could actually 
outperform them in transition metal catalysis.
These azolylidene ligands have shown great promise as auxiliary ligands. Due to the 
excellent ¿r-bonds formed between the metal and carbon, they have shown great 
thermal stability [41,42], appear to be strong co-ordinating ligands that undergo little 
to no dissociation to the metal in solution [43] and act as non-participating ligands 
that are not consumed in the catalytic process [44,45]. Therefore, they compare 
favourably in all aspects to the phosphines. Furthermore, due to the nature of the azole 
entity various substituents can be introduced that can affect the electronic properties,
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steric demands and chirality of the ligand. Thus, the azolylidene carbenes satisfy the 
criteria of being efficient catalytic ligands in organometallic cross-coupling reactions.
The following reactions give an idea of how the azolylidene ligands have been 
applied in transition metal-mediated cross-coupling reactions: Sukuzi coupling 
[46,47], aryl amination [48], amide a-amination [49], hydrosilylation [50], 
ethylene/carbon monoxide copolymerisation [51], Kumada coupling [52,53], the 
Stille coupling [54], furan synthesis and alkyne coupling [55], olefin cyclopropanation 
[56], arlyation and alkenylation of aldehydes [57], reduction of aryl halides [58] and 
in asymmetric catalysis [40]. It should be noted that while co-ordination compounds 
o f the imidazolylidenes, imidazolinylidenes, benzimidazolylidenes and triazolylidenes 
have been prepared, so far in the vast majority of cases it is imidazolylidenes that 
have been applied to organometallic catalysis.
1.2.2.2 Heck reaction
The Heck reaction (Scheme 1.6) is the palladium-catalysed arylation of alkenes that is 
now one o f the most versatile tools in organic synthesis for the creation of C-C 
bonds. It was first pioneered by both Heck [59] and Mizoroki [60] independently in 
the late 1960s, and through much further investigation of its scope, it is now one of 
the simplest methods of synthesising various substituted olefins, dienes and other 
unsaturated compounds.
H Ar /
PdX, / 2L 'y
i + ArX + Base
\
Scheme 1.6. The Heck reaction.
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In the Heck reaction the electrophile can be an aryl, heterocyclic, benzylic or a vinylic 
halide/triflate. A Pd(II) compound, such as palladium dichloride or palladium acetate 
is the most widely employed type of catalyst. Although the reaction can be carried out 
using just the Pd(II) salt, it has been shown the reaction will proceed far more 
effectively if  specific ligands are employed. The most generally used ligands are the 
triarylphosphines. However, as the Heck reaction is so wide ranging the tailoring of 
ligands to particular reaction partners and conditions is sometimes either desirable or 
necessary.
In the Heck reaction, the nucleophiles are usually mono- or 1,1-disubstituted alkenes 
as they are more reactive. Generally as the substitution number in the alkene increases 
the reactivity decreases, to the point where there are only a few limited examples of 
trisubstituted alkenes undergoing cross-coupling [61]. Aprotic solvents, such as NJJ- 
dimethylformamide (DMF), dimethyl sulfoxide (DMSO) or acetonitrile, are typically 
used. Finally, a base is essential in the catalytic cycle and is either a secondary or 
tertiary amine or a sodium/potassium acetate, carbonate or bicarbonate salt.
The mechanism of the Heck reaction (Figure 1.5) can be divided into four main steps: 
the preactivation, oxidative addition, ligand substitution, migratory insertion and 
reductive elimination.
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Figure 1.5. The mechanism o f  the Heck reaction.
1.2.2.3 Azolium/palladiunt systems in the Heck reaction
The Heck reaction was one of the first transition metal-mediated reactions to which 
the novel TV-heterocyclic carbene co-ordination compounds were applied. Herrmann et 
al. showed that complexes (25) and (26) were able to couple aryl bromides and aryl 
chlorides to aikenes in yields of 99% [62]. Furthermore, it was shown that the 
precursor to (25) -  l,3,dimethylimidazolium iodide (27) -  could be introduced into 
the reaction and generate the coupled product in comparable yields to 25 and 26, thus 
eliminating the need to prepare the palladium complexes (25 and 26) beforehand 
(Scheme 1.7).
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(25)
Scheme 1.7. First use o f  imidazolylidene complexes in the Heck reaction.
Other groups have also employed imidazolylidene ligands in the catalysis of the Heck 
reaction. Nolan et al. employed very facile imidazolium salt/palladium systems to the 
Heck reaction (Scheme 1.8) [62,63], This group has shown that it is not necessary to 
prepare the carbene co-ordination compound beforehand. They also found that bulkier 
imidazolium chlorides possessing JV-aryl o/t/zo-substitutents displayed the best 
constant activity when used with palladium acetate. Imidazolium precursors 
(28a)-(31a) were tested along with their imidazolinylidene analogues (28b)-(31b) 
(Scheme 1.8). It was found that 2,4,6-trimethylbenzene imidazolium salt (30a) 
yielded the best overall catalytic system [63] when used for the coupling of 
arylbromides.
H2C Pd
N'I
\ Me' N ^ ,N  M(; /  Pd<Ac0>2
-Me
(26) (27)
-Br +
___ COjBt
2 mol% Pd(OAc)z 
4 mol% L
CszC03 / DMAc /1 h/120°C
L = Cl
R =
(28a)
\ _ J ~
(29a)
\\ / r  
(30a)
90%
13%
94%
Cl
! r ^ u ì . n  r
(28b)
26%
■ S _ J
(30b)
64%
C 02Bt
(31a)
66% 90%
(31b)
Scheme 1.8. The investigation o f  Nolan et al. in the electronic and steric effect o f  the 
imidazolium precursor on reaction rate.
A number of reports are given in the literature about the application o f the 
imidazolylidene complexes and the imidazolium salts to the Heck reaction. There 
have been comparisons of mono, bi and tridentate carbene systems (e.g. 32) and 
mixed carbene/nitrogen donor systems (e.g. 33) [46,64,65] (Figure 1.6).
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Figure 1.6. Chelate imidazolium and mixed carhene/nitrogen donor systems that have 
been applied to the Heck reaction.
Nolan et al. [62] prepared a mixed carbene/phosphine imidazolium chloride that 
showed comparable results to the monodentate imidazolium chloride salts employed 
(Figure 1.7).
A .  N íiíN *\ v  ^
(34)
PPh,
Br
Figure 1.7. The mixedphosphine/carbene system (34) used by Nolan et al.
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1.2.3 Azoles as solvents in organic processes
1.2.3.1 Ionic liquids
Chemistry is dominated by the study of species in solution. Any refinement or 
improvement upon the existing range o f solvents used in synthetic techniques is of 
much interest to chemists. So the discovery of ionic compounds that have melting 
points at or below 298 K (fused salts) -  the so-called ‘ionic liquids’ -  has created a 
very lively avenue of research, as they have the potential to create new solvent 
systems for the many varied preparative reactions that are used commercially (for 
fully comprehensive reviews see Refs. [66,67]).
They offer many advantages over traditionally used organic solvents. They are:
• Non-volatile -  no measurable vapour pressure, so product recovery by distillation 
is possible, which may not be the case with some organic solvents used 
commercially. Also there is no evaporation with ionic liquids, so there would be 
no release of volatile organic compounds (VOCs) as is associated with organic 
solvents.
• Wide liquid range -  they are thermally stable up to 400°C, so distillation of 
compounds is possible at high temperature.
• Chemically stable -  no special conditions need be applied to due chemical 
sensitivities.
• Ability to dissolve a wide range of organic, organometallic and inorganic 
compounds -  so a wide range o f possible reactions can be carried out, including 
catalytic systems.
• Immiscibility with a wide range of organic solvents -  allows biphasic systems to 
be set up.
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• Controllable physical properties -  melting point, density, viscosity, liquidus 
range, miscibility with other solvents, polarity and co-ordination properties can all 
be fine-tuned with careful selection and adjustment of anion and cation.
Ionic liquids are typically composed of an organic salt. As they are fused salts (i.e. 
liquids that are composed solely o f ions), they resemble ionic melts, but whereas very 
high-temperatures are required to produce melts (800°C for NaCl), ionic liquids 
remain liquid at room temperature and below -  even to -96°C.
There are four types of ionic liquids grouped according to the cation (Figure 1.8). 
Generally they are based on a bulky cation coupled with a wide variety of anions (e.g. 
PF<f, N (V , AlCLf).
]Ai3cr r —  “ p f 6-
i ' ' + N_Et I N N I
[NRnH ^ ]+ BR ; [PR„H4J + X - | ! Bu Mei
(35) (36) (37) (38)
Figure 1.8. The four types o f  salts that form  ionic liquids: (35) alkylammonium, (36) 
alkyphosphonium, (37) N-pyridinium and (38) 1,3-dialkylimidazolium 
salts.
The alkylammonium and alkyphosphonium have been shown to be hydrophobic and 
have limited applications due to their low conductivity, instability and difficulty of 
preparation [68,69], while the ionic liquids based on 1-methylimidazole are becoming 
the most commonly used systems.
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1.2.3.1.1 Ionic liquid development
Ambient temperature fused salts have been know since 1913, for example 
[EtNH3][NC>3], which has a melting point o f 12°C [70], However, it was in the 1950s 
that they became something of a chemical curiosity with the study of alkylpyridinium 
chloroaluminate-based ionic liquids (37). Then it was in the 1980s with the discovery 
of the room temperature imidazolium-based chloroaluminates, with their wider 
liquidus range and high conductivity, that the ionic liquids became a serious research 
interest.
1.2.3.1.1.1 Chloroaluminates(III)
Aluminium chloride-vV-ethylpyridinium bromide ([vV-etpyJBr-AlCb) (37) was the first 
chloroaluminate to be discovered as a molten salt at room temperature [71]. The range 
of aluminium chloride-iV-alkylpyridinium halides was then extended with the 
synthesis of aluminium chloride-yV-butylpyridinium chloride ([vV-bupyJCl-AlCb) 
(38), one of the most extensively investigated ionic liquids [72]. In the 1980s, a series 
of 1,3-dialkylimidazolium ionic liquids were developed that were found to have a 
wider liquidus range, higher conductivity and were easier to prepare. Of these 
aluminium chloride-1 -ethyl-3 -methylimidazolium ([EMIMJCl-AlCb) (39) and 
aluminium chloride-1 -butyl-3-methylimidazolium ([BMIMJCl-AlChEt) (40) have 
been the most widely studied systems (Figure 1.9).
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Figure 1.9. The most studied chloroaluminate ionic liquids.
It was thought that the adjustable acid-base properties of the room-temperature 
chloroaluminates would make them attractive solvents for acid-base dependent 
chemical processes. However, the 1,3-dialkylimidazolium chloroaluminate(III) 
species are extremely air and moisture sensitive and so must be protected rigorously 
from moisture and other oxide impurities [6 6 ]. Also there is a tendency of many 
substrates to react with halometallates, presenting further problems. Thus, their 
application to organic synthesis was limited.
1.2.3.1.1.2 Air and moisture stable azolium ionic liquids
The area of ionic liquid chemistry was renewed in 1992 by the discovery of Wilkes et 
al. [73] and Fuller et al. [74] of the air and moisture stable ionic liquids. These were 
initially based on the 1-ethyl-3-methylimidazolium ([EMIM]+) cation. The inert salts 
that were produced were shown to have low melting points, with the [EMIM]PF6 salt 
having a melting point range of 58-60°C, while the BF4“ and CH3COO- salts had 
melting points of 15 and -45°C, respectively.
The [BMIM]+-based BF4- and PF6~ salts then followed from Suarez et al. in 1995 
[75], and then in 1996 Bonhote et al. [6 8 ] synthesised a series of 1,3- 
dialkylimidazolium salts. A great variety of cations with different alkyl groups at the 
C(2), C(4) and C(5) positions of imidazole were combined with a variety of inorganic
anions, such as CF3COO“, CF3SO3-, C4F9 SO3- and (CF3S0 2 )2N~. They all possess 
melting points below room temperature, furthermore, they possess low viscosities, 
were air and moisture stable and were inexpensive to prepare. These characteristics 
coupled with the fact that they could solubilise a wide range of organic and inorganic 
compounds, meant that their applicability to classical organic chemistry could be 
realised.
The specific properties of the moisture stable imidazolium ionic liquids that make 
them so suitable as solvents for organic processes are:
i. their high degree of thermal stability up to 400°C [76];
ii. their chemical stability -  they are non-flammable, stable against strong reducing
metals, such as sodium and lithium, and have shown great inertness to organic 
reagents in synthesis;
iii. have controllable miscibility with organic reagents [68,77,78];
iv. are polar compounds, thus are able to dissolve inorganic compounds (i.e.
catalysts).
1.2.3.2 Synthetic applications o f  the ionic liquids
The ionic liquids can be applied for use in (i) classical organic synthesis and (ii) 
biphasic catalysis. The most important application of the ionic liquids is the 
employment of the neutral, moisture stable ionic liquids for biphasic catalysis.
1.2.3.2.1 Classical organic synthesis
The chloroaluminates, of which the acidic [EMEMJCl-AlCb is the most widely used, 
are employed as solvents for reactions that are typically catalysed by AICI3.
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The Friedel-Crafts acylation was the first reaction to be thoroughly investigated in the 
chloroaluminate ionic liquids. Wilkes et al. successfully used the acidic 
[EMIM]C1-A1C13 system for the Friedel-Crafts alkylation and acylation of simple 
benzene derivatives [6 6 ]. More recently, it has been shown that Friedel-Crafts 
acylation in ionic liquids can be applied to organometallic compounds in 
[EMIMJI-AlCh, with ferrocene being acetylated with either acid anhydrides or acid 
chlorides and the rate of reaction and selectivity (mono or bis substitution) being 
controlled by the AlCb concentration in the melt [79] (see Scheme 1.9).
The acylative cleavage of ethers, in which a variety of cyclic and acyclic ethers were 
cleaved using benzoyl chloride to give difunctionalised iodobenzoate adducts [80] 
(see Scheme 1.10), was carried out in [EMIM]C1-A1C13.
Scheme 1.10. The acylative cleavage o f cyclic and acyclic ethers in chloroaluminate 
melt.
O
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Scheme 1.9. Friedel-Crafts acylation o f ferrocene.
O
R + R— Cl
The use of the moisture stable ionic liquids has grown rapidly in recent years, as due 
to the ease o f their handling, it appears that they can be applied to any synthetic
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procedure. One of the most important classical organic reactions in which they have 
shown to be excellent solvents is the Diels-Alder reaction. The reaction between 
cyclopentadiene and methyl acrylate was shown to proceed well in [EtNH3]N0 3 , 
[BMIM]BF4, [BMIM]C104, [EMIM]CF3S 03) [EMIM]N03 and [EMIM]PF6 [81-83]. 
These ionic liquids gave a high endo selectivity and reactions proceeded at a faster 
rate compared to non-polar solvents.
Furthermore, in the only instance where the ionic liquids have been used purely for 
their Lewis acidity, rather as solvents, they were used as recyclable Lewis acid 
catalysts for the Diels-Alder reaction [84], Using cyclopentadiene and either 
methacrolein or crotonaldehyde, the imidazolium salts were added to the system in 
catalytic quantities (0.2 eqs.) in dicholoromethane (with no other Lewis acid present) 
and were found to catalyse the reaction, demonstrating that even the simple, neutral 
imidazolium-based ionic liquids were able to act as Lewis acids (see Scheme 1.11).
CO,Me -r
C 02Me
C 02Me
endo exo
N .'-.N
Br
CF,COO
L ^  J
N .N
Br'
Methacrolein 
Yield Endo/exo
40 15:85
40 13:87
40 10:90
Scheme 1.11. Catalysis o f  Diels-Alder reaction using 1,3-dialkylimidazolium salts.
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1.2.3.2.2 Biphasic catalysis
Biphasic catalysis is usually based on the transposition of known reactions from a 
one-phase homogenous system (solvent phase) to a two-phase homogenous system 
(ionic liquid and solvent/reagents phases). With the catalyst dissolved in the ionic 
liquid phase and the reactants forming an organic phase to be collected by 
decantation, extraction or distillation.
One of the best investigated applications of the ionic liquids to transition-metal 
catalysis and the development of a two-phase homogenous system from a one-phase 
system using ionic liquids is the nickel-catalysed oligmerisation of short chain alkenes 
in the chloroaluminate melts. Industrially, these reactions are used for the synthesis of 
polyethylene co-monomers or intermediates for the preparation of detergents, 
plasticisers and lubricating oils. However, the processes involved suffer from 
expensive catalysts, poor catalyst isolation and recovery leading to high operational 
and environmental costs.
In 1990, Chauvin et al. carried out the dimerisation of propene to hexenes using 
various organochloroaluminate salts, such as [BMIMJCl-AlCb and [bupyJCl-AlCh, as 
the solvent and various NiX2L2 (L=methylallyl or phosphine ligands) complexes as 
the catalyst [85]. This reaction has been extended to the oligmerisation of ethylene 
[8 6] and butene [87,88],
One of the most impressive examples of the oligomerisation of alkenes in 
chloroaluminate solvents was the use of the nickel catalyst [(cod)Ni(hfacac)] 
(cod=cyclooct-4-ene-l-yl) in acidic [iV-bupyJ-AlCh with the addition of an organic
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buffer such as vV-methylpyrrole. These conditions yielded the linear dimerisation o f 1- 
butene in a 98% selectivity [89] (Scheme 1.12). It was also found that the catalyst 
remained contained in the ionic liquid to be reused.
Scheme 1.12. Oligomerisation o f 1-butene in a chloroaluminate melt.
In biphasic catalysis, often the Lewis acid properties of the moisture/air sensitive 
organochloroaluminate salts are not required and actually can prove problematic. As a 
result the moisture stable neutral ionic liquids are becoming ever more popular. As 
such a wide variety of different transition metal-mediated reactions have been carried 
out in these neutral (i.e. non-acidic) ionic liquids.
An example to illustrate the use of the moisture stable imidazolium salts in biphasic 
catalysis is their application to hydrogenation reactions. It was shown that these ionic 
liquids could be reused as the products could be simply isolated by filtration and that 
negligible leaching of the catalyst from the ionic liquid phase into the organic layer 
occurred. Thus, the catalyst could be immobilised in the ionic liquid without specially 
designed ligands, as was previously required, and the catalyst could be recycled for 
further use.
[bupy] Me / AICI3 / base
n-octenes
methylheptenes
dimethylhexenes
De Souza and Dupont et al. first showed this in 1995 using the Wilkinson’s complex 
[RhCl(PPh3)] to hydrogenate cyclohexane in [BMIM]BF4 and [BMIM]PF6 [75]
(Scheme 1.13). Although there was no noticeable difference in the reaction rate 
compared to conventional solvents, the ease of product isolation by simple 
décantation and recycling of the catalyst was shown.
C 02Me + H2
[Pd] ---------- »»
C02Me
Scheme 1.13. Selective hydrogenation o f  methyl sórbate.
This has been extended, with all of the classical Ru, Rh, Co and Pd catalytic systems 
having been successfully carried out in the ionic liquid-organic system for the 
hydrogenation o f simple olefins, conjugated dienes and arenes, such as benzene, 
toluene and cumene, [90] in the 1-butyl-3-methylimidazolium ([BMIM]+) salt 
systems. Furthermore, asymmetric hydrogenations with the hydrogenation of 2- 
arylacrylic acids using the chiral Ru-BINAP catalyst in [BMIM]BF4 was successfully 
carried out with enantiomeric excesses of 8 6% [91]. Also (5)-Naproxen (41) was 
synthesised in this procedure in 80% e.e. (Scheme 1.14).
H
Me
[BMIM]BF4 / /-PrOH
(41)
Scheme 1.14. Formation o f (S)-naproxen in an ionic liquid.
Other transition metal-mediated processes utilising a biphasic ionic liquid system as a 
means of immobilising the catalyst include, for example, hydroformylations and
oligomerisations. See Ref. [92] for a comprehensive review o f ionic liquids in 
catalytic processes with an emphasis on industrial application.
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1.3.1 Electrochemical sensing of anions
In order for a sensing device to be realised, the exploitation of a host-guest 
interaction is necessary, where upon this can be converted into a measurable signal -  
transduction. Therefore, for molecular sensing, a molecule that will undergo some 
physical or chemical transformation on interaction with an incoming (guest) species is 
required. For practical application of the compound in sensor technology, it is 
essential that the host molecule is selective for one species, while being unresponsive 
to others, and that the binding interaction is reversible.
Another important essential consideration in a sensor may include the immobilisation 
of the host into a polymer membrane. Thus, there have been various approaches 
towards the development o f novel molecules capable of detecting small molecular 
guests. There are two main transduction modes used in molecular recognition: 
electrochemical and optical methods [93].
In the electrochemical methods, usually a transition or lanthanide metal is used in an 
organometallic compound or an inorganic complex for both guest binding and 
electrochemical signalling through changes in the metal redox potential on 
anion-receptor complexation.
In the optical methods, molecular recognition occurs when the proximal association of 
the guest and host molecules causes either a quenching or enhancement of a 
chromophore’s absorption or a fluorophore’s fluorescence.
1.3 Anion recognition
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The most popular technique is that of electrochemical sensing based on the shift of 
metal redox potential as measured by cyclic voltammetry. The most common design 
o f a chemoreceptor has a metal redox centre coupled to organic appendages capable 
o f the selective co-ordination with molecular guest species (Figure 1.10). This brings 
the guest into close proximity to the redox centre perturbing its electrochemical 
properties and producing a measurable shift in redox potential. The host-guest co­
ordination is usually through electrostatic interactions, hydrogen bonding and/or 
ion-dipole attractions.
—  \  I >
X=Host, G=Guest
G t
Figure 1.10. The production o f an electrochemical response generated from the 
reversible receptor guest-host interaction.
To achieve specificity in designing a host, guest/host functional group topology in the 
binding site needs to be considered. It has been shown that acyclic host molecules can 
conform to a three-dimensional structure, sometimes being able to wrap around a 
guest (Figure 1.11). However, macrocyclic hosts have shown superior selectivity 
being able to discriminate between guests due to the set geometry o f the cavity 
[94,95],
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Figure 1.11. Fixed form versus free form o f  host-guest recognition.
While the field of cation recognition has long been established, the corresponding 
area o f anion recognition has lagged behind. Although the first synthetic host receptor 
was first developed in the 1960s, it has only been over the last decade that the co­
ordination chemistry of anions to host molecules has became such a lively area of 
research. This is perhaps surprising considering the ubiquitous roles that anions play 
in numerous biological and chemical processes and their importance in medicine and 
the environment.
For example,
• In chemical processes -  anions act as catalysts, bases, redox mediators and 
reagents. The use of receptors could alter their chemical reactivity, aid mixture 
separation or stabilise unstable species
• In biological processes -  anions are essential in many metabolic systems and also 
carry genetic information, e.g. DNA is a polyanion and the majority of enzyme 
substrates and co-factors are anionic.
• In medicine -  anions are of great importance in pathological pathways. For 
example, cystic fibrosis is caused by a misregulation of chloride channels [96] and 
Alzheimers has been linked to anion-binding enzymes [97].
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• In the environment -  anions pose a large pollution problem. Pollutants such as 
nitrates and phosphates in soil water have been linked to the eutrophication of 
rivers
Therefore, there is a clear need for anions to be monitored, detected and extracted. So 
consequently, the selective binding and sensing of anions is necessary.
As has already been seen in nature, a complementary relationship between host and 
guest is essential. An example of this in nature is the phosphate binding protein (PBP) 
that transports phosphate ions into bacteria cells. The precise positions of the 
hydrogen bond donor groups in the active site of PBP match the hydrogen bonding 
oxygen atoms o f the tetrahedral phosphate ion and do not allow binding with other 
anions. For the PBP-phosphate complex, the dissociation constant ^ d = lx l0 -6 M at 
pH 8.3.
By bringing together of many different binding elements, such as geometry, 
functional group topology, exact dipoles and hydrogen bonding, a system can achieve 
high specificity. The design of synthetic macrocycles should aim to match the 
selectivity of naturally occurring supramolecules. Therefore, some of the most 
selective anion receptors that have been prepared have been macrocyclic with clefts or 
cavities allowing only a guest with a very specific geometry access.
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The design of ionophores capable of anionic recognition has always been regarded as 
a challenge, and the various factors that must be considered in the design of these 
molecules include:
• Anions are larger than isoelectronic cations, so will have a lower charge to radius 
ratio, meaning that electrostatic binding interactions will be less effective.
• Anions have a variety of structures -  such as spherical (e.g. Hal”), linear (e.g. 
CN~), triagonal planar (e.g. NO3 '), tetrahedral (e.g. SO4-), octahedral (PFg-) and 
complex geometries (e.g. DNA double helix) -  that must be catered for.
• Many anions are typically pH sensitive (e.g. PO4, F”), as they have a tendency to 
become protonated at low pH values losing their negative charge. So a receptor 
must function within the pH window of the target anion.
• Solvent effects play a crucial role in the control of the binding strength and 
selectivity of an anion. A receptor is effectively competing with the solvent 
environment for electrostatic/hydrogen bonding interactions with the anion.
While the design of anion receptors is in its relative infancy and has more inherent 
difficulties than that of the well-established field of cation receptor technology, there 
have been various approaches to their design. The variety of these approaches arises 
from the different possible interaction modes between the host molecule and the guest 
anion. These interactions can be:
1.3.2 Design of anion receptors
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(i) purely electrostatic as in the macrocyclic quaternary mmonium hosts (42) and (43) 
[98-103] (Figure 1.12).
Me CH2PhCOO
N ’
(CH2)a.
(CH2)6 <Cl^ e
/ \
(CH2)e,
Me
OOCPhCH2
(CH2)0
(c h 2)6
Me
(CH2)6
N
Me CHjPhCOO
(42) (43)
Figure 1.12. The anion host molecules relying on electrostatic attraction only,
(ii) based on hydrogen bonding, such as the first hydrogen bonding amide anion 
receptor (44) [104] (Figure 1.13). Therefore, good hydrogen bond donors, such as 
simple amide, urea and thiourea, have made very effective anion receptors [105].
0
Figure 1.13. An amide-basecl anion receptor using only hydrogen bonding fo r  anion
O
(44)
co-ordination.
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(iii) or can be a combination of both hydrogen bonding and electrostatic interactions. 
In fact in many of the nitrogen-based anion receptors both hydrogen bonding and 
electrostatic interactions are involved, especially with heterocycle based receptors.
(iv) alternatively, electron deficient Lewis acidic centres have been employed for 
anion co-ordination. There are many novel receptors containing atoms such as 
boron, mercury, silicon, germanium and tin. The preparation and anion 
recognition studies of tin macrocycles (45) and (46) provide an example (Figure
1.14) [106].
Ph2Sn------(CH2) ------ SnPh2
(CH2)
(CH2)
Ph2Sn SnPh2 ( a y  (CH2)
Ph2Sn------(CH2) ------ SnPh2
(45) (46)
Figure 1.14. The incorporation o f tin atoms into macrocycles fo r  anion receptors 
based on Lewis acid co-ordination.
Therefore in the design of an efficient ionophore, the mode of host-anion co­
ordination is an important point to consider. While effective receptor systems have 
been based on the electrostatic interaction model, this does suffer the drawback of the 
host’s counterions interfering in the recognition or in fact simple anion exchange 
maybe the phenonmen that is being observed. Hydrogen bonds are directional, and 
thus, allow the possibility o f designing host molecules with receptor cavities with 
specific topologies so that anions with differing geometries and functionality's can be 
selected for.
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These systems have only very recently begun to be investigated as potential anion
receptors. In 1999, Sato et al. recognised that 1,3-dialkylimidazolium salts could act
as an alternative to the ammonium and guanidinium groups that were being used as
binding sites for anions in receptor molecules. These two groups form stable
host-guest complexes through both electrostatic force and hydrogen bonding (Figure
1.15).
1.3.3 1,3-Dialkylazolium compounds as anion receptors
(47) (48)
Figure 1.15. (a) An ammonium receptor (47) fo rN A D + and a guanidinium receptor 
(48).
As has been established through the structural studies of 1 -ethyl-3 -methylimidazolium 
salts [107], the imidazolium cation is capable of both electrostatic interaction and 
hydrogen bonding with anions. Thus, Sato et al. performed initial *H NMR binding 
studies on 1 -methyl-3-methylimidazolium hexafluorophosphate (49), which showed 
significant downfield shifts of the imidazolium 2-H in deuterated acetonitrile. They 
then prepared dipodal and tripodal systems (50) and (51), which contain a potential 
binding cavity [108] (Figure 1.16). Through 'H NMR titration studies, ESI-MS and 
molecular modelling, it was shown that these compounds bind strongly to chloride, 
bromide and iodide anions.
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Bu
(51)
R = H, Me
Figure 1.16. The imidazolium systems (49)-{51) employed by Sato et al. showing 
anion recognition properties.
Howarth et al. [109] took this tripodal system and introduced chiral substituents. This 
horaochiral tripodal imidazolium salt (52) (Figure 1.17) was then shown to be able to 
distinguish between anionic enantiomers. Using 'H  NMR spectroscopy, it was shown 
that 52 formed a complex with (J?)-2-aminopropionate when added to a racemic 
mixture of sodium 2-aminopropionate. A downfield shift in the «-proton o f the 
proponiate was observed, while there was no shift in that of the (S) enantiomer. Thus, 
leading to the conclusion that this system was able to differentiate between 
enantiomers.
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Figure 1.17. Homochiral tripodal imiazolium salt (52) capable o f  differently binding 
between (R)-2-aminopropionate and (S)-2-aminopropionate.
Macrocyclic imidazolium cyclophanes, although not a recent discovery, have only 
just begun to be applied to anion recognition. In 1998, Alcalde et al. prepared the 
imidazolium cyclophane (53) and reported that the introduction of different 
tetrabutylammonium salts caused significantly varying downfield shifts for the 
imidazolium 2-H in the order H2P0 4  >F">CH3C0 0 ”>CN_>C1” [110]. This was 
extended by Yuan et al. who prepared imidazolium and benzimidazolium cyclophanes 
[111]. Compound 54 was found to be able to bind selectively to chloride (Figure 
1.18). Using UV-Vis spectroscopic titration measurements along with !H NMR 
titration experiments, it was shown that the binding constant for chloride was 
4.06x104 M"1, which was 2, 5 and 2000 times that of bromide, fluoride and iodide, 
respectively.
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Figure 1.18. Imidazolium cyclophanes studied fo r  selective anion recognition.
1.3.4 Metallocene-based anion receptors
The classical sandwich metallocene has the formula M (7 5-C5Hs)2. The structure is 
held together by a highly efficient overlap between the ^--electrons of the filled p- 
orbitals of the cyclopentadiene (Cp) rings and the vacant ¿-orbitals of the metal centre 
(in the case of ferrocene Fe2+=i/). Slight back-bonding from the metal to the n* 
orbitals of the Cp rings also occurs (Figure 1.19).
Figure 1.19. (a) The sandwich structure o f  a metallocene devised by Wilkinson, (b) p- 
complexation, (c) p-orbitals o f  the Cp rings and (d) the generally used 
representation in the literature.
One of the most interesting properties of the metallocenes comes from their redox 
active metal centres. Ferrocene and cobaltocene are particularly attractive in this 
aspect both undergoing one electron reduction/oxidation processes. Ferrocene can be 
reversibly oxidised from ferrocene (Fe2+) to the ferrocenium ion (Fe3+). Whereas, 
cobaltocene is most stable in its oxidised (Co3+) form and will undergo a facile 
reduction to Co(II) (Figure 1.20). These ferrocene/ferrocenium and 
cobaltocenium/cobaltocene redox couples can be achieved electrochemically, 
photochemically or through the use of oxidising agents. Often these metallocenes are 
introduced into a structure simply to exploit their redox properties in one of these 
ways. The most popular of these is their application in electrochemistry.
However, out of the two metallocenes ferrocene has been shown to be the most 
robust, stable and practical. It possesses stronger covalent bonding between the Cp 
rings and metal, is able to undergo electrophilic aromatic-type substitution reactions 
more easily, is soluble in most organic solvents, is inexpensive and is available from 
commercial sources.
1 e-
18VE 19 VE
£ o=+0.90 V vs. SCE (CH3CN)
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-1 e-
Fe +
18 VE 17 VE
Eo=+0.31 V vs. SCE (CHjCN)
Figure 1.20. Electrochemical redox couples o f cobaltocenium/colbalt and ferrocene/ 
ferrocenium.
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The oxidation is reversible and the potential applied is a function of the substitutents 
on the Cp units. For example, alkyl groups tend to aid oxidation whereas aryl groups 
will hinder oxidation. Furthermore, if  the substituents bring a guest species into close 
proximity to the redox centre then the electrochemistry will be affected. So ferrocene 
and colbaltocenium have been incorporated in many different types of molecules, e.g. 
macrocycles, cryptands and cavitands, with a view to developing molecular receptors 
capable of electrochemical transduction. The traditional concept of recognition for 
ferrocene compounds is shown in Figure 1.21.
Figure 1.21. Diagram o f the principle o f electrochemical recognition.
If the substituents attached to the metallocene are capable of selectively binding to the 
guest -  through electrostatic attractions, hydrogen bonding, Van der Waals 
interactions, etc. -  the potential needed to oxidise the metallocene unit will then 
become indicative of the guest species.
1.3.4.1 Cobaltocenium anion receptors
Beer et al. [112] prepared the first redox-responsive metallocene anion receptor, 
which was based on the cobaltocenium moiety. Macrocyclic (55) was shown to be 
capable of the electrochemical signaling of bromide anions (Figure 1.22). Since then 
ferrocene has also been employed as the redox centre and a whole plethora of
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metallocene-based anion receptors has been developed. Acyclic, macrocyclic and 
calixarene cobaltocenium- and ferrocene-based host molecules have been prepared.
(55)
Figure 1.22. The first metallocene-based anion receptor capable o f  the sensing o f  
anions.
The first cobaltocenium-based receptor molecule only employed electrostatic 
interactions between the host and guest. The design o f these molecules has been 
extended so that hydrogen bond donors, such as amide functionalities, have been used 
to co-ordinate the anion, and increasingly complex three-dimensional structures have 
been created to increase selectivity (Figure 1.23).
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Figure 1.23. Acyclic, marcocylic and calixarene derived cobaltocenium receptor 
molecules (56) -(61).
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Amide fimctionalised receptors (56) and (57) demonstrated selective anion co­
ordination [113,114]. 'H NMR experiments showed downfield shifts of the receptor 
protons, especially the amide protons, indicating strong hydrogen bonding between 
the host and guest. Cyclic voltammetry experiments showed significant cathodic 
shifts of the reversible CpCo+/CpCo redox couple for H2PO4'  of 200 and 240 mV 
compared to 30 and 85 mV for CP anions. Receptors (58) and (59) demonstrated a 
macrocyclic effect in the complexation with anions [115]. Macrocycle (58) was found 
to have a stability constant with chloride of K -250 M~' in DMSO compared to acyclic 
receptor (59) where AT=20_1 M.
The coupling of cobaltocenium to the calixarene systems (60 and 61) was performed 
to exploit the topolgical advantage offered by the macrocycle in order to improve 
anion selectivity (60)] [116]. It has been found that it is the degree of preorganization 
on the upper rim of the calixarene that determines the anion-host co-ordination. 
Receptors (60) and (61), for example, show strong selectivity depending on the 
position of the toysl group on the lower rim. Receptor (60) binds CH3COO- much 
better than H2PO4”, while the opposite is true in receptor (61) [117,118].
1.3.4.2 Ferrocene anion receptors
The initial prototype ferrocene-based anion receptors were often analogous to that of 
the cobaltocenium receptors. However, one of the main differences is that ferrocene is 
neutral and, thus, does not interact directly with the anion until it is ‘switched on’ by 
being oxidised to ferrocenium. So the stability constants for ferrocene are lower than 
for cobaltocenium. Now a vast array of different classes of ferrocene receptor 
molecules exists. There are simple amide fimctionalised systems, amide-phosphine
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systems, calixarene derivatives, ferroceneamines, ferrocenylboronic acid and its 
derivatives, polyaza and aza-oxo compounds, ferrocene-isophthalimides and 
-disulphonamides and calixpyrrole derivatives. In Figure 1.24, examples of these 
different classes of ferrocene-based receptors are given.
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Figure 1.24. Examples from  the different classes offerrocene anion receptors 
prepared, (a) Amide functionalised systems, (b) amide-phosphine 
systems, (c) calixarene derivatives, (d) ferroceneamines, (e) 
ferrocenylboronic acid derivatives, (f) polyaza and aza-oxo compounds, 
(g) isophthalimide and disulphonamide and (h) calixpyrrole derivatives.
All of these classes of ferrocene system have been shown to be capable of co­
ordination with anions. Of particular interest are the amide functionlised receptors
(62)-(64), which were among the first to be prepared. They are able to detect H2PO4 
anions, inducing cathodic shifts of up to 240 mV in the presence of a ten-fold excess 
o f hydrogen sulphate and chloride ions [118]. However, the lack of inherent 
electrostatic attractive forces gives them lower stability constants, as determined by 
*H NMR, than the analogous cobaltocenium compounds. Receptor (63) was able to 
selectively bind HSO4-  ions in the presence of H2PO4- ions [119]. Protonation of the 
amine by the acidic sulphate ion causes the receptor to become positively charged, 
which then binds strongly to the sulphate ion, as shown by the electrochemical 
response.
Like in the analogous cobaltocenium receptors the ferrocene-calixarene derivatives 
(6 8 ) and (69) showed increased selectivity for H2P()4~ ions. The ferroceneamine 
compounds (70)-(73) selectively bind and electrochemically detect phosphate ions, 
sulphate ions and nucleotides in water [120-122]. The selectivity of the 
ferroceneamines depends on the pH, hence they are the so-called dual purpose pH 
dependent receptors with the potential to act as prototype ampherometric sensors.
However, the most selective ferrocenyl chemoreceptor is ferrocenylboric acid (74) 
[123], It showed excellent selectivity for fluoride ions in the presence of other halide 
ions, SCN~, S 04- and H2PO4” For fluoride, ATOX=1000 NT1 in MeOH/TkO, whereas 
for chloride and bromide the AT0X values were less than 2 1VT1. So from this simple
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molecule other derivatives have been prepared (e.g. 75), which have been shown so 
far to bind saccharides at neutral pH [124],
A range o f pH stable ferrocenyl-imidazolium and ferrocenyl-benzimidazolium salts 
(83)-(87) were prepared by Thomas et al. [125] and Hanlon [126] (Figure 1.25). It 
was shown that they bind through a possible combination of C -H  ---X“ hydrogen 
bonding and electrostatic attraction between the electron deficient Lewis acidic 
azolium centre and the anion. However, the 'H  NMR studies that were conducted 
using CT, Br", T, NO3” and HSO4 " anions did not shown any selectivity o f these 
compounds towards any particular anion.
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Figure 1.25. The l-ferrocenylmethyl-3-alklyazolium salts (83)-{87) in anion
recognition 1H  NMR titration experiments by Thomas et al. and Hanlon.
1.4 Functionalisation of azole systems
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1.4.1 Ferrocenyl-azolium systems
1.4.1.1 Synthesis
It was Benito et al. in 1995 [127], who first linked a ferrocenyl moiety with an azole 
by preparing l-ferrocenylmethyl-2-ferrocenylbenzimidazoIe (8 8) and 2- 
ferrocenylbenzimidazole (89) by the reaction of ferrocenecarboxaldehyde and o- 
phenylenediamine in the presence of toluenesulfonic acid (see Scheme 1.15).
(88) (89)
Scheme 1.15. Synthesis o f  l-ferrocenylmethyl-2-ferrocenylbenzimidazole and 2- 
ferrocenyl benzim idazole.
Since then Babin et al. [128-130] has prepared various ferrocenyl-azolium systems 
with a view to using them as anti-tumour agents, including benzotriazoHum, 
benzimidazolium and imidazolium ferrocenylmethyl derivatives, both as the 
monosubstituted and disubstituted isomers (Figure 1.26).
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Figure 1.26. The ferrocenyl-benzimidazolium tetrcifluoroborate salts prepared by 
Babin et al., e.g. ferrocenylpolyfluorobenzimidazoles (90), l,l'-b is[(l-  
ferrocenylmethylbenzotriazolium)ethyl]ferrocene bistetrafluoroborates 
(91) and l,3-bis(ferrocenylmethyl)-2-methyl benzimidazolium 
tetrafluoroborate (92).
The general method used to prepare these compounds involved the acidic nucleophilic 
displacement of a ferrocenyl alcohol compound, such as 1 -hydroxyethylferrocene, 1 - 
hydroxymethylferrocene (93) or l,l'-bis(hydroxyethyl)ferrocene, using 
tetrafluoroboric acid and the appropriate azole compound (Scheme 1.16).
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Scheme 1.16. Use o f  tetrafluoroboric acid to couple ferrocenylhydroxy compounds to 
benzimidazole (Babin et al).
With an interest in developing novel carbene precursors, Bildstein et al. [131-133] 
also prepared ferrocene-azolium derivatives. They were interested in the preparation 
of monosubstituted ferrocenyl azolium systems and have successfully synthesised 
ferrocenyl-benzimidazolium derivatives with a methylene spacer, ethylene spacer and 
no spacer functionalities, such as (94)—(96). The preparations from 
(trimethylammonium)methylferrocene iodide and 2 -bromoethylferrocene are outlined 
in Scheme 1.17.
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Scheme 1.17. Pathways taken by Bildstein et al. to ferrocenyl-benzimidazoles.
Other couplings of the ¡midazolium and ferrocenyl units have been reported. These 
include the facile introduction of the imdiazole unit by treatment of a ferrocenyl 
alcohol with AyV’-carbonydiimidazole (CDI) (97) (Scheme 1.18) [134], A variety of 
chiral and achiral ferrocenylethylimidazoles (98)-(102) were produced in this way for 
biological applications.
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Scheme 1.18. Use o f  CDI to couple ferrocenyl alcohols to imidazole.
This technique was also used in the introduction of an imidazole entity into the first 
ferrocenyl-imidazole system with planar chirality (103). Starting from (S)-S- 
ferrocenyl-^-4-tolyl sulphoxide, going via an alcohol intermediate that was treated 
with CDI, a planar chiral ferrocenyl-imidazole was prepared. This was then 
converted with methyl iodide into the corresponding imidazolium salt (104) (Scheme 
1.19) [135],
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Scheme 1.19. Synthesis o f  the first planar chiral ferrocene-imidazole.
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Bildstein et al. then employed the ferrocenyl-azolium salt systems that were 
synthesised by his group as ¿V-heterocyclic earbene derivatives [136] (Scheme 1.20).
1.4.1.2 Ferrocenyl- azolium systems as carbene ligands
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Scheme 1.20. The preparation o f  ferrocenyl-azolylidene complexes by Bildstein et al.
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1 -Methyl-3-(ferrocenylmethyl)benzimidazolium (94), 1,3-dimethylferrocenyl
benzimidazolium (95) and 1,3-diethylferrocenylbenzimidazolium salts (96) were 
deprotonated in situ in the presence of metal acetate salts to the give the respective 
palladium, tungsten and mercury carbene complexes.
Also using 1,3-diferrocenylbenzimidazolium iodide (108), a silver complex (109) was 
prepared, although it was found that the preparation of palladium and mercury 
complexes was not possible. This was presumably due to the steric interaction of the 
ferrocenyl substituent and the insufficient basicity of the acetate anion preventing the 
palladium(II) planar geometry (Scheme 1.21).
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Scheme 1.21. Preparation o f a silver carbene complex (109) with a 
ferrocenyl-azolylidene ligand (108).
A planar chiral carbene complex was prepared by Simenel et al. [135], The planar 
chiral ferrocenyl-imidazolium salt (104) was employed as a carbene precursor for 
chromium (110) and rhodium (111) complexes (Scheme 1.22).
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Scheme 1.22. Chiral chromium and rhodium ferrocenyl-imidazolium complexes.
1.4.2 A zole-phosphine compounds
1.4.2.1 P, N  compounds as mixed ligands for catalysis
Bisphosphine chelate ligands have been employed very successfully in catalysis, 
however, it is of interest to investigate the effects of a mixed chelate system and the 
possible advantages it can offer in terms of improving catalyst efficiency. A ligand 
that employs both phosphorous and nitrogen atoms for co-ordination offers one of the 
most accessible and viable mixed ligand systems. P,N mixed ligands have a soft 
phosphorous donor and a hard nitrogen donor, and as such are classified as hemilabile 
ligands. The differing chelating properties of the two donor atoms means that 
hemilabile ligands offer a great potential for use in catalysis.
The phosphorous acts as a ^-acceptor that can stabilize a metal center in a low 
oxidation state, whereas the nitrogen uses cr-donation, making the metal susceptible to 
oxidative addition reactions. Furthermore, the nature of the ligand can be modified
through the extensive substitution chemistry of the phosphorous atom, so that the 
reactivity o f the particular system involved can be controlled. For example, phosphine 
sulphides and phosphine oxides can be obtained through the sulphonation and 
oxidation of phosphines.
Due to the hemilability of these mixed ligands, they can stabilize metals in a variety 
of co-ordination modes, geometries and oxidation states. It is this that leads to their 
usefulness in catalysis. Firstly, in an otherwise stable complex one end of the ligand, 
depending on the donor atom and the metal center, can dissociate allowing co­
ordination o f the organic substrate and the subsequent transformation can be carried 
out. Secondly, the additional stability associated with chelates ensures that the 
complex will still be stable in the absence of a substrate. Thirdly, as the P,N-ligands 
can act as bridging, bidentate or monodentate ligands, a variety of geometries and the 
stabilization of metal centers in different oxidation states are possible. This means that 
hemilabile ligands can stabilize the various oxidation states and geometries that can 
occur during a transition metal catalytic cycle.
So therefore, one approach to the design of a ligand for transition metal catalysis is 
where there are two different sites for co-ordination, leading to a complex where there 
is an inherently weaker bond. This then provides a point o f preferential reactivity. 
Also a hemilabile ligand can often increase the reactivity of a catalyst compared to an 
inert diphosphine system. In some instances, a very weak chelate is needed to activate 
a transition metal to act in a catalytic system. But on the other hand, a strong bidentate 
ligand is needed in asymmetric catalysis so as not to allow unselective monodentate 
ligands to compete and reduce the enantioselectivity o f the catalyst.
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Furthermore, for the catalytic system to be effective and robust, the precursor should 
be stable to the inherent degradation processes in the cycle, but able to provide a high 
level of reactivity by offering a good supply of the intermediate reactive species. The 
stronger metal-ligand bond promotes the stability o f the system by tethering the metal 
to the ligand as a monodentate ligand, keeping it in close proximity for the recovery 
step and minimizing entropy effects.
The coupling together o f an azole or azolium moiety together with a phosphine 
functionality would provide a hemilabile system where there is a phosphorous atom 
available for co-ordination and then either a nitrogen or a carbene. 
Azole/azolium-phosphorous systems are relatively rare in organic synthesis and only 
a few such molecules exist. Typically, these two are employed as mixed ligands in co­
ordination chemistry. However, there have been very few linkages of an azole 
heterocyclic ring with a phosphorous to create a novel mixed donor ligand.
It is the substitution of the phosphine functionality at the 2-position on the imidazole 
ring that has been the popular linkage so far. This group divides into two types: 
monoazol-2-yldiphenylphosphines and bis- and trisazol-2-yl(phenyl)phosphines. The 
latter group will be discussed first.
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1.4.2.2 Bisazol-2-ylphenylphosphines and trisazol-2-ylphosphines
A variety o f heterocycles, e.g. furan, thiophene and pyridine and also pyrimidine, 
substituted with a phosphine entity have been reported [137-139], but the first 
synthesis of a 2-imidazolylphosphine was by Curtis and Browne in 1980 [140] -  
tris(4,5-dimethylimidazol-2-yl)phosphine (112). This was prepared by lithiation of 
imidazole and subsequent treatment with PCI3, creating a triheteroarylsubsitituted 
tertiary phosphine.
Moore and Whitesides a little later in 1982 [141], prepared a range of heterocyclic 
tertiary phosphines, including tris(l-methylimidazol-2-yl)phosphine (113), (1- 
methylbenzimidazol-2-yl)diphenylphosphine (114) and bis(l-methylbenzimidazol-2- 
yl)phenylphosphine (115), and some of which were co-ordinated to platinum (1,5- 
cyclooctadiene)dimethylplatinum(II), (COD)Pt(CH3). Cw-dimethylbisphosphine 
platinum(II) complexes (e.g. 116) were yielded where the ligands were found to act 
exclusively as monodentate ligands, binding through the phosphorous atom (Figure 
1.27).
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Figure 1.27. Azole tertiary phosphines.
Other tris(imidazol-2-yl)phosphines have been prepared and then employed as ligands 
(Figure 1.28). However, in contrast to the findings of Moore and Whitesides it has 
been seen that these ligands usually act as tridentate N-donors (117) and as such have 
been used as biomimics of the active site of enzymes whose active sites are lined by 
histidine residues. Tris[2-(l-wo-propyl-4-ier/.-butylimidazol-2-yl)]phosphine (Pim,Pr’ 
iBu) (118) represents a very good structural model of the enzyme carbonic anhydrase. 
The active site of this enzyme contains three histidine residues that bind a zinc cation 
in a tridentate manner, and the ([PimlPr’ iBu]Zn[OH])+ complex (119) reproduces this 
environment very well, allowing the evaluation of the coordination abilities of the 
enzyme’s active site [142]. To this end, several studies have been performed on this
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system, where other zinc, cadium [143] and cobalt [142,144] complexes have also 
been employed as the central metal, e.g. [(Pim,Pr,'Bu)Cd(0 H2)(0 C10 3)]C10 4  (120) and 
(Pim'Pr’'Bu)M (N03) (M=Zn, Co) [144].
(119) (1 2 0 )
Figure 1.28. Tris(imidazol-2-yl)phosphines.
Imidazol-2-ylphosphines have also been used as mimics for hemocyanin, which has a 
dicopper active site where each copper Cu(I) center is coordinated to three histidine 
moieties. Complexes of the type [Cu(TlEt4RIP)L]X, where TlEt4RIP=tris(l-ethyl-4- 
R-imidazol-2-yl)phosphine, R=Me and 'Pr, L=MeCN and O2 and X=PFf„ CIO4 and 
CF3SO3, were prepared and it was seen that the imidazolylphosphine ligand acted as a 
tridentate N-donor system [145].
A group of enzymes have been isolated that contain diiron active sites, including 
hemerythrin, ribonucleotide reductase and pseudocatalase, all of which have five 
histidine residues in the active site. Kurtz et al. [146] employed the 
phosphine-imidazole ligands in order to investigate the structural and physical
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properties of these enzymes. Iron and manganese cluster compounds were assembled, 
yielding (//-oxo/hydroxo)bis(//-carboxylato)diiron(III) and dimanganese(m) 
complexes that used tris(imidazo-2 -yl)phosphines as tridentate capping ligands -  
[Fe2 0 (L)(TMIP)2] (C10 4)2, where L=acetato or hydroxyl and TMIP=tris(l- 
methylimidazol-2 -yl)phosphine.
1.4.2.2 Monoazol-2-yldiphenylphosphines
The synthesis and subsequent use of monoazol-2-yldiphenylphosphines as ligands for 
uses other than as enzyme active site mimics has been very limited. The synthesis of 
bis(2-diphenylphosphinoimidazol-l-yl)methane (121) [147] and various
alkylimidazolium phosphines (122) [148] have been reported (Figure 1.29). The 2- 
imidazolium phosphines were successfully employed as ligands in the Rh-catalysed 
hydroformylation of 1 -octene in basic conditions.
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Figure 1.29. Monoazol-2-yldiphenylphosphines.
l-Methylimidazol-2-yldiphenylphosphine (dpim) (123) has been effectively used as a 
monodentate ligand for Pd (124) and a novel type of P -N  bridging ligand for 
binuclear Pd (125), Ag(I) (126) and Cu(I) (127) complexes [149] (Figure 1.30). In the 
case of the mononuclear palladium(II) complex, dpim acted as a monodentate P-donor 
ligand, which in solution exists in the cis and trans forms. This was obtained by
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treatment of PdCl2(PhCN)2 with the ligand producing [Pd2Cl2(dpim)2] (124), which 
by further treatment with Pd(dba)2 (dba=dibenzylideneacetone) yielded the bridged 
dinuclear [Pd2Cl2(dpim)2] complex (125). Here, though, dpim acts as a bidentate P,N- 
donor ligand.
Complex 126 was characterized as a nitrate-bridged polymeric silver(I) complex. A 
stoichiometric reaction of dpim with silver nitrate in methanol gave a complex with 
an eight-membered annular core with the formula [Ag2(/¿-dpim)(N0 3 )]N0 2  (126). 
Again, the dpim acting as both a P and N-donor, with two ligands bridging the silver 
metal centers in a head-to-tail configuration.
On reaction of [Cu(MeCN)4]C10 4  with dpim, a rare type of triply-bridged Cu(I) 
complex was yielded -  [Cu2(//-dpim)3(MeCN)]C1 0 4 (127). It was seen that the dpim 
ligand used both the nitrogen and phosphorous in its co-ordination. Its geometry was 
such that one copper center had a distorted tetrahedral co-ordination, using two 
phosphorous atoms and one nitrogen with MeCN also acting as a ligand and the 
second copper center was triply co-ordinated with two nitrogens and one 
phosphorous.
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Figure 1.30. Dpim (123) and its use as a monodentate and P -N  bridging ligand fo r  
Pd, Ag and Cu.
1.4.2.3 Other phosphine -azole compounds
Very few compounds with linkages between azole and phosphine moieties have been 
reported. Wasserscheid et al. [150] have prepared compounds with a phosphine as an 
iV-terminal attachment with alkyl or aryl spacer groups (128-130) as part of research 
into ionic liquids (Figure 1.31). However, so far these compounds have not been 
applied as chelate ligands or to catalysis.
Ph,P
(128)
PhP
(129) (130)
Figure 1.31. Phosphine-azole systems prepared by Wasserscheid et al.
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1.5 Ferrocenyl-phosphine systems
1.5.1 Ferrocenyl diphosphines
Ferrocene-phosphorous chemistry has been a very widely investigated area for many 
years, and of which ferrocenyl diphosphine compounds are among the most 
intensively studied species. In the late 1970s, Kumada et al. synthesised 1,1'- 
bis(diphenylphosphino)ferrocene (dppf) (131) (Figure 1.32) and discovered that it was 
an excellent catalyst for the coupling of Grignard reagents and alkyl halides and 
alcohols [151,152], leading to considerable research attention focusing primarily on 
the use of dppf compounds as ligands in catalysis.
A vast array of co-ordination compounds have been prepared using dppf as a chelate 
ligand due to the various co-ordination modes it employs [153]. The skeletal 
flexibility of the ferrocene backbone, variations in metal geometry and the bonding 
modes of co-ligands leads to many diverse and unpredictable structures being 
produced. Shown in Figure 1.33 are some of the co-ordination compounds prepared 
employing dppf as a ligand (132)-{135) [153-157].
Fe
(131)
Figure 1.32. Dppf.
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(135)
Figure 1.33. Some o f the co-ordination compounds formed using dppf as a ligand 
(132)-(135),
The most closely related compounds to the ferrocenyl diphosphines include the 
analogous alkyl 1,1'-ferrocenyl alkylphosphines (136) [158,159], 1,1'-
bis[(diphenylphosphino)methyl] ferrocene (dpmf) (137) [160] and monosubstituted 
ferrocenyl dialkylphosphines [161] (Figure 1.34).
R = Me. Et, 'Pr, 'Bu
(136) (137)
Figure 1.34. 1,1 -Ferrocenyl alkylphosphines (136) and (137).
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Another important class o f ferrocenylphosphines are the [l]phosphaferrocenophanes, 
having the structural formula FcPR (Fc=ferrocene). In 1980, Seyferth prepared the 
first ferrocene compound internally bridged by phosphorous, ( 1 , 1 '- 
ferrocenediyl)phenyl phosphine (138) [162] (Figure 1.35). Full structural analysis 
[163] showed the two Cp rings tilting inwards to accommodate the phosphorous 
bridge.
Figure 1.35. First prepared and characterised [1]phosphaferrocenophane (138).
Ferrocene, when it was first discovered, was treated very much as an organometallic 
aromatic species analogous to benzene; however, it was soon observed that it could 
give rise to planar chirality as well as atom-centered chirality. An asymmetrical 1,2- 
relationship between the substituents on the same Cp ring will create enantiomers 
based on a plane of symmetry running through the molecule (Figure 1.36). This 
stereoisomeric feature of ferrocene is one of the principal reasons for the large amount 
of interest in using ferrocene as a ligand. Chiral ferrocene molecules have been 
employed very successfully in asymmetric transition metal catalysis.
Fe P
(138)
1.5.2 Chiral ferrocenyl-phosphines
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Figure 1.36. Enantiomers o f  ferrocene resulting from (a) atom-centred chirality and 
(b) planar chirality.
The first chiral ferrocenyl phosphine reported was prepared by Hayashi in 1974, R,SP- 
jV,jV-dimethyl-l-[(2-diphenylphosphino)ferrocene]ethylamine (PPFA) (139) [164]. 
The synthesis of which is shown in Scheme 1.23. The chiral auxiliary ensures that 
ortho-lithiation occurs and is highly diastereoselective, through chelation of the 
lithium by the amine nitrogen. Reaction then with an electrophile gives a 1,2- 
disubstituted ferrocene.
(139)
Scheme 1.23. The synthesis o f  (R,Sp)-N,N-dimethyl-l-[(2-diphenylphosphino) 
ferrocene] ethylamine.
This technique has led to many planar ferrocenylphosphines based on N,./V-dimetliyl- 
1-ferrocenylethylamines as the chiral auxiliary. In addition, racemic mixtures of chiral 
ferrocenes have been prepared that have been separated by the classical technique of 
resolution using an enantiomerically pure base to prepare diastereoisomers that can be 
separated by chromatography.
H Me H Me H Me
/ /
Fe
N BuL N
1 .5 .3 .1  D p p f
Since Kumada et al. first employed dppf as a ligand in the catalysis o f Grignard cross­
coupling between organic bromides [165] and allylic alcohols [152] with PdCh, there 
has been an expanding catalogue of transition metal catalysed reactions in which it 
has been successfully used as a ligand.
So far it has been its use in palladium complexes that has created most of the interest. 
Some recent developments in this ever-expanding area of research are given in Figure 
1.37 as an indication of the scope of applications of dppf as a ligand in transition 
metal catalysis [166-170].
1.5.3 Use of ferrocenyl-phosphines in catalysis
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Figure 1.3 7. The use o f dppf as a ligand in palladium-catalysed organic reactions, (a) 
Hydroamination [166], (b) benzyne/alkene insertion [167], (c)
thiocarbonylalion [168], (d) borylation [169], (e) carbonylation and
nitrogenation [170].
However, there has been limited use of other transition metals, such as rhodium in the 
coupling o f arylboronic acids and carbonyl compounds [169,171], cobalt and nickel 
[170] (Scheme 1.24).
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B(OH)z
1
Scheme 1.24. Rhodium-catalysed cross-coupling using dppf
1.5.3.1 Chiral ferrocenyl -phosphines
The driving force behind the area of chiral ferrocenyl phosphines has been their use in 
catalysis. For asymmetric catalysis, these compounds have several features that make 
them attractive. Firstly, planar chiral systems, such as ferrocene, never undergo 
racemisation. Secondly, ferrocene, due to having two Cp rings, can act either as a 
mono or bidentate ligand, and the chelating entities can either be the same or mixed. 
Therefore a great variety in bonding modes is possible. Finally, in the case of 
ferrocenylphosphines having both planar and central chirality, the atom-centered 
chiral side-chain can participate in the reaction site, aiding the asymmetric selectivity 
of the product (Figure 1.38).
These factors give the chiral ferrocenylphosphines a major advantage in that they are 
very flexible with regard to the side-chains and the phosphine groups, meaning that 
there is a huge potential for modification and hence fine-tuning of the ligand for 
specific catalytic tasks.
A few examples include the synthesis of (+)-biotin [171], asymmetric hydrogenation 
of ketoesters [172], asymmetric aminolysis [173], Grignard cross-coupling [174], 
asymmetric allylations [175] and hydrosilylation [176], and are shown in Figure 1.38.
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Figure 1.38. The use o f  chiral ferrocenylphosphines in asymmetric catalysis.
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As discussed, the azole/azolium system has a lot of potential applications and as such 
our compounds were designed with two main purposes in mind: as auxiliary ligands 
in transition metal catalysis and as chemoreceptors for anion recognition. It was 
proposed to couple together an azolium moiety together with a ferrocene unit. This 
offers the novelty in both applications, as ferrocene has not been employed as 
appendage to an azolium system in transition metal-mediated catalysis and the 
azolium system was only very recently discovered as a promising ligand for use in the 
electrochemical detection of substrates.
1.6.1 For application as auxiliary ligands in transition metal cross-coupling
reactions
In the 1,3-disubstitutedimidazolium salts applied as auxiliary ligands in 
organometallic cross-coupling reactions, as discussed in Section 1.2.2, a variety of 
different R substituents have already been employed. However, one substituent that 
has not been used though is the metallocene unit ferrocene. Thus, the rationale behind 
applying the proposed ferrocenyl-azolium systems to transition metal catalysis was to 
investigate the effect of this organometallic species on a specific transition metal- 
mediated reaction.
Ferrocene has the well-known property of being able to stabilize adjacent electron 
deficient centers. The stabilization of simple carbénium ions R2FcC+ is achieved by 
delocalisation of the positive charge via a 7 6-fulvene-//5-cyclopentadienyl-Fe(II)
(140) resonance structure with an exocyclic bent fulvenoid double bond (Scheme 
1.25) [41].
1.6 Design of ferrocenyl-azolium salts
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Scheme 1.25. Stabilisation o f  a ferrocenylcarbenium ion via the resonance structure 
(140).
It was thought that the ferrocenyl unit may be able to effectively stabilize a generated 
carbene center. It has also been shown that more sterically demanding R groups in the 
imidazolium structures were able to increase the reaction rates in these catalytic 
reactions [63]. To this end, substituted phenyl rings had been incorporated in the 1,3- 
dialkylimidazolium salts [62,63], but so far a ferrocenyl substituent -  which would 
offer a comparitive bulk -  had not be utilized.
Therefore, as ferrocenyl-imidazolium salts had previously been prepared (83 and 84) 
for anion recognition studies [125,126] (Figure 1.25), it was decided to extend the 
application of these compounds to transition metal-mediated synthesis. Also, as no 
studies had been carried out on the application of benzimidazolium salt systems as 
auxiliary ligands for cross-coupling reactions, we decided to prepare a series of 
ferrocenyl-benzimidazolium compounds (141) of the type outlined in Figure 1.39.
Figure 1.39. The proposed ferrocenyl-benzimidazolium salts.
Furthermore, ferrocene offers the possibility of inducing planar chirality into the 
system. Although a range of chiral imidazolylidene complexes have been reported and 
applied to asymmetric transition metal catalysed cross-coupling processes [40], no 
chiral ferrocenyl-azolylidene complexes have been employed in catalysis. The 
introduction o f central chirality can be easily accomplished in azolium salts, which 
can then be applied to asymmetric cross-coupling reactions, as has already been 
shown. However, it was thought a novel pathway to a chiral azolium compound could 
be achieved by incorporating planar chirality via the ferrocene unit (Figure 1.40) 
(142). Planar chirality offers the clear advantage that racémisation of the compound 
never occurs, thus, extending the lifetime of the catalyst.
1  X
Fe
(142)
Figure 1.40. Proposed ferrocenyl-imidazolium salt (142) with planar chirality.
For the anion recognition application o f the ferrocenyl-azolium system, it was 
envisaged that ferrocene could be used to provide a redox centre capable of the 
electrochemical recognition of anions. The pendant imidazolium salt moieties would 
be able to co-ordinate to the anions and, hence bring them into close proximity for 
transduction to occur at the ferrocene metal centre.
The application of ferrocenyl-azolium hexafluorophosphate salt systems (83)-(87) to 
anion recognition has already been shown by Thomas et al. and Hanlon [125,126] 
(Section 1.3.4.2), but these monosubstituted ferrocenyl-azolium systems did not show 
any selectivity. A novel type of molecule is therefore required to induce selective 
anion binding. Macrocyclic ferrocenyl-azolium systems of the two types -  (143) and
(144) -  shown in Figure 1.41 were proposed.
1.6.2 For application as chemoreceptors for anion recognition
(143)
(144)
Figure 1.41. Proposed macrocyclic ferrocenyl-azolium structures.
A cavity is present in both systems that may aid selective anion binding. In structure 
143, the cavity is more rigid and has two azolium functionalities present, in structure
4 X ~
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144 there are four azolium centres with linking alkyl chains that are capable of 
allowing the system to be more flexible. In both cases, the orientation of the azolium 
rings and, thus, the direction of the hydrogen bonds will need to be considered in the 
topology of the cavity and, thus, will be important in the co-ordination of anions and 
any possible selectivity.
1.6.3 Synthesis
While a synthetic route to the monosubstituted ferrocenyl-azolium salts has been 
established [125,126], a novel synthetic procedure for these macrocyclic systems was 
required. Thus, it was proposed that the l,r-bis(l-methylazole)ferrocene (145) would 
be the key starting point from which the macrocycles could be prepared. This would 
then allow the preparation of l,r-bis(l-alkyl-3-methylazolium)ferrocenyl salts (146), 
which could also be employed as novel 7V-heterocyclic carbene ligands and novel 
bidentate auxiliary ligands for transition metal-mediated catalysis (Figure 1.42).
r  n  2 x
(145) (146)
Figure 1.42. 1,1 '-Bis(l-methylazole)ferrocene (145) as a starting point fo r  the 
macrocycles (143) and (144) and 1,1 -bis(l-alkyl-3- 
methylazolium)ferrocenyl salts (146).
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We also proposed the preparation of a linear bisazolium-ferrocenyl system (Figure 
1.43) that could be applied both as a bidentate ligand and a possible anion receptor. It 
would enable a comparative study against the l,l'-(bisazolium)ferrocenyl salt 
compounds (146). In the case of its application as an iV-heterocyclic carbene ligand, it 
can be compared to 146 to determine what effect the spacer unit between the two 
carbene moieties would have on the efficiency of the bisazolium systems as chelates. 
For the anion recognition studies, it would be interesting to observe it as an acyclic 
analogue of marcocycle (144) and if  it could confer any selectivity as a receptor, 
possibly by wrapping around the anion. Thus, the preparation of the bridged 
monosubstituted unit -  [l-(l-ferrocenylmethyl)-3-alkylazolium]-3-(l- 
ferrocenylmethyl)azolium salt (147) -  was envisaged.
- | 2 X‘
"'N . - N —  (CH2)„- V ,  ,N !
Fe
(145)
Figure 1.43. The proposed linear bisazolium-ferrocenyl system.
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Chapter 2
Synthesis of Ferrocenyl-Azolium Salts
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2.1 Introduction
As outlined in Section 1.6, a range of monosubstituted ferrocenyl-imidazolium and 
ferrocenyl-benzimidazolium salts would be prepared along with 1 , 1 '- 
bis(azolium)ferrocenyl (146) and linear bisazolium-ferrocenyl (147) salts. Also the 
preparation o f macrocyclic systems (143) and (144) would be attempted.
2.2 Results and discussion
2.2.1 Monosubstituted ferrocenyl-azolium salts
2.2.1.1 l-Ferrocenylmethylazoles
The initial aim was the extension of the already prepared ferrocenyl-azolium systems.
1,3-Disubstituted imidazolium salts can be prepared by a few different methods: (i) 
via preparation of a 1,4-diazobutadiene (DAB) from the condensation of an amine 
with a glyoxal followed by treatment of the DAB with />ara-formaldehyde and HC1
[177]; (ii) one-pot condensation of amines, para-formaldehyde and glyoxal under 
acidic conditions [178] or (iii) by alkylating 1-substitutedazoles with an alkyl halide 
(usually iodoalkanes) [6 8] (Scheme 2.1).
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Scheme 2.1. Methods fo r  imidazolium salt synthesis.
Following the synthetic route taken by Thomas and Hanlon [125,126] a 
ferrocenyl-imidazole system was prepared initially, which would then be quartemised 
by alkylation [method (iii)], yielding ferrocenyl-imidazolium iodides. So the starting 
point for the synthesis of the ferrocenyl-azolium salts was 1 - 
ferrocenylmethylimidazole (148), along with the benzimidazole analogue, 1- 
ferrocenylmethylbenzimidazole (149) (Figure 2.1).
Fe
\ ___ /
Fe
(148) (149)
Figure 2.1. The key intermediates - 1  -ferrocenymethylazoles (148) and (149).
In coupling the ferrocene and azole unit in a facile and high-yielding manner, 
(ferrocenylmethyl)trimethylammonium iodide (150) had proved an ideal starting
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material. This compound is an excellent electrophile due to the well-known leaving 
group properties of the trimethylamine entity, and it can be produced in a convenient 
route almost directly from ferrocene via an adaptation of the Mannich reaction 
(Scheme 2.2).
+
^ J  (CH3)2NCH2N(CH3)2 C f r y  n <ch3)2 ch3i ^ 07  N(CH3)3 I
Fe ----------------------------- *■ pe ------------ Fe
CH3COOH / h3p o 4 \
71%
(150)
Scheme 2.2. Synthesis o f  150.
The azole unit is then employed as the nucleophile. For the electrophilic attack of the 
ring-nitrogens in the azoles, there are two possible pathways: The first is the 
electrophilic attack of the neutral azole entity and the second is the electrophilic attack 
of the azolide anion.
Following the S & ' mechanism, the classical imidazole alkylation illustrates the first 
pathway. The imidazole and alkyl halide are reacted together; here, the pyridine-like 
nitrogen will attack the alkyl halide, generating a positively charged ion that will lose 
the pyrrole-hydrogen to become neutral (Scheme 2.3). This pathway often leads to 
loss of product through quaternary salt formation.
H* /  \
:N .X  N - R  R -— 8 r
V ^ i ^
Scheme 2.3. Se2 'mechanism o f imidazole alklyation.
However, if a base is employed and the azolide anion is generated then high yields of 
1-substituted imidazoles are yielded (Scheme 2.4), with little or no quartnerisation 
occurring.
Scheme 2.4. Se2cB mechanism o f  imidazole alklyation, in basic media.
So rather than using the neutral imidazole, the sodium imidazolide salt was employed. 
Salt 150 was heated to reflux with the sodium imidazolium salt for 12 h, which 
yielded 148 in an 69% yield after a simple work-up and purification on silica gel 
using dichloromethane (DCM)-methanol (95:5). Later 150 was heated to reflux with 
imidazole and sodium/potassium carbonate in acetonitrile, with the imidazolium anion 
being generated in situ, producing 148 in a yield of 72%. This second method was 
then extended to the synthesis of 149, avoiding the necessity o f prior preparation of
HN N: -X
,< n^ n
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the benzimidazolide anion, with a yield of 81% (Scheme 2.5). It was observed that the 
benzimidazole compound was prepared in a higher yield than the imidazole 
compound. However, as both 148 and 149 could be produced easily in good yields 
both compounds were used to generate the respective ferrocenyl-imidazolium and 
-benzimidazolium salts.
(a)
(150) + N N
MeCN
Na2C 03
Fe
(69%)
(148)
N„ ->N
(b) / = \  
(150) + HIM ,N
MeCN
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MeCN
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(148)
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(149)
Scheme 2.5. Synthesis o f  1-ferrocenylmethylazole intermediates (148) and (149).
Predictably, the NMR data for these two compounds are very similar (Figure 2.2). 
From the 'H  NMR (CDCI3) spectra it can be seen that (ignoring the obvious 
additional phenyl signals for 149), the characteristic signals for the Fc Cp ring 
hydrogens, the methylene linker and the 2-H of the azoles are very similar. The
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ferrocene peaks are at ~4.10-4.13 ppm for 148 and ~4.16-4.25 ppm for 149, 
FC-CH2-  resonates at 4.80 (148) and 5.07 (149) ppm and the 2-azole H resonates at 
7.42 and 7.86 ppm for 148 and 149, respectively. In comparison with the 
unsubstituted ferrocene (4.18 ppm) and the unsubstituted azoles [imidazole (CDCI3): 
7.25 (4,5-H), 7.86 (2-H) ppm], it seems to suggest that while the azole substituent 
does not exert a large influence on the ferrocenyl unit, the ferrocenyl substituent acts 
as an electron-donating group towards the azole causing an upfield shift in the azole 
proton resonances. If the *H NMR data o f the 1-methylimidazole are examined, it is 
seen that the chemical shifts are almost identical [1-methylimidazole (CDCI3): 6 .8 8  
(5-H), 7.08 (4-H), 7.47 (2-H) ppm cf. 148 (CDCI3) 6.85 (5-im H), 6.95 (4-im H), 7.42 
(2-im H) ppm]. From the 13C NMR spectra, again the significant peaks are the 2-CH 
of the azole rings resonating at 122.77 (148) and 143.70 (149) ppm and the FC-CH2-  
resonating at 44.72 and 44.67 ppm, respectively for 148 and 149.
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F igure 2.2. The JH a n d 13 C NMR spectra fo r  149.
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The imidazolium cation centre was then generated in two ways (Schemes 2.6 and 
2.7): Firstly, 148 was treated with the appropriate alkyl halide thereby quartemising 
the neutral imidazole into the imidazolium centre via the mechanism discussed in 
Scheme 2.1c. The alkyl iodides were employed due to the better leaving group 
properties of the iodide anion (Scheme 2.6), yielding l-ferrocenylmethyl-3- 
alkylimidazolium iodides (151)-(154). In the case of l-ferrocenylmethyl-3- 
benzylimidazolium chloride (155), benzyl chloride was used instead due to 
availability.
I C C f r ^ N© N" CH3 '
Fe
(151)
Scheme 2.6. Quartemising o f the neutral imidazole into the imidazolium salt, e.g., 
preparation o f  l-ferrocenylmethyl-3-methylimidazolium iodide (151).
Several experimental techniques were employed for the generation of these salts. In 
the first case, the alkyl iodide and 148 were heated to reflux in acetonitrile for 1-3 h, 
and the reaction was monitored by thin layer chromatography (t.l.c.), worked up and 
the product isolated by column chromatography. Another variation of this was the 
addition of 148 and the alkyl halide together in the minimum amount of acetonitrile. 
This was left overnight at room temperature and a large volume of diethyl ether 
added, with crystals forming after 48 h.
2.2.1.2 l-Ferrocenylmethyl-3-alkylazolium salts
(148)
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In the second approach, 150 was used as the starting material and was treated with the 
appropriate 1-alkylimidazole (Scheme 2.7). The two reactants were heated to reflux in 
acetonitrile and the l-ferrocenylmethyI-3-alkylimidazolium iodide salt was collected 
by column chromatography. The 1-alkylated imidazoles were prepared according to 
the procedure o f Bonhote et al. [6 8] or bought commercially. This method allowed the 
intermediate step of the preparation of 148 to be left out, which makes the overall 
synthesis from ferrocene to the l-ferrocenylmethyl-3-imidazolium salts more efficient 
(Table 2.1). However, in the case of more varied alkyl substituents these could not be 
bought commercially so an extra synthetic step involving the preparation o f the 1 - 
alkylimidazole by the method of Bonhote et al. [6 8] was required.
(150) (151)
Schem e 2.7. Nucleophilic substitution o f  150 by l-alkylimidazoles, e.g., 151.
In Table 2.1, the different compounds prepared and their respective yields are given, 
showing a comparison o f the different techniques used. Using 150 as the starting 
material proved the most efficient as regards to yields. However, the preparation of 
the l-alkylimidazoles proved to be more demanding practically as they are liquids and 
so are more difficult to purify than the solid 150. Therefore, the salt being generated 
and time considerations generally dictated which technique was used.
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R Anion Compound Method of Yield from
no. preparation ferrocene
(%r
-c h 3 r isi (a) 40
(b) 36
(c) 50
-c 2h5 r 152 (a) 42
(c) 48
-CjH7 r 153 (c) 48
-C4H9 r 154 (a) 48
(c) 58
-CH2C6H6 el­ 155 (b) 40
aThe yield of 150 from ferrocene was 71% and the yield of 148 from 150 and
ferrocene was 69 and 49%, respectively.
Table 2.1. Comparison o f  methods used to generate I -ferrocenylmethyl-3- 
alkylimidazolium salts: (a) reflux o f 148 with an alkyl halide in 
acetonitrile, column chromatography; (b) treatment o f  148 in 
acetonitrile with an alkyl halide at RT, crystallisation; (c) reflux o f 150 
with a 1-alkylimidazole in acetonitrile, column chromatography .
For the preparation o f l-ferrocenylmethyl-3-alkylbenzimidazolium salts, the most 
convenient method was found to be heating 149 with the appropriate alkyl halide in
95
acetonitrile and collecting the product by column chromatography. [1 - 
Alkylbenzimidazoles are not commercially available and it was thought unnecessary 
to have to prepare them.] It was found that the yields of the benzimidazolium salts 
from the 1 -methylferrocenylazole intermediate were lower than those of the 
corresponding imidazolium salts (Scheme 2.8).
(146) Rl Fe
L"
'N  , ; N R
R X Yield
CH3 1 (156) 95
C2H5 1 (157) 42
C3H7 1 (158) 51
C4H9 I (159) 42
CH2C6H5 Cl (160) 48
Scheme 2.8. Preparation (156)-(160).
Imidazolium and benzimidazolium ‘claw’-type structures were also prepared where 
the azole entity was //-substituted by two methylferrocene units (Scheme 2.9). These
l,3-di(ferrocenylmethyl)azolium iodide salts -  l,3-di(ferrocenylmethyl)imidazolium 
iodide (161) and l,3-di(ferrocenylmethyl)benzimidazolium iodide (162) -  were 
prepared according to the procedure of Thomas et al. and Hanlon [125,126] (Scheme 
2.9): The starting material (150) was heated to reflux with intermediates 148 and 149 
in dry acetonitrile for 18 h. Compounds 161 and 162 were obtained after column 
chromatography and with yields of 80 and 57%, respectively.
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(150) + (149) _MeCN^  _Fe_ Fe
Na2C 0 3
(162)
Scheme 2.9. Preparation o f  l,3-di(ferrocenylmethyl)imidazolium iodide (161) and 
1,3-di(ferrocenylmethyl)benzimidazolium iodide (162).
The diversity of these salts in varying the R substituted and the central azolium 
moiety meant that it would be possible to see if there would be any effect on the 
lipophilicity of the compounds for their application in anion recognition studies, 
bioactivity studies and catalytic studies.
As a new substituent is added to the pyridine-like nitrogen, the 3-nitrogen develops a 
positive charge. This means that the ring is now a positively charged aromatic 
heterocyclic ring (Figure 2.3a). As a result, the lH NMR signals are shifted downfield 
(Figure 2.3b) compared to that of the neutral azole compounds. This is most markedly 
seen at the 2-CH position. In Figure 2.3b, 1,3-dimethylimidazole is given as an 
illustration.
Figure 2.3. Effect o f  quamerisation on (a) the electronic structure o f  imidazole and 
(b) the !H  NMR chemical shifts (CDCh) o f  imidazole.
In general, for the ferrocenyl-azolium  salts it was seen that the ferrocenyl Cp 
hydrogens resonated downfield o f  the unsubstituted ferrocene and the 
ferrocenylmethylimidazole at ~4.25-4.50 ppm. This suggests that there maybe some 
delocalisation o f  the electron density in the Cp rings to stabilise the positively-charged 
azolium ring, as previously discussed, or an electron-withdrawing effect due to the 
increased electronegetivity o f  the nitrogen atoms in the rings. The methylene spacer 
unit also shifted downfield from 4.72 ppm  for the imidazolium salts and 4.94 ppm for 
the benzimidazolium salts to -5 .4  and 5.6 ppm, respectively, reflecting the increased 
electron-withdrawing effect o f  the now positively charged, aromatic azole ring. 
However, the most significant shift in the *H N M R signals came from  the 2-azole H  
from  7.41 ppm  for the imidazolium derivative and 7.77 ppm  for the benzimidazolium 
derivative to ~10 ppm  for both types o f  salts. This too was observed in the I3C NM R 
spectra with the 2-C shifting from 82.49 ppm [in the l-ferrocenylmethyl-3- 
alkylimidazolium] and 143.70 ppm in the [l-ferrocenylmethyl-3- 
alkylbenzimidazolium salts] to ~ 135 and 210 ppm, respectively. The signals for alkyl
chain protons for the different derivatives generally appear at approximately 
4.00-4.50 ppm if  they are directly adjacent to azolium ring, but then will be observed 
at 0.95-2.00 ppm depending on their position in the chain, the In Figure 2.4, the 'H 
spectra of 156 is shown.
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Having prepared the monosubstituted ferrocenyl-azolium salts that could potentially 
act as monodentate //-heterocyclic carbene ligands or as anion chemoreceptors (see 
Chapters 3 and 4), it was of interest to prepare other ferrocenyl-azolium systems that 
would contain two azolium centres in a molecule. Molecules with two azolium nuclei 
could be used as bidentate //-heterocyclic ligands or chemoreceptors that may provide 
greater specificity than the previously prepared monosubstituted ferrocenyl-azolium 
systems.
So far only a few examples of bidentate ligands being employed in transition metal 
catalysis have been reported [42-54], so it was thought that it would be interesting to 
compare the monodentate ferrocenyl-azolium precursors for //-heterocyclic carbene 
ligands with the proposed chelate ligands. Furthermore, a comparative study against 
the l,r-(bisazolium)ferrocenyl salt compounds (146), which contain a ferrocene unit 
as a spacer unit, to the alkyl spacer group in the linear bridged system (147) could be 
carried out to compare any subsequent effect on catalyst efficiency (see Figure 2.5). 
Furthermore, it was proposed to employ these compounds as chemoreceptors to see if 
they are able to selectively co-ordinate with anions.
2.2.2 Bisazolium-ferrocenyl salts
1— 2 X~ 2X
N. ,.>N -R ' N ^ V —  (CH2) „ -
Fe Fe Fe
R -N . N
Figure 2.5. Two possible structures offerrocenyl-bisazolium salts.
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A facile way of introducing two azolium centres was the linking together of two 
monosubstituted ferrocenyl-azole systems to a create a [l-(l-ferrocenylmethyl)-3- 
alkylazolium]-3-(l-ferrocenylmethyl)azolium salt (147) (Figure 2.5). The linker 
group chosen was a four atom spacer (an «-butyl group) and the synthesis involved 
treating 148 and 1,4-diidobutane to obtain the corresponding l-(l-ferrocenylmethyl)- 
3-(4-iodobutyl)imidazolium iodide (163). This was collected and heated to reflux with 
the corresponding aliquot of 148, yielding the bridged bisazolium-ferrocenyl iodide 
salt system -  l-[(l-ferrocenylmethyl-3-butyl)imidazolium]-3-
ferrocenylmethylimidazolium diiodide (164). The benzimidazolium analogue was 
prepared by the same method, with 149 and 1,4-diidobutane being heated to reflux, 
obtaining l-(l-ferrocenylmethyl)-3-(4-iodobutyl)benzimidazolium iodide (165). Then 
further treatment of 165 with 149 produced l-[(l-ferrocenylmethyl-3- 
butyl)benzimidazolium]-3-ferrocenylmethylbenzimidazolium diiodide (166) (Scheme 
2 . 10).
2.2.2.1 Bridged bisazolium -ferrocenyl salts
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(149) MeCN
r
'  2 1
. . \  % 
•f
N N - ( C H J , - N V N \ < f) >  
Fe Fe
' O '  ¿ C 'A
(166)
Scheme 2.10. The synthesis o f  bridged bisazolium-ferrocenyl iodide structures 165 
and 166.
The syntheses were simple and high-yielding. For the imidazolium derivatives, the 
yields were 74% for 163 and 50% for 165, whereas for the benzimidazolium salts, 
yields of 79% for the intermediate 164 and 55% for the bridged product (166) were
obtained. However, it should be noted that purification of these salts proved to be 
more difficult than with the monosubstituted ferrocenyl-azolium salts. The solubility 
of these salts is such that salts 164 was sparingly soluble in chloroform and 
acetonitrile, while 166 was totally insoluble in dichloromethane, methanol, 
acetonitrile and other commonly used polar solvents. Thus, they could not be purified 
by column chromatography. However, both compounds were shown to have a high 
purity by microanalysis, although some slight impurities remained.
On examination of the 'H NMR spectra o f 163-166 (Figure 2.6), it is seen that there 
is a downfield shift in the methylene linker group and the imidazolium protons as 
would be expected when an azolium centre is generated. In the imidazolium 
compounds, the 2-H o f the imidazolium unit resonates at 9.21 and 9.74 ppm for 163 
and 164, respectively. A comparison between l-methylferrocenyl-3-«- 
butylimidazolium iodide (154) and 163 shows that the terminal -CH3 group in 154 
appears at 0.88 ppm, while the protons on the carbon adjacent (C4) to the iodo group 
are shifted much more downfield to 4.45 ppm for 163. In the butyl chain, protons
1,2,3 show signals at 5.20, 1.74 and 1.22 ppm for 154 and at 5.19, 1.88 and 1.75 ppm 
for 163. The bridged product 165 is symmetrical and as such only two resonances are 
seen for the butyl spacer group, one in the upfield region of the spectrum at 4.21 ppm, 
reflecting its proximity to the imidazolium centre, and the other at 2 .1 2  ppm.
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(154)
n==: 1 2 3 4
N ^ . N — CIH2 - CH2— CHz—  CHz
I » t t
£5.19 ¿1.88 £1.75 ¿>4.45
(163)
— >  1 2 2 1
\  J  N N —  CH2 -  CH2—  CH2— CH2
y T  ; I y i
.54.2] £2.12 £2.12 £4.21
(164)
Figure 2.6. A comparison o f  the 'H  NMR shifts fo r the butyl chain in compounds 154, 
163 and 164 (CDCh).
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2.2.2.2.1 1,1 '-(l-Methylazole)ferrocenes
The second route to introducing two azolium centres into the ferrocenyl-azolium 
system was the preparation of a 1,1 '-disubstituted ferrocene (Figure 2.7).
2.2.2.2 1,1 '-Bisazolium ferrocenyl salts
2 x
N N
N N
Fe
(145)
Rl
N N -R
R - V  N
Fe
(146)
Figure 2.7. The proposed neutral 1 ,1-disubstitutedferrocene-azole (145) and 1,1 - 
disubstituted ferrocenyl-azolium salt (146).
Two approaches to preparing these compounds were available. Again, as it had 
proven successful with the monosubstituted ferrocenyl-azoles, it was decided to first 
prepare the neutral ferrocenyl-azole compound (145), which could then later be 
converted into the quartemary salt via alkylation with a haloalkane (Figure 2.7). 
However, the synthesis of these compounds proved not to be as facile as the 
monosubstituted ferrocenyl-azoles. A couple of different routes were explored before 
a satisfactory pathway was found.
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The first route employed l,r-ferrocenyldicarboxaldehyde (167) as the starting 
material (Scheme 2.11). This was prepared from l.l'-lithiated ferrocene treated with 
DMF and then reduced in methanol using sodium borohydride to form 1,1'- 
ferrocenyldimethanol (168). Treatment with phosphorus trichloride and pyridine in 
acetonitrile formed the chloro- derivative -  l,l'-bis(chloromethyl)ferrocene (169) -  in 
situ. In a one-pot procedure, the chloro groups were displaced with imidazole in THF 
using sodium carbonate to generate the imidazolium anion. 1,1 '-Bis(l- 
methylimidazoIe)ferrocene (170) was afforded as a yellow powder after column 
chromatography on silica gel using DCM/methanol (50:50).
O  a20  C S r - C H 0  NaBH<
OH
Fe + BuLi + TMEDA + DMF ‘------~  Fe —
_, MeOH ' i ) sCHO OH
(167) (168)
. - N N THF/ Na2C 0 3 
Fe ___ ,— '
'N  N H N ^ .N
(170)
PCI3, pyridine 
THF
_ j 'C l 
Fe
Cl
(169)
Scheme 2.11. Synthesis o f  1,l'-(l-methylimidazole)ferrocene (170) from 1,1'- 
ferrocenyldicarboxaldehyde (167) via a dichloromethyl derivative 
(169).
As the yield for the last step was very poor (5%), it was envisaged that a tosylate 
group would be a better leaving group than the chloro group and so improve the 
efficiency o f the imidazole substitution. ( 1 ,1  '-Ferrocenylmethyl)-p-toluene sulphonate
(171) was prepared from the alcohol intermediate, />-toluenesulphonyl chloride and
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pyridine in chloroform (which had been purified and dried to remove any ethanol and 
water) affording a brown gum. However, it did not prove possible to displace the 
tosylate with the imidazole nucleophile (Scheme 2.12).
OH r .-—'77 OTs THF/Na2C 03
TsCI, pyridine — ' M7m
Fe -------------------------»- Fe ----------- :------------- •>■ (1 '° )
OH Me0H / =
HN .N
(168) (171)
Scheme 2.12. Attempt use o f a tosylate derivative to prepare 170.
Overall, this general route proved to be lengthy, inconvenient and inefficient, so a 
different method of introducing the azole functionality into the ferrocene system was 
required.
It had recently been reported in the literature that ferrocenyl alcohols can be linked to 
imidazoles using A^/V'-carbonyldiimidazole (CDI) as the reagent [134,135], Njar 
[179] extended the previously known, albeit very low-yielding, use of CDI to convert 
alcohols to imidazole functionalities by simply changing the solvent from DCM to 
acetonitrile. It was shown that nearly all types of alcohols, apart from tertiary 
alcohols, (i.e., primary, secondary, allylic, homoallylic, enolic, benzylic and phenolic 
alcohols) could be transformed into the desired imidazole or triazole in near 
quantitative yields. Simenel et al. [135] were able to prepare substituted ferrocenyl 
imidazoles by the treatment of the precursor ferrocenyl alcohols with CDI (Chapter 1, 
Section 1.4.1.1). Therefore, it was decided to treat 168 with CDI, preparing 170 in a 
yield of 71%. The reaction was carried out by heating to reflux all reagents for 4 h in 
acetonitrile under nitrogen. The product was then isolated by column
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chromatography, using DCM/methanol (50:50). This provided a very simple, high- 
yielding pathway from ferrocene to the desired bisimidazole product (170) (Scheme 
2.13).
o
MeCN
(168) + N N ' N 'N  ----------»- (170)
Scheme 2.13. The synthesis o f  1,l ’-bis(l-methylimidazole)ferrocene (170) from 1,1'- 
ferrocenedimethanol (168) using CDI.
However, this route could not be used for the benzimidazole derivative. Therefore, an 
alternative route rather than using 168 as the key intermediate was needed. In an 
analogous pathway to the preparation of the monosubstituted ferrocenyl-azoles from 
the ferrocenyl-methiodide salt (150) as the starting material, a procedure for the 
convenient synthesis of the bis derivative was found [180].
Glidewell et al. treated 1,1 '-dilithiated ferrocene with Eschenmoser’s salt -  N,N- 
dimethylmethyleneammonium iodide. However, due to commercial problems 
obtaining Eschenmoser’s salt, we used the chloride Schiff base -  NJV- 
dimethylmethyleneammonium chloride (172), prepared by the procedure of Dimmock 
et al. [181] -  producing exactly comparable results, and yielding 1, l'-bis(N,N- 
dimethylaminomethyl)ferrocene (173). This was methylated to the corresponding 
methiodide salt -  ferrocene-r-diylbis-(methyltrimethylammonium iodide) (174). 
Compound 174 was prepared in an overall yield of 57% from ferrocene. (Scheme 
2.14).
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0
1
CH, Cl + (CH3)2N N(CH3)2
c h 2ci2
o°c
CH,
C H ,= N
Cl
(172)
— ^  1 CHj Cl hexane
Fe + n-BuLi + TMEDA + C H ,= N *  Fe
CH'3  _
N(CH3)2 
N(CH3)2
(173)
Mel/MeOH
Fe
N(CH3)3
N(CH3)3 I
(174)
Scheme 2.14. Synthesis o f  ferrocene-1 -diylbis-(methyltrimethylammonium iodide) 
(174). using an adaptation o f  the procedure o f  Glidewell et al.
The preparation of 74 enabled us to use the same procedure as that for the 
monosubstituted ferrocenyl-azoles, where the azole could be substituted into the 
ferrocene unit by replacement of the methiodide groups (Scheme 2.15).
Fe
¿(ch^ i
N(CH3)j I
HN. .¿N
(174)
Fe_
J  r~> \
(145)
/ —\ 
N. . , N
Scheme 2.15. The proposed use o f  ferrocene-1 '-diylbis-fmethyltrimethylammonium 
iodide) (174) fo r  the preparation o f  l,l'-(l-methylazole)ferrocenes
(145).
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In an analogous procedure to the synthesis of the monosubstituted ferrocenyl-azole 
salts, the 1,1'-disubstituted ferrocenyl-azoles were prepared (Scheme 2.16). 
Compound 174, the desired azole and potassium carbonate in acetonitrile were heated 
to reflux and then purified by column chromatography. However, while the reaction 
was an overnight reaction for the monosubstituted ferrocenyl-azoles, 1 week was 
required to produced the 1,1'-disubstituted ferrocenyl-azoles. Both the imidazole and 
benzimidazole analogues -  170 and l,l'-bis-(l-methylbenzimidazole)ferrocene (175) 
-  were produced in yields of 12 and 20%. This shows that the while this is a useful 
route to the synthesis of the benzimidazole derivative, the reaction was too low- 
yielding to be of synthetic value for the imidazole derivative as compared to the CDI 
method. As can be seen from Table 2.2, the most efficient route proved to be via 
employment of CDI for the synthesis of 170.
— \
20%
(175)
Scheme 2.16. Preparation o f  l,l'-(l-methylazole)ferrocenes (145) — (170) and (175) 
-fro m  intermediate (174).
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Compound Compound no. Method Yield from ferrocene
(%)a
fc-CH 2-im b 170 via 169 2
via 168 and CDI 28
via 174 7
fc-CH 2-bzim b 175 via 174 12
“Based on yields of 167=45%, 168=39% and 174=58% from ferrocene. 
bfc=l,l'-Disubstituted ferrocene (as compared to Fc for 1-monosubstituted ferrocene).
Table 2.2. A comparison o f  the different methods employed to prepare the 1,1'-(1- 
methylazole)ferrocenes (145).
As to be expected the NMR data of the monosubstituted ferrocenyl-azoles and the 
l,r-(l-methylazole)ferrocenes correlate very closely. For the ferrocenyl-imidazole 
compounds, 148 and 170, and the ferrocene-benzimidazole compounds, 149 and 175, 
almost identical shifts are seen in the key functionalities of the ferrocene Cp rings, the 
methylene linker and the 2-CH group of the azole ring. As expected the most 
significant difference between the mono and disubstituted ferrocene-azoles are the 
integrations recorded. For example, the key integrations in the monosubstituted 1- 
methylferrocenylazoles (e.g., 149) are 9:2:1 for the Cp:-CH2- : 2 -Az protons 
compared to 8:4:2 for the l,r-(l-methylazole)ferrocenes (e.g., 175, Figure 2.8)
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Fe
(175)
F ig u re 2.8. The lH NM R spectra o f 1 7 5  (CDCI3).
The quartemisation of these compounds was achieved in the same way as with the 
monosubstituted compounds. The bisazole-ferrocenyl systems were heated to reflux 
in acetonitrile with the appropriate haloalkane. The compounds produced by this 
procedure are shown in Scheme 2.17. It was decided to concentrate on 
benzimidazolium salts as they were the most easily prepared.
1.2.2.2.2 l,l'-Bis(l-alkyl-3-methylazolium) ferrocenyl salts
R
CH3 (176) 60%
C4H8 (177) 75%
Scheme 2.17. The preparation o f 1,1 -bis(l-alkyl-3-methylazolium)ferrocenyi salts 
(176) and (177).
The methyl and «-butyl salts were produced. The product precipitated out of the 
reaction mixture and was collected by filtration. Further purification was carried out 
by column chromatography. NMR analysis showed that the product had been 
prepared (Figures 2.9 and 2.10). However, microanalysis showed that some impurities 
remained that could not be removed by chromatography or crystallisation. Thus, it 
was concluded that the bisazolium salts -  both the bridged and l,l'-bisazolium 
ferrocenyl derivatives -  were harder to isolate as completely pure products than the 
monosubstituted analogues.
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Again, analogous to the monosubstituted compounds, the trimethylammonium iodide 
salt, 174, was treated with a 1-alkylimidazole to see if  the l,l'-bis(l-methyl-3- 
methylimidazolium)ferrocenyl diiodide could be prepared without the 
ferrocenyl-azole intermediate (170) (Scheme 2.18). However, after heating 174 with 
1-methylimidazole in acetonitrile for 7 days no product was formed, showing that this
I
(174) + CH,— N N
K2C03
\  i Fe
\  /  N . t  N CH3
MeCN CH3
2 I
(178)
is not a viable method for the preparation of 1,1 '-bis( 1 -alkyl-3-
methylazolium)ferrocenyl salts.
Scheme 2.18. Treatment o f  174 with 1-methylimidazole as an alternative route to
1,1 -bis(l-alkyl-3-methylimidazolium)ferrocenyl salts.
On formation of the azolium centre, as in the monosubstituted ferrocenyl-azolium 
compounds, salts 176 and 177 showed a large shift in the signal for the 2-CH of the 
azolium moiety and a significant shift of the methylene linker resonance compared to 
the neutral intermediates, 170 and 175. For compounds 175 and 176, 2-CH resonates 
at 9.46 ppm, compared to 7.80 ppm, and Cp-CH2-  resonates at 5.40 vs. 4.92 ppm, 
respectively, in the *H NMR spectra. A comparison of the
ferrocenyl-benzimidazole/benzimidazolium compounds is given in Figure 2.9 and the 
*H spectra for 176 are given in Figure 2.10.
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Figure 2.9. The key 1H NMR resonances fo r  175, 156 and 179.
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Figure 2.10. 'H  NMR spectra o f 167.
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2.2.3 Ferrocenylcyclophanes
2.2.3.1 1,1 -Ferrocenediazole systems
The preparation o f l,r-ferrocenediazole systems where the azole and ferrocene units 
are directly linked (without any bridging -CH 2-  spacer group) was attempted, with 
the same initial aim as with the l,l'-(l-methylazole)ferrocene systems (145): to 
prepare a neutral (l,l'-ferrocene)diazole compound (180) as a building block for a 
cyclophane structure, such as (179) or (180) (Figure 2.11).
(179) (18°)
Figure 2.11. Proposed macrocyclic ferrocenyl-azolium systems (179) and (180) and 
intermediate (178).
The proposed method o f preparation of 178 was based on copper-catalysed aromatic 
nucleophilic substitution. It has been well-recorded that nitrogen nucleophiles will 
readily undergo nucleophilic aromatic substitution if  an appropriate copper catalyst is
2 x-
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used, e.g., the Rosenmund-von Braun reaction and the Ullman condensation 
[182,183]. Sato and Ebine, were able to perform the Gabriel synthesis using 1,1'- 
dibromoferrocene (181) to produce l,l'-bis(phthalimido)ferrocene (182) in moderate 
yields [184] (Scheme 2.19) using this approach.
O
Scheme 2.19. Preparation o f 1 ,1 -bis(phthalimido)ferrocene (182) from  1,1 - 
dibromoferrocene (181) via the Gabriel synthesis.
The Gabriel synthesis of mono(phthalimido)ferrocene has also been performed using
1-ferrocenylboronic acid, ‘copper phthalimide’ (derived from the metathesis of 
potassium phthalimide) and dry acetone as the solvent [185]. Both of these 
investigations show that ferrocene is capable of undergoing nucleophilic aromatic 
copper-catalysed substitution with a nitrogen nucleophile. This work suggests that 
l,l'-ferrocenyldihalides (X=Br, 181) and (X=I, 183) could be used as substrate 
molecules for copper-catalysed nucleophilic substitution with azole compounds 
(Scheme 2.20).
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X
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(183)
(178)
Scheme 2.20. The proposed method fo r  the synthesis o f  1,1 '-ferrocenediazoles (180).
This basic reaction was tried many times, using l,l'-dibromoferrocene (1 8 1 ) and 1,1'- 
diiodoferrocene (1 8 3 ) as the substrates in various solvents (DMF, water, DCM and 
pyridine) with copper acetate, copper(I) oxide, ‘copper imidazole’ and ‘copper 
benzimidazolium’ (obtained by metathesis of sodium imidazolium) as sources of 
copper and with benzimidazole, imidazole, sodium imidazolium and benzimidazolium 
as the azole nucleophiles.
These attempts proved unsuccessful in preparing the target compounds (178). Thus, it 
was concluded that copper catalysed nucleophilic substitution of azole entities into the 
ferrocene structure via bromo or iodo intermediates was not viable. Possibly steric 
factors could be responsible. The approach of two azoles to the relatively small 
ferrocene molecule to displace two halo groups may be difficult. Also the halo groups 
may not have been sufficiently electron withdrawing for the activation of ferrocene to 
nucleophilic displacement.
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Therefore, attention was concentrated on realising the proposed series of 1- 
ferrocenylmethylazolium and l,r-bis(l-alkyl-3-methylazolium)ferrocenyl salt 
systems, which contain a -C H 2-  spacer (179 and 180).
2.2.3.2 Macrocyclic tetraazolium -ferrocenyl salts
Thus far, the acyclic linear bridged bisazolium-ferrocenyl salts (164) and (165), 1,1'- 
bisazolium-ferrocenyl salts (176 and 177) and the ‘claw’-type 1,3- 
di(ferrocenylmethyl)azolium salts (161) and (162) had been prepared. The next step 
was extending these systems to produce a macrocycle.
Chemoreceptors with a cavity have shown superior selectivity, being able to 
discriminate between guests due to the set geometry of the cavity. So while the 
acyclic ferrocenyl-azolium systems were able to co-ordinate with anions [125,126], a 
ferrocenyl-azolium salt with a cleft of a specific geometry and topology may be able 
to offer greater selectivity with regard to anion recognition. The two target 
macrocycles are shown in Figure 2.12. The targets, 143 and 144, contain two different 
types of cavities, with two and four azolium centres, respectively. Compound 143 
possesses a more rigid cleft, whereas 144 could have more flexibility. Therefore, it 
was of interest to prepare the two and then compare their respective ionophore 
properties.
Fe
'N. ,-N +
-N X .
Fe
(CH,)— N<:- ,N
Fe Fe
,N" N—  ( Chy— X
(143) (144)
Figure 2.12. Proposed ferrocenyl-azolium macrocycles (143) and (144).
4X -
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Compound 143 was to be prepared in a similar manner to the 1,3- 
di(ferrocenylmethyl)azolium iodides (161) and (162). Compounds 161 and 162 were 
prepared by the reaction o f the intermediate 1-ferrocenylmethylazole (148) and (149) 
with the mono-substituted ferrocenyl methiodide salt (150) in a 1:1 stoichiometry. In 
order to prepare compound 143, the l,l'-bis-(l-methylbenzimidazole)ferrocene (175) 
was treated with the disubstituted ferrocenyl methiodide salt (174) in an analogous 
method: heating to reflux in acetonitrile (Scheme 2.21). However, this reaction was 
not successful. After nearly 2 weeks of heating, with constant monitoring of the 
reaction by t.l.c., no new product could be observed.
MeCN
■ Im ( 1 4 8 ) ------------a
(148) Bzim (149) Na2C 03
Az
Im (161) 
Bzim (162)
K2COa
(174) +  (175) — r —
MeCN
(186)
Scheme 2.21. Attempted synthesis o f  a ‘cage ’-type macrocycle from 174 and 175.
120
Therefore, it was concluded that this reaction may not work or would be too time- 
consuming or low-yielding to be of practical use. It was seen that reaction of the 
monosubstituted ferrocenyl methiodide salt (150) with the 1-methylferrocenylazole 
requires much longer reaction times than that of the reaction of the 1- 
methylferrocenylazoles with alkyl halides. Furthermore, the preparation of the 1,1'- 
bis(methylazole)ferrocenes from the bis ferrocenyl methiodide salt (174) is much 
more low yielding than the corresponding preparation of the 1-methylferrocenylazoles 
from 150. It appears that as the substitution on the ferrocene compound increases, the 
approach of an incoming nucleophile is hindered, especially in this case as the 
nucleophile is a l,r-bis(methylazole)ferrocene, which is also subject to being 
anchored by the ferrocene skeleton, further restricting any freedom of movement. The 
preferred conformation of 175 is thought to be with the two benzimidazole rings on 
opposite sides of the ferrocene unit. In order to form the macrocycle 186, 175 would 
have to have the two benzimidazole rings orientated on the same side of the ring, and 
so obviously would be more unstable due to repulsive steric effects (Figure 2.13). So 
it could be concluded that there is too much steric hindrance for this reaction to 
proceed.
Figure 2.13. The (a) preferred conformation o f 175 and (b) more unstable form.
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However, the preparation of the macrocyclic structure 144 with four azolium centres 
linking two ferrocene units was successfully carried out. The same synthetic route 
used to prepare the linear bisazolium-ferrocenyl salts (164) and (166) was employed. 
1,4-Diidobutane was again chosen as the spacer group, which was used to treat 1,1'- 
bis(l-methylbenzimidazole)ferrocene (175) to obtain the iodo- intermediate bis[l- 
(l,r-ferrocenylmethyl)-3-(4-iodobutyl)]benzimidazolium iodide (185). Reaction of 
this compound with a further aliquot of 175 gave the final macrocycle -  bis{ 1-[(1,1'- 
ferrocenylmethyl-3-butyl)benzimidazolium]-3-ferrocenylmethyl}benzimidazolium 
tetraiodide (186) (Scheme 2.22).
MeCN
(185)
MeCN (175)
i
y
I 4 I
" N ^ N —  (CH2)4-—
Fe Fe
(186)
Scheme 2.22. Preparation o fb is{ l-[(l,l -ferrocenylmethyl-3-butyl)benzimidazoliumJ 
-3-ferrocenylmethyl}benzimidazolium tetraiodide (186).
Both compounds were obtained by heating to reflux in acetonitrile for 2 h, then 
stirring at room temperature for a day. A precipitate was formed, collected by 
filtration and washed with diethyl ether. Both the intermediate (185) and the product 
(186) are insoluble in most solvents, being only soluble in DMSO and DMF, so 
further purification by column chromatography or crystallisation was not possible. 
Fortunately, while it was shown that some impurities were present, possibly 
polymeric products or salt impurities, 186 was approximately 90% pure. The yields 
obtained were 22% for 185 and 33% for 186, with an overall yield from 175 of 7%.
The ‘H NMR spectrum of 186 is given in Figure 2.14. The 2-bzim H peak is seen at 
9.84 ppm, the methylene linker is at 5.77 ppm and the butyl chain peaks are at 4.44 
and 2.01 for -CH7CH7CH7CH?- and -CH2CH2CH2CH2-, respectively. These shifts 
compare well with the shifts for compounds 164 and 166.
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Figure 2.14. The ' HN MR spectra o f  186 (DMSO-d¿).
Computer modelling experiments, conducted by Dr Dermot Brougham o f  Dublin City 
University, showed that 186 may exist as different rotameric isomers. There are 
several possible rotamers o f  this compound where the contortion o f  the 
benzimidazolium moieties and the butyl spacer groups leads to different cavity 
shapes. In Figures 2.15 and 2.16, four different projected geometries are given using 
MM+ and PM3 optimisation. Figure 2.17, four possible rotamers are given in a space 
filling computer modelling projections. The existence o f  186 as different rotational 
isomers could explain the poor resolution o f  the signals in the 'H NMR.
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Figure 2.15. M M \ optimisation o f  a model o f  I he structure. The Fe atoms are 
removed, showing the Cp rings to be constrained to be 3.32A apart. The 
cavity is asymmetric; c. 5.5x8.5A  (aspect ratio 1:1.55).
F igure 2.16. PM3 optimisation o f  186 (starting at MM+ opt geometiy; using no
constraints), showing an asymmetric cavity; c. 8 .5x10.5 A  (aspect ratio 
1:1.24).
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F igure 2.17. Computer modelling projections o f  fo u r  possible rotamers o f  186, using 
PM 3 optimisation.
2 .3  Conclusion
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A range o f monosubstituted 1-methylfeirocenylazolium salts was prepared along with 
the l,l'-bis(l-methylazolium)feirdcenyl iodide analogues. The monosubstituted 1- 
methylferrocenylazolium salts were prepared either from 1-methylferrocenylazole or 
from (ferrocenylmethyl)trimethylaxmnonium iodide (150). The syntheses were simple 
and high-yielding (Scheme 2.23).
N(CH3)3 1"
R - N  N
(150)
c o y  N v  N~ R
Fe
ch3
c2h5
c 3h7
C4H9
X
(151)
(152)
(153)
(154)
1 X
N(CH3)3 I k 2c o 3 r |  ^
2 3„  7 7  — N .^ .N -R
(150) HN— N
' Fe
Az
Im (148)
Bz (149) Az R X
Im CH2C6H5 Cl (155)
Bzim CH3 I (156)
Bzim C2H5 I (157)
Bzim C3H7 I (158)
Bzim C4H9 I (159)
Bzim CH2CeH5 Cl
Scheme 2.23. The preparation o f  the l-methylferrocenyl-3-alkylazolium halides
(151)-{160).
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While the 1-methylferrocenylazolium halides were prepared in a simple route from 
(ferrocenylmethyl)trimethylammonium iodide (150), a novel synthetic route was 
needed to obtain the l,r-bis(azolium)ferrocenyl salts. A few different procedures 
were employed to obtain the precursor l,l'-bis(l-methylazole)ferrocene compound. 
Two efficient routes were found: the treatment of l.l'-ferrocenyldimethanol (168) 
with CDI to yield l,l'-bis(l-methylimidazole)ferrocene (170) and the treatment of 
ferrocene-r-diylbis-(methyltrimethylammonium iodide) (174) with benzimidazole 
and potassium carbonate to yield 175. These intermediates were then treated with the 
appropriate alkyl halide to obtain the azolium salt (Scheme 2.24).
Fe
(168)
OH
OH
+ N N N N
0
■I MeCN Fe
/= \
N
f= \  
'N . N
(170)
N(CH3)3
N(CH3)3
(174)
K2C 0 3
+ / —X
R—N^. ,N
Fe
(175)
Rl
Fe
2 I
<'
\
R
CH3 (176) 
C4H9 (177)
Scheme 2.24. The preparation o f 1,1 -bis(l-methylazolium)ferrocenyl iodides (176 
and 177).
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The coupling of two 1-methylferrocenylazole compounds to prepare linear 
bisazolium-ferrocenyl compounds (164) and (166) was carried out. The 1- 
methylferrocenylazoles were used as the starting materials and an «-butyl group was 
the spacer (Scheme 2.25).
N N +  (CH2)4I2 MeCN
Fe
Az
lm (148) 
Bz (149)
^ ' N.. - N
Fe
Az
lm (163) 
Bz (165)
Fe
'm I]4*]1 j MeCN Bz (149) )
N. >N+—  (CH2)4 +N . ,N '
2 I
Fe I
Az
lm (164) 
Bz (166)
Scheme 2.25. The preparation o f  the l-[(l-ferrocenylmethyl-3-butyl)azoliumJ-3- 
ferrocenylmethylazolium diiodides (164) and (166).
This system was extended to the preparation of the benzimidazolium cyclophane 
(186) (Figure 2.18, see Scheme 2.22). This is a novel tetracationic, macrocycle that 
has a flexible cavity, thus, it is a very interesting compound structurally and has a lot 
of potential for application in systems requiring selective associations.
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Figure 2.18. Benzimidazolium cyclophane (186).
Thus, a series of ferrocenyl-azolium systems had been prepared for application in 
transition metal-mediated catalysis, chemorecognition and antimicrobial activity. The 
compounds ranged from simple monosubstituted ferrocenyl-azolium salts and 
bisazolium-ferrocenyl systems, linked by an alkyl spacer or the ferrocene unit, to a 
macrocyclic tetrabenzimidazolium-ferrocenyl cyclophane.
Chapter 3
Application of Azolium Systems to Transition 
Metal Catalysed Cross-Coupling Reactions: the
Heck Reaction
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3 .1  R e su lts  a n d  d iscu ssion
3.1.1 Azolium salts as auxiliary ligands in the Heck reaction
In order to investigate the catalytic properties of the monosubstituted 
ferrocenyl-azolium salts and the chelate bisazolium-ferrocenyl salts, a very simple 
Heck reaction system was chosen. Ethyl acrylate and a substituted bromobenzene 
together with sodium acetate as the base, DMF as the solvent and Pd(OAc)2 as the 
catalyst precursor were employed (Scheme 3.1). The DMF/sodium acetate/Pd(OAc)2 
system had previously been shown to be a highly effective system [186] using 
triphenylphosphine as the auxiliary ligand. Therefore, in order to base a comparison, 
two additional reaction runs were carried out: one with triphenylphosphine as a co-
Br
c 0 2Et DMF, 120°C, N2
+ ___  + NaAcO --------------------- >
,  ^ I
. Pd(OAc)2, ligand
R
r =n o 2, c h o
ligand and one without any ligand.
Scheme 3.1. The Heck reaction system employed.
The ferrocenyl-azole compounds used were varied. In each case, the following 
imidazolium and benzimidazolium analogues were employed: the methyl and butyl 
salts of the monosubstituted ferrocenyl-azolium salts (151), (154), (156) and (159); 
l,3-di(ferrocenylmethyl)azolium iodides (161) and (162); the bridged structures (164) 
and (166) and the l,r-di(l-methyl-3-benzimidazolium)ferrocenyl salts (176). The 
reaction conditions employed were as follows: DMF as solvent, 1.25 equivalents of
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sodium acetate, Pd(OAc)2 at 1 mol%, the ligand at 1 mol% for bidentate ligands or at
2 mol% for monodentate ligands, under nitrogen, for 24 h and at 120°C.
The first reaction to be carried out was the coupling o f bromobenzaldehyde and ethyl 
acrylate. The relative yields are shown in Table 3.1. It was observed that the 
imidazolium ligands outperformed the benzimidazolium ligands. Salt 151 produced a 
product yield of 95%; however, the benzimidazolium analogue 156 only produced a 
yield of 42%. It was also found that the monodentate ligands performed better than 
the bidentate ligands. The yield with compound 164 was 85%, which was less than 
that of 151. It should noted that compound 151 performed on a comparable level with 
tripheny Iphosphine.
Compound Yield (%)
151 95
156 42
164 85
176 41
PPh3 100
No auxiliary ligand 3
Table 3.1. A comparison o f  the yields fo r  the cross-coupling reaction between 4- 
bromobenzaldehyde and methyl acrylate using ferrocenyl-azolium salts as 
auxiliary ligands.
The second set of reactions was the coupling of 4-bromonitrobenzene with ethyl 
acrylate. However, with this set of reactions, while overall all the ferrocenyl-azoles
133
performed very well in relation to triphenylphosphine, a couple of patterns emerge 
which show that the benzimidazolium salts performed slightly better than the 
imidazolium salts. Compound 156 produced a higher yield than 151 (89 vs. 74%). 
Also while there proved to be no significant difference between the monodentate and 
bidentate ligands (Table 3.2), the bidentate ligands did produce slightly higher yields.
Compound Yield (%)
151 74
156 89
154 78
162 91
164 94
166 85
177 91
PPh3 100
No auxiliary ligand 20
Table 3.2. A comparison o f  the yields fo r  the cross-coupling reaction between 4- 
bromonitrobenzene and ethyl acrylate using ferrocenyl-azolium salts as 
auxiliary ligands.
In the Heck reaction the role of the ligand in the catalytic cycle is essential to the 
efficiency of the reaction. So far the exact mechanism by which the ligand stabilises 
the palladium centre is unknown; however, from experimental studies it has been 
concluded that electron donating and/or sterically demanding ligands are able to 
promote the reaction as outlined in Chapter 1 [59-61].
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Scheme 3.2 The mechanism o f the Heck reaction with N-heterocyclic carbene ligands 
as the auxiliary ligands.
The precursor Pd(II) complex [Pd(HCN)2h] (HCN=W-heterocyclic carbene) is 
generated in situ (Scheme 3.2) by the reaction of an imidazolium salt with Pd(OAc)2- 
Reduction of this complex forms the co-ordinatively unsaturated 14-electron complex 
[Pd(HCN)2], which is the catalytically active species. This complex then undergoes a 
nucleophilic attack on the aryl halide to give the oxidative addition product. It is this 
step which is recognised as being the rate determining step. Then, via migratory
135
insertion and reductive elimination the aryl and alkene species are coupled and the 
catalyst is regenerated.
The effect of the imidazolium and benzimidazolium salt compounds on the Heck 
reaction efficiencies are best examined with the results from the reaction between 4- 
bromobenzaldehyde and ethyl acrylate. 4-Nitrobromobenzene is a highly activated 
system towards cross-coupling reactions and so distinctive patterns in the catalytic 
efficiencies of different ligands are harder to discern. However, the aldehyde group is 
not as activating towards this reaction, so the relative efficiencies of the different 
compounds as auxiliary ligands are easier to evaluate.
It was seen that the imidazolium salts (151 and 164) increased the product yield much 
more effectively than the benzimidazolium salts (156 and 176). This indicates that 
there are clear differences between the stability of the imidazolium and 
benzimidazolium palladium complexes that are formed during the catalytic cycle. So 
far there have not been any reported comparative studies in the literature on the 
stability of imidazolylidene and benzimidazolylidene palladium complexes.
As the rate determining step is the oxidative addition of the aryl halide to the metal 
centre [59], it is the availability of the Pd(0) species and its ‘nucleophilicity’ that will 
determine the reaction rate. As both azolium salts are known to readily form carbene 
complexes perhaps it is the relative nucleophilicity of the resulting azolylidene Pd(0) 
complexes that determines which one will be the more effective auxiliary ligand in 
the catalytic cycle. As the benzimidazolium 2-H is known to be more acidic than the 
imidazolium 2-H, it would seem that the imidazole ring would be able to act as a
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better electron donor and, thus, increase the nucleophilicity of the resulting Pd(0) 
complex. In this study the imidazolium salts have been shown to be more effective in 
the reaction between ethyl acrylate and 4-bromobenzaldehyde and so it can be 
concluded that the imidazolylidene complexes are more electron rich and thus more 
nucleophilic.
However, in the case of the 4-nitrobromobenzene and ethyl acrylate, the 
benzimidazolium salts perform considerably better than in the first reaction, almost 
doubling their efficiencies. As the 4-nitrobromobenzene is such a highly activated 
system, perhaps the electronic factors that may have been responsible for the 
imidazolium salts performing well in the first reaction are not as important in this 
reaction. The efficiency of triphenylphosphine as an auxiliary ligand has been 
attributed to its bulkiness as well its electron donating abilities, therefore in this 
reaction perhaps the extra bulk of the benzimidazolium moiety adds to its efficiency, 
thus making it a more effective auxiliary ligand relative to the imidazolium ligand.
On examination of both reactions, there appears to be little appreciable difference 
between the monosubstituted and disubstituted azolium salts. In the literature some 
groups have found chelating azolium ligands can promote organometallic cross- 
coupling reactions more effectively [64], while others have seen monosubstituted 
azolium ligands to be more effective [42], In the first reaction with 
bromobenzaldehyde, it is seen that the l-methylferrocenyl-3-methylimidazolium 
iodide (151) is more efficient than the bridged bisimidazolium iodide (164), while the
l-methylferrocenyl-3-methylbenzimidazolium iodide (156) and 1 ,l'-bis(l-methyl-3- 
methylbenzimidazolium)ferrocenyl iodide (176) salts show the same reactivity. In the
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second reaction, the reaction yields are all fairly similar so it is more difficult to 
identify relationships.
In conclusion, it has been shown that the ferrocenyl-azolium salts are effective 
auxiliary ligands in the catalysis of the Heck reaction. It has been shown that the 
effectiveness of these salts as ligands, however, depends on the system employed. It 
can be argued that for a less activated system, such as the olefination of 4- 
bromobenzaldehyde, electronic factors are more important and, therefore, the 
imidazolium salts and monosubstituted ligands are more effective. If a more activated 
system is considered, such as the 4-bromonitrobenzene, it is seen that steric factors 
have a greater priority. Therefore the benzimidazolium salts become more effective 
than the imdazolium salts. This interplay of steric and electronic factors should be 
considered when applying a salt as a potential auxiliary ligand in organometallic 
cross-coupling reactions.
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Ionic liquids are ideal candidates for use in biphasic catalysis. As such, a system can 
be designed where the appropriate ionic liquid is coupled together with an organic 
solvent that it is immiscible with. The organic reactants, and the products, will be 
contained in the organic phase, while the ionic liquid will then be able to provide a 
weakly co-ordinating medium to dissolve the catalyst (very often transition metal 
complexes) and be able to recycle it. Or ionic liquids may be found to be superior 
solvents for the reaction and replace the organic solvent completely, with the products 
being collected by distillation. Thus, the ionic liquids may enable recycling of the 
catalyst.
The use of a 1,3-dialkylimidazolium salt as a solvent in homogenous catalysis was 
examined. It was decided that the Heck reaction would provide a good model system. 
Presently, due to their favourable characteristics, it is the 1-methylimidazolium-based 
ionic liquids that are the most commonly used and investigated systems. One of the 
most popular of these in use currently is [BMIMJPF6 (189). It is a neutral (non-acidic) 
stoichiometric compound, has a viscosity of 3.12 g cm-3 s at 30°C, is air and moisture 
insensitive and is inexpensive to prepare. It was this salt that we decided to employ as 
the solvent for the Heck reaction. We hoped to prove that the Heck reaction can be 
carried out in 189 and that the catalyst and ionic liquid could be recycled.
The Heck reaction has so far been carried out in the tetraalkylammonium and 
tetraalkylphosphonium salts. Kaufmann et al. first used tetraalkylammonium and 
tetraalkylphosphonium bromides in which to immobilise the Pd(0) catalyst precursor 
[61]. The vinylation of bromobenzene by «-butyl acryate to butyl iraHS-cinnamate
3.1.2 Azolium salts as solvents for the Heck reaction
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was successfully carried out in these melts at 100°C and the product was collected by 
distillation.
Hermann and Böhm used tetraalkylammonium melts also, and showed that they were 
superior to the commonly used aprotic organic solvents used, such as DMF [44]. In 
one example, a molten [NBiuJBr (m.p.=103°C) system with bromobenzene and 
styrene and a diiodobis(l,3-dimethylimidazolin-2-ylidene)palladium(II) catalyst 
produced stilbene in a 99% yield compared to the 20% yield when DMF was the 
reaction medium used. Furthermore, they demonstrated easy product isolation using 
distillation and were able to recycle the catalyst.
For our investigation we selected a simple model system, using a number of 
bromobenzene derivatives with methyl acrylate and Pd(OAc)2/PPh3 as the catalytic 
system and sodium acetate as the base (see Scheme 3.3). A comparative study was 
then performed, between DMF and [BMIM]PF6, to determine the efficiency of 
[BMIM]PF6 for the Heck reaction.
C 02Me
R
C 02Me
R
OCHa
N02
CHO
Cl
H
(190)
(191)
(192)
(193)
(194)
Scheme 3.3. The model Heck reaction system used.
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The reaction conditions used were as follows: the catalytic system of Pd(OAc)2/PPh3 
was added to the ionic liquid and after slight heating and stirring was fully dissolved, 
then the base (sodium carbonate), bromobenzene derivative and methyl acrylate were 
added. The reaction mixture was heated to 140°C with stirring for 17 h. After 
completion of the reaction, two work-up procedures were attempted. The first of these 
involved the addition of water to the reaction mixture with thorough stirring and 
separation to remove the halide salt by-products. After removal of the water and 
subsequent filtering, the ionic liquid was extracted with diethyl ether and the products 
were dried over MgSCU, filtered and evaporated to dryness, then finally purified on 
silica gel using dichloromethane. The products were identified by *H NMR 
spectroscopy, and all the spectral data for the compounds were found to be in 
agreement with those given in the literature [186-190].
The alternative work-up procedure involved the addition of water to the reaction 
mixture followed by its removal and filtration. The reaction was then heated under 
vacuum and the product collected by distillation. Using both of these methods the 
product was efficiently collected and the ionic liquid/palladium catalyst was reused 
and the reaction repeated with similar yields being obtained, thus showing that the 
palladium catalytic system had remained in the ionic liquid and was still active. The 
results are given in Table 3.3.
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Product Solvent Yield (%)
190 DMF 35
[BMIMJPF6 29
191 DMF 95
[BMIM]PF6 83
192 DMF 70
[BMIMJPFs 62
193 DMF 70
[BMIM]PF6 69
194 DMF 76
[BMIM]PF6 61
Table 3.3. The yields o f  the products from the model Heck reactions (using the 
separation technique o f work-up).
It was found that the yields of the reactions carried out in DMF and [BMIM]PF6 were 
comparable. Although the yields of the products from the DMF system were slightly 
higher, this could be due to the reaction conditions not being fully optimized as these 
were a preliminary qualitative set of experiments. Also, for a set volume of ionic 
liquid used, a substantially greater amount of product can be produced due to the 
recyclability of the catalyst.
It appears that there was negligible leaching of the catalyst, since when the ionic 
liquid was used the catalyst could be recycled for a repeat reaction. Each yield was 
similar, any slight decrease could be due to the slight loss of solvent in the work up 
procedure, and hence loss of the catalyst. Also, a solution of ionic liquid with
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Pd(OAc)2/PPh3 contained in it was extracted with water six times, then diethyl ether 
six times. Upon removal of the water and diethyl ether, respectively, catalyst was 
recovered, indicating that the extraction techniques used in the work-up procedures do 
not remove the catalyst from the ionic liquid.
Therefore, it can be concluded that [BMIM]PF6 can be used as a viable, efficient 
solvent for the Heck reaction, having comparable efficiency to the most commonly 
used solvent, DMF. Furthermore, it provides the advantage of being able to anchor the 
catalyst in solution enabling it to be reused for further reactions to be carried out. 
Hence, after product isolation the palladium moiety is not lost, unlike in the DMF 
system. Thus, the ionic liquids clearly show that they would offer obvious 
environmental and economical advantages over the presently used organic solvents.
3.2  C onclu sion
Thus, it has been shown that azolium salts can aid transition metal-mediated cross­
coupling reactions in two ways: First they can act as auxiliary ligands for palladium in 
the Heck reaction, as has already been reported; however, we have shown that the 
ferrocenyl-azolium salts were able to aid the catalysis of the Heck reaction and that 
benzimidazolium salts could be as effective as the imidazolium ligands in certain 
systems.
Second, while the use of air and moisture stable azolium salts that are liquid at room 
temperature in transition metal catalysis has been the subject of many investigations, 
it has now been shown that they are able to act as efficient solvents in the Heck 
reaction and are capable of retaining the catalyst for repeated use.
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Chapter 4
Biological and Chemoreceptor Studies on 
Ferrocenyl-Azolium Compounds
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As demonstrated in Chapter 1, the azole/azolium class o f compounds is remarkably 
versatile in its functions. Having employed azolium salts in the catalysis of cross­
coupling reactions and as solvents in the Heck reaction, their application to anion 
recognition and biological objectives was examined.
One area of biological relevance (and environmental applications) where there is a 
lively field of research is anion recognition. Anions play a role in numerous biological 
and chemical processes and have great impact in both medicine and the environment. 
For example, many metabolic systems and pathological pathways are dependent on 
anions, e.g., the misregulation of chloride channels will result in cystic fibrosis and 
Alzheimer's has been linked to anion-binding enzymes.
Azolium salts are now beginning to be applied as ionophores. They make very 
attractive centres for anion co-ordination as they have the ability to form hydrogen 
bonds with anions through the acidic 2-H and electrostatic interactions between the 
positively charged azolium ring and the negatively charged ion. If they are then 
introduced into a system that allows only selective co-ordination then a very efficient 
system could be developed.
One of the rationales behind the design of these compounds was that their selectivity 
as anion chemoreceptors could be examined. It has been reported that simple 
monosubstituted ferrocenyl-imidazolium and ferrocenyl-benzimidazolium systems 
were capable of anion co-ordination [125,126]. However, these systems did not show 
any selectivity, an essential feature in a chemoreceptor for practical application. The
4.1 Introduction
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macrocyclic salt and the bisazolium-ferrocenyl salts prepared (Chapter 2) were 
proposed to be an extension to the early prototype monosubstituted
ferrocenyl-azolium salts (Chapter 1, Figure 1.25, [125,126]). It was thought that these 
bisazolium-ferrocenyl salts could ‘wrap’ around the anion, thus, having a three- 
dimensional structure induced in them by an anion of a particular geometry or the 
cavity in the macrocycle, could ‘hold’ an anion (Figure 4.1). Perhaps through one of 
these modes of binding a greater degree of selectivity for anion binding might be 
observed.
Of the compounds prepared, the bridged l-[(l-ferrocenylmethyl-3-
butyl)imidazolium]-3-ferrocenylmethylimidazoIium diiodide (164), the 1,1'-
bisazolium ferrocenyl -  1, l'-bis( 1 -methyl-3-/z-butylbenzimidazolium)ferrocenyl
iodide (177) and the macrocyclic salt -  bis{l-[(l,l'-ferrocenylmethyl-3-
butyl)benzimidazolium]-3-ferrocenylmethyl}benzimidazolium tetraiodide (186)
ligands were chosen for anion recognition studies. These compounds and their
possible co-ordination modes with anions are shown in Figure 4.1 (195-197).
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(197)
Figure 4.1. The application o f  compounds 164, 177 and 186 as anion receptors, 
forming complexes 195-197.
4.2 Results and discussion
4.2.1 !H  NM R titration studies
Anion co-ordination studies were attempted on compounds 164, 177 and 186 to see if 
these ligands would selectivity bind to anions, thus conferring a greater degree of 
specificity than the ferrocenyl-azolium salts (83-87) already investigated [125,126]. 
In compounds where hydrogen bonding is thought to be one of the main modes of 
anion co-ordination, *H NMR spectroscopy titration experiments were used to 
evaluate the degree o f anion binding. The reports of 1,3-dialkylazolium salts as anion
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chemoreceptors have shown that the signal conesponding to the 2-H proton shifts 
significantly downfield on addition o f  anion guests [105,107-111,125,126], Thus, ]H 
NMR spectroscopy is a valuable tool for the monitoring o f  host-guest interactions. 
Compounds 164 and 177 were chosen as they represented a comparison o f  the spacer 
group and a comparison o f  the azolium functionalities. Furthermore, they were 
soluble in acetonitrile-c^, the solvent that had been used in the previous anion binding 
studies.
Stoichiometric amounts o f  various anions as their tetrabutylammonium salts, [NBilJX  
(X=C1, Br, I, N 0 3, HSO4) were added to solutions o f  the ferrocenyl-azolium salts in 
acetonitrile-i/3. In our NM R titration experiments, we were aiming to observe the 
interaction o f a ligand with a specific anion only.
Equivalents of Anion Added
F igure 4.2 P lot o f  chem ical shift o f  C-2 proton o f  164 versus equivalent o f  anion 
added in acetonitrile-d3.
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It would appear from Figure 4.2 that 164 is interacting with all o f  the halides. The 
titration results indicate that 164 binds with bromide in a 1:4 stoichiometric ratio, 
alternatively it would seem that 164 binds with iodide in a 1:2 ratio. For bromide, we 
believe that both anion exchange and H-bonding with 164 is occurring, in the case o f  
iodide we observe solely H-bonding since 164 is an iodide salt. Chloride is interesting 
in that it would appear that a 1:1 complex with 164 has occurred. Chloride may bind 
with 164 in a chelate fashion as outlined by structure 195. The oxyanion, nitrate, 
interacts with 164 in a non-stoichiometric fashion, thus, binding ratios and mode o f  
binding cannot be determined.
Titration data for 177 is outlined in Figure 4.3.
Equivalents of Anion Added
F igure  4.3. P lo t o f  chem ical shift o f  the C-2 proton o f  1 77  versus equivalent o f  anion 
added in acetonitrile-d3.
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The titration data for 177 again show interaction between the ligand and all anions. 
Determination of stoichiometric binding from this data is not possible, it would 
appear that the proposed mode of binding for 177, as outlined in Figure 4.1 (196), is 
not occurring. Perhaps the cleft outlined in 196 is either too small to fit the halides 
tested or there is too much steric hindrance between the benzimidazole groups on the 
ferrocene to form the proposed binding cleft in the first place.
The benzimidazolium cyclophane (186), however, proved to be too insoluble for *H 
NMR titration experiments to be conducted, as it was only soluble in DSMO-r/6- A 
control titration experiment was carried out with 162 (previously carried out in 
acetonitrile [126]) in DMSO-c4. Results of this experiment showed no shift in the C-2 
proton chemical shift upon addition of anion. This result is contrary to what was 
found in acetonitrile and can be best explained by the strong solvating effect of 
DMSO-c/6. Thus DMSO-i/6 is not a suitable solvent for these imidazole/benzimidazole 
systems. We will be testing 186 using potentiometric techniques, particularly ion 
selective electrode analysis. Results of this testing are not available at this time.
4.2.2 Antimicrobial activities of ferrocenyl-azoles and ferrocenyl-azolium 
compounds
It was decided to screen the antimicrobial activities of the ferrocenyl-azole/azolium 
compounds against a yeast, Candida albicans, and a Gram-negative bacterium, 
Pseudomonas aeruginosa. Both of these microbes form biofilms that are resistant to 
antimicrobial agents [191] and have been recognised as opportunistic pathogens that 
infect immunocompromised human hosts [192,193], The Candida species are the 
principal etiological agents o f nosocomical fungal infections, of which C. albicans is
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the most abundant and significant [194], C. albicans forms biofilms in vitro on 
various inert surfaces and under different nutrient conditions, and hence can cause 
infections associated with biomedial implants [195-198]. P. aeruginosa is one of the 
most nosocomical acquired pathogens and has a great ability to adapt to varied 
environments. Thus, it is found ubiquitously in hospitals, and is nearly impossible to 
eliminate from hospital environments, has a wide range of pathogencity and, 
therefore, poses a great threat to seriously immunocomprised individuals in care
[199].
A representative selection of the ferrocenyl-azole/azolium salts prepared was 
screened for their antibiotic capabilities against P. aeruginosa and C. albicans. These 
antimicrobial screenings were carried out by Dr Alan Farrell and Dr Brid Quilty from 
the School of Biotechnology, Dublin City University. The compounds tested were the 
neutral 1-methylferrocenylazoles (148 and 149), l-methylferrocenyl-3-methylazolium 
iodides (151 and 156), l,3-di(l-methylferrocenyl)azolium iodides (161 and 162) and 
the l-[(l-ferrocenylmethyl-3-butyl)benzimidazolium]-3-ferrocenylmethylazolium 
diiodides (164 and 166). The results are given in Tables 4.1 and 4.2 for P. aeruginosa 
and C. albicans, respectively.
The antibiotic activities were calculated as reductions in cell growth calculated using 
the following formula:
reduction in grow th={[(C-5)-(r-5)]/C -5)}xl00, 
where C is the average absorbance per well for control wells (organism with no 
compound), B is the average absorbance per well for blank wells (no organism with
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no broth) and T  is the average absorbance per well for treated wells (organism and 
compound).
Compound Percentage reduction in growth (%)
Compound concentration (|xg ml-1)
25 50 75 100 250 500
1-Ferrocenylmethylazoles (148 and 149)
148 0.00 10.27 0.00 9.08 6.38 0.00
149 0.00 30.80 29.40 210.29 0.00 0.00
l-Ferrocenylmethyl-3-methylazole iodides (151 and 156)
151 2.16 0.00 0.00 0.00 0.00 0.00
156 0.00 0.00 6.59 17.19 21.18 28.43
1,3-Di(l -methylferrocenyl)azolium iodides (161 and 162)
161 0.00 5.30 0.00 7.67 0.00 0.00
162 0.00 0.00 0.00 0.00 2.81 0.00
l-[(l-Ferrocenylmethyl-3-butyl)benzimidazolium]-3-ferrocenylmethylazolium diiodides (164
and 166)
164 0.00 13.29 0.00 1.84 8.75 18.37
166 0.16 31.02 11.02 15.02 0.00 0.00
Table 4.1. The antimicrobial activities o f  ferrocenyI-azole compounds against P. 
aeruginosa.
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Compound Percentage reduction in growth (%)
Compound concentration (|ig ml-1)
25 50 75 10 0 250 500
1-Ferrocenylmethylazoles (148 and 149)
148 0.00 0.00 0.53 0.16 0.00 0.00
149 3.72 6.10 6.35 5.23 9.11 11.23
l-Ferrocenylmethyl-3-methylazole iodides (151 and 156)
151 0.00 0.41 0.78 0.00 1.35 33.89
156 0 .0 0  0.0 0  0 .0 0 0.00 2 .2 2 0.47
l,3-Di(l-methylferrocenyl)azolium iodides (161 and 162)
161 3.72 18.18 21.69 11.30 71.95 88.16
162 2.10 2.85 1.85 0.00 0.00 0.00
l-[(l-Ferrocenylmethyl-3-butyl)benzimidazolium]-3-ferrocenylmethylazolium diiodides (164
and 166)
164 0.00 1.47 2.79 1.97 4.73 7.54
166 3.10 12.74 30.14 89.60 91.16 90.60
Table 4.2. The antimicrobial activities o f  ferrocenyl-azole compounds against C. 
albicans.
From the data summarised in Tables 4.1 and 4.2, it can be seen that some of the 
ferrocenyl-azolium compounds are showing antifungal activity. All compounds 
tested gave very poor responses as antibacterial agents.
It would appear that compounds 161 and 166 have excellent potential as antifungal 
agents with calculated LD50 values of 175 and 84 |ig ml-1, respectively. It is
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interesting to note that both 161 and 166 are bisferrocenyl-azolium derivatives. It 
would appear that both the neutral and charged monoazole-ferrocenyl compounds 
show little bioactivity. The presence of two ferrocenes seems to be essential for 
bioactivity. Perhaps the ferrocene groups are playing an electrochemical role, as has 
been seen with ferrocenyl antimalarials [126]. To better understand the bioactivity of 
both 161 and 166 a series o f structural modifications on these compounds will have to 
performed in the future and from these studies a new pharmacophore can be 
generated.
4.3 Conclusion
In the employment of ferrocenyl-azole/azolium salts to biological applications, it has 
been shown that the ferrocenyl-azolium salts have potential as pharmocophores but 
would need great optimisation of the current compounds for use as ionophores.
The !H NMR titration experiments showed that selected bisazolium-ferrocenyl 
compounds were capable of interaction with anions. Compound 164 showed 
prefential binding with chloride, binding in a 1:1 stoichiometry; however, salt 177 did 
not show any such specificity and did not show the same degree of anion co­
ordination as 164. Perhaps 164 was able to wrap around the chloride anion in the way 
predicted, while 177 is a too sterically constrained system for this mode of anion co­
ordination. Thus, the «-butyl spacer group appears to allow the conformational change 
necessary in anion co-ordination as opposed to the ferrocene unit which appears not 
to. It was hypothesised that of the ferrocenyl-azolium systems developed macrocycle 
186 would be able to co-ordinate most selectively to anions due to its cavity.
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However, 186 proved to be only soluble in DMSO-dô, which unfortunately proved to 
be a poor solvent for the observation o f anion binding.
Two bisferrocenyl-azolium compounds (161 and 166) were able to act as very 
effective antifungal agents against C. albicans with impressive LD50 values being 
observed in antimicrobial testing. However, they did not show any significant 
antibacterial activity against P. aeruginosa.
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Chapter 5
Design and Synthesis of 
Ferrocenyl-Azole-Phosphine Systems
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As the application of the ferrocenyl-azolium salts to catalysis, complexation and 
anion recognition had proved successful, we decided to introduce another co­
ordinating functionality into the ferrocenyl-azolium salts. The purpose of this was so 
that it could act as a second co-ordination point in addition to the carbene moiety that 
could be generated in the case of complex formation. Ideally, it was thought that it 
should be a different functionality and so have different ligating properties, thereby 
creating a hemilabile ligand.
A hemilabile ligand can often increase the reactivity of a catalyst compared to an inert 
diphosphine system. In some instances, a very weak chelate is needed to activate a 
transition metal to act in a catalytic system. But on the other hand, a strong chelate 
ligands can perform very well in asymmetric catalysis by not allowing unselective 
monodentate ligands to compete and reduce the enantioselectivity of the calalyst. 
Therefore, in addition to the carbene co-ordination point, a phosphine functionality 
seemed a good choice for the second group to create a bidentate ligand, as the 
efficiency o f the phenylphosphines as ligands is well known.
The target compounds are shown in (Figure 5.1). The first compound was based on 
the introduction of a diphenylphosphine on the second Cp ring o f the 
ferrocene-azolium salt, giving a l-diphenylphopsphine-r-(l-alkyl-3-
methyl)imdazolium ferrocenyl salt (198) -  a 1,1'-disubstituted ferrocene. The second 
compound has a diphenylphosphine functionality introduced onto the same Cp ring as 
the azolium ring on the ferrocene, thereby creating a chiral 1 -diphenylphopsphine-2- 
(l-alkyl-3-methylimidazolium)ferrocenyl salt (199) -  a 1,2-disubstituted ferrocene.
5.1 Introduction
157
(198) (199)
Figure 5.1. The proposed ferrocenyl-azolium systems with the introduction o f  a 
phosphine functionality.
5.2 Results and discussion
5.2.1 Synthesis of a l-diphenylphopsphine-l'-(l-alkyl-3-methyl)imdazoIium
ferrocenyl salt
A very convenient starting point for the preparation of (198) was the ferrocenophane 
-  (l,r-ferrocenediyl)phenylphosphine (200) -  which could be nucleophilically 
opened using phenyl lithium. This allows the desired diphenylphosphine group to be 
generated on one Cp ring, while the other is open to reaction with an electrophile. 
This was seen as perhaps the best way to introduce the imidazole or other precusor 
functional groups.
It was decided to employ DMF as the electrophile, resulting in the formation of an 
aldehyde group. From here simple reduction to an alcohol was envisaged. The next 
step was the linking of the imidazole species via the alcohol and finally conversion to 
the imidazolium salt.
While these were the major steps, a further stage was required: the protection of the 
phosphine group so that it would not be converted to a phosphonium ion during
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alkylation of the imidazole. The final step would then be the deprotection of the 
phosphorus yielding the desired product 198. (See Scheme 5.1 for the outline o f the 
synthetic route to 198).
(205) (206) (207)
Scheme 5.1. Synthetic outline o f  the preparation o f 198.
5.2.1.1 Synthesis o f f l  '-(diphenylphosphinosulphide) ferrocenyl]methanol (204) 
The starting point of the synthesis was the preparation of the ferrocenophane (200)
[200], which was then nucleophilically opened using phenyl lithium (Scheme 5.2).
# t t 
Reaction o f the 1 -(diphenylphosphmo)lithioferrocene intermediate (201) with DMF
and subsequent crystallisation gave r-(diphenylphosphino)ferrocenecarboxaldehyde
[Fe(^5-C5H4PPh2)(775-CsH4CHO)] (202) in 69% yield. Reduction of 202 to the
159
methylhydroxy functionality using sodium borohydride then afforded [1'- 
(diphenylphosphino)ferrocenyl]methanol [Fe( //-CsELtPPl^X ^ -CsILiCtkOH)] (203).
The diphenylphosphine group was protected by conversion into a phosphine sulphide 
(P=S) group. This was achieved by reaction of 203 with sulphur in dry benzene, 
giving [l'-(diphenylphosphinosulphide)feiTOcenyl]methanol {Fe[ 77s-
C5H4P(S)Ph2](775-C5H4CH2 0 H)} (204) in a yield of 65% after purification by column 
chromatography.
Fe
BuLi/TMEDA
S
H
/ — pph,
Fe
OH
(204)
(200)
LiPh
C c> > — PPh,
Fe PPh ---------^  Fe
CH3(CH2)4CH3 Et20  / "
1— PPh
PhH
Fe
(203)
OH
(201)
'2 NaBH,
MeOH
Fe
(202)
-PPh,
-CHO
Scheme 5.2. Synthesis o f  {V-(diphenylphosphinosulphide)ferrocenyl}methanol (204).
The structures of 202-204 were confirmed by NMR and IR spectroscopy and 
microanalysis. The standard techniques of 'H, 13C and 31P NMR spectroscopy allowed
the structures to be determined, with the shifts being consistent with previously
* * 1 1 ^  reported compounds. The methylene shift at 4.28 and 60.42 ppm m the H and C
NMR spectra, respectively, for 204 is noteworthy as this becomes an important
barometer of change in the adjoining functional group. The phosphorus NMR
160
spectrum of 203 has a chemical shift of -16.3 ppm. This is shifted to a value of 42.6 
ppm with the introduction of sulphur.
5.2.1.2 Introduction o f  the imidazole (205)
Once, the alcohol was obtained and the phosphorus protected, then the imidazole 
moiety was introduced to give compound 205, which could then be converted to the 
imidazolium salt (206). This was attempted in two ways: conversion of the hydroxy 
group to a tosylate derivative for the nucleophilic substitution of imidazole or the use 
o f CDI with the alcohol.
5.2.1.2.1 Tosylation
Using a procedure reported in the literature [201], the preparation of a tosylate 
followed by displacement by an imidazole in situ was attempted (Scheme 5.3). Here 
204, />-tosyl chloride, sodium hydride and imidazole were stirred overnight in 
dimethoxyethane (DME) under nitrogen. However, this was unsuccessful. So the 
intermediate tosylate (208) was prepared by reaction of 204 with /»-tosyl chloride and 
pyridine in chloroform at room temperature for 4 h. Purification was attempted by 
column chromatography. This proved very difficult and a yield of over 100% was 
observed, showing that impurities were still present. However, *H NMR spectroscopy 
showed the introduction o f a -C H 3 group, the shift of the -C H ?0 - protons from 4.28 
to 5.82 ppm and a large multiplet of aromatic protons with an integration of 
approximately 14, indicating that 208 had been prepared. No further characterisation 
was carried out, due to the difficulties in purification.
161
HN ,'N 1 Na2C03/Me0H
y
(205)
Scheme 5.3. Attempted synthesis o f 205 via a tosylate intermediate (208) (i) without 
isolation o f208 and (ii) with isolation o f208.
It was felt that 208 could be reacted further and the final purification carried out after 
the substitution of the imidazole. Compound 208 was treated with sodium 
imidazolium to see if it could nucleophilically displace the tosylate and yield 1- 
diphenylphosphinosulphide-r-(l-methylimidazole) ferrocene (205). However, this 
was unsuccessful, as was the case with the l,l'-bis(l-methylimidazole)ferrocene 
(170). It appears that nucleophilic substitution of a tosylate with an imidazole moiety 
does not work for these ferrocene systems, possibly due to steric factors. The 
approach of the imidazole to the electrophilic carbon may be hindered by the 
ferrocene, tosylate and bulky diphenylphosphine groups. It could be argued that the 
ferrocene system is too constrained to allow nucleophilic displacement of such a large 
leaving group as the tosylate.
5.2.1.2.2 Using CDI
An alternative method using CDI was attempted. Treatment of 204 with CDI in 
acetonitrile produced 205 in a yield of 61% after purification by column 
chromatography (Scheme 5.4).
MeCN
(204) + CDI ------------  (205)
(61%)
Scheme 5.4. The introduction o f imidazole to obtain 205.
The 'l l  and 13C NMR spectra confirmed the replacement of the -O H  functionality 
with the imidazole unit. The -O H  peak at 2.04 ppm was lost and the characteristic 
imidazole peaks at 6.79, 6.95 and 7.20 ppm (5-H, 4-H and 2-H Im) were seen, as was 
confirmed with the 13C NMR spectrum with three additional peaks at 84.86, 134.20 
and 135.22 ppm (2-H, 4-H and 5-H Im, respectively). Also a change in the chemical 
shift for the methylene linkage was seen in both the *H and 13C NMR spectra, from 
4.28 to 4.65 ppm and 60.42 to 46.28 ppm, respectively. Furthermore, in the IR spectra 
the broad O-H  band at 3467 cm-1 disappeared indicating the loss of the -O H  group.
5.2.1.3 Quarternisation o f  the imidazole moiety
Using the established procedure of treating an imidazole species with an alkyl iodide 
to obtain an imidazolium salt, 205 was refluxed in iodoethane, whereupon adding 
diethyl ether, a yellow precipitate was formed and collected (see Scheme 5.5) in a 
yield of 94%, giving l-diphenylphosphinosulphide-l'-(l-ethyl-3-methyl)imdazolium 
ferrocenyl iodide { F e f^ -C sH ^ S jP h ^ -C s^ C H ^ H a N z C H z C H j)}  I (209).
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Scheme 5.5. Preparation o f  1-diphenylphosphinosulphide-l '-(l-ethyl-3- 
methyl)imdazolium ferrocenyl iodide (209).
There was clear confirmation by !H and l3C NMR spectroscopy of the formation of 
the imidazolium sait as the proton and carbon at the 2-position of the 
imidazole/imidazolium shifted from 7.20 ppm in (205) to 10.04 ppm in (209) and 
from 84.86 to 207.48 ppm, due to the increased acidity of the proton. The 'H NMR 
spectra for 205 and 209 are given in Figure 5.2.
Figure 5.2. lH  NMR spectra fo r  205 and209 (CDCI3).
The deprotection o f the phosphine group was the next stage in the total synthesis of 
the l-diphenylphopsphine-r-(l-alkyl-3-methyl)imdazolium ferrocenyl salt (198). 
Due to having trace amounts of 209, the deprotection was attempted using a model 
compound (210) (Scheme 5.6). Raney nickel was used as the deprotecting agent 
[202], however, in monitoring the reaction by t.l.c., none of the deprotected 
compound (211) was observed
(210) (2 1 1 )
Scheme 5.6. The attempted deprotection o f  a diphenyl phosphinosnlphide using a 
Raney nickel on a model system.
Thus, it was concluded that either this reaction did not work in these conditions or 
only a very poor yield would be obtained. So it was decided that the sulphide could 
potentially be used as a co-ordination point instead of the phosphorus. This could 
demonstrate a novel bidentate ligand, as no mixed sulphide-nitrogen or 
sulphide-carbene ligands have been reported in the literature.
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5.2.2 Attempted synthesis of a l-diphenyIphopsphine-2-(l-alkyl-3- 
methylimidazolium)ferrocenyI salt (199)
The synthesis of a 1,2-ferrocenyl-azole-phosphine system -  1-diphenylphopsphine-
2-(l-alkyl-3-methylimidazolium)ferrocenyl salt (199) -  leading to a chiral system had 
no obvious starting point as with (198). Although the preparation of a ferrocene 
structure with planar chirality was envisaged, we realised that a resolution step would 
be required.
Three possible methods were employed to prepare 199: the first involved the 
introduction of a diphenylphosphine substituent onto the Cp ring of ferrocene 
followed by the introduction of imidazole; the second involved the introduction of 
diphenylphosphine into the ferrocene-imidazole system; the third involved the 
introduction of the diphenylphosphine into a ferrocenyl-imidazolium salt.
5.2.2.1 Route 1: via the synthesis o f  l-diphenylphosphino-l -acetoferrocene 
(213)
(R,S)~ 1 -Diphenylphosphino-2-(dimethylaminomethyl)ferrocene (212) [203] was seen 
as a potential starting material as the diphenylphosphine group was already present 
and with an amino substituent in a 1,2-relationship with it. By manipulation of this 
group, it was envisaged that the imidazole could be substituted into this position. It 
was thought that changing the amino group to an acetate group would provide a better 
leaving group. Therefore, using the route of Hayashi et al. [204], the amino 
substituent was replaced with an acetate functionality by heating 212 to reflux in 
acetic anhydride producing l,2-bis(diphenylphosphino)ferrocene methyl acetate (213) 
as orange crystals in a yield of 45% (Scheme 5.7).
The next step involved the displacement of the acetate group with the imidazole unit. 
This was attempted using imidazole and sodium carbonate to produce the imidazolide 
anion in situ by refluxing in methanol. Both imidazole and 1-methylimidazole were 
employed as potential nucleophiles with the target compounds being 1- 
diphenylphosphino-2-(l-methylimdiazole)ferrocene (214) and 1-diphenylphosphino-
2-(l-methyl-3-methylimidazolium)ferrocenyl acetate (215) (Scheme 5.7). However, 
neither of these methods were successful in producing either of the targets.
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Scheme 5.7. Attempted synthesis o f 214 and 215 via 213.
5.2.2.2 Route 2: via phosphorylation o f  1-methylferrocenyl imidazole
This route was based on introducing the diphenylphosphine after the imidazole unit as 
outlined in Scheme 5.8. Using 1-methylferrocenylimidazole (148) as the starting 
material, the aim was to substitute the phosphine entity into the Cp ring, protect the 
phosphorus, convert the system into an imidazolium salt and deprotect the 
phosphorus.
168
s(199) (217)
Scheme 5.8. Synthetic outline o f  the preparation o f a l-diphenylphopsphine-2-(l- 
alkyl-3-methylimidazolium)ferrocenyl salt (199) from 148.
So it was devised that l-(methyiferrocenyl) imidazole (148) would be used as the 
starting material and the experimental method employed was the same as found in the 
literature for the addition of a diphenylphosphine group to the Cp ring of a ferrocene 
[204]. It was thought that the a-H of ferrocene would be abstracted with n- 
butyllithium, and using chorodiphenylphosphine, the diphenylphosphine functionality 
would be nucleophilically substituted into the Cp ring ortho to the ¿V-methylimidazole 
moiety.
However, it was found that under the reaction conditions employed [143], with 
diethyl ether as the solvent, at -78°C, under nitrogen with stirring, that this reaction 
did not proceed and two different products were yielded. l-(Methylferrocenyl)-2- 
(diphenylphosphine) imidazole (211) and l-(methylferrocenyl)-2-
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(diphenylphosphineoxide)imidazole (218) were produced in yields of 31 and 22%, 
respectively, and none of the desired product (214) (Scheme 5.9).
N >N i. n-BuLiii. PPh2CI N N W  N^ N
Fe
Fe +
Et20, -70°C, N2 Fe PPh. 0 = P P h 2
(148)
(211)
31% 22%
(218)
Scheme 5.9. Products o f  the phosphorylation o f  148.
This shows that of the two available acidic hydrogens, the ferrocene a-H and 
imidazole 2-H, it was the 2-H on the imidazole that was abstracted by the «-butyl 
lithium and not the ferrocene a-R  as was wanted. The p v a l u e s  for both the 
unsubstituted ferrocene a-H and the imidazole 2-H are very similar at 15.00 and 
14.52, respectively, with the imidazole 2-H being only slightly more acidic. So it 
could have been predicted that maybe a mixture of both the isomers would be 
produced -  211 and 214. As this was not the case, it could be suggested that in 148 
the imidazole hydrogen is significantly more acidic, so will be abstracted first, or 
alternatively steric factors could be responsible. Perhaps access of the butyl anion to 
the ferrocene a-R
is hindered by the imidazole group, so the imidazole 2-H will be abstracted 
preferentially.
The 'H and 13C NMR data for 211 and 218 are very similar to that of. the parent 
compound 148 (Figure 5.3). The key signals of the methylene linker, 4-im H and 5-im 
H are shifted downfield, with the diphenylphosphine oxide product showing the 
greatest shift in signals due to the introduction of the electronegative oxygen atom.
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Figure 5.3. The !HNM R shifts fo r  compounds 148, 211 and 218.
The most significant change is seen in the 31P NMR shifts. In 211, the phosphorus 
resonates at -31.53 ppm, while in 218 it resonates at 20.93 ppm. Despite this the 
structures of these compounds could not be fully determined by NMR spectroscopy, 
so X-ray crystallographic determinations were carried out to fully elucidate their 
structures (Chapter 6).
As the diphenylphosphine oxide (218) chalogenide had been prepared, it was thought 
that the sulphide analogue would be an interesting future ligand also. So 211 was 
heated to reflux with sulphur in benzene, which after purification by column 
chromatography, gave 1 -(methylferrocenyl)-2-(diphenylphosphineoxide)imidazole 
(210) in a yield of 84% (Scheme 5.10).
f = \
(211)
(210)
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Scheme 5.10. Preparation o f  gave l-(methylferrocenyl)-2-(diphenylphosphineoxide) 
imidazole (210).
The phosphorus 31P NMR shift was found to be 30.73 ppm. This compares with 
-31.53 ppm for 211 and +20.93 for 218 ppm. This compound was completely 
characterised by NMR, IR and microanalysis.
The phosphorylation reaction was carried out using (1- 
methylfeixocenyl)benzimidazole (149) under the same reaction conditions (Scheme 
5.11). Again none of the desired [l-diphenylphosphine-2-(l- 
methylbenzimidazole)]ferrocene was prepared, but l-(methylferrocenyl)-2- 
(diphenylphosphine)benzimidazole (219) was isolated in the absence of any oxide. 
The pA^ a of the 2-H of benzimidazole is more acidic that than of imidazole -  
(PKa=13.2) and the benzimidazole even bulkier, so it is unsurprising that none of the
1,2-disubstituted ferrocene product was produced.
Fe Et20 , -78°C, N.
(149) (219)
Scheme 5.11. Phosphorylation o f  149.
In comparison with 149, the shifts in the ’H NMR spectrum are very similar. The Fc 
Cp protons resonate at 4.19-4.23, -C H 2-  at 5.42, 6,7-Bzim H at 7.26, 8-Bzim H at 
7.45 and 5-Bzim H at 7.84 ppm. The only marked difference is the downfield shift of
the methylene group and the disappearance of the 2-bzim proton, as to be expected. 
The phosphorus resonates at -27.48 ppm, which is very close to that of 211. This 
along with microanalysis confirmed that the phosphorus had not been oxidised during 
the reaction.
5.2.2.3 Route 3: via phosphorylation o f l-(methylferrocenyl)-3-alkylimidazolium 
iodide
A third route was then attempted where the diphenylphosphine functionality would be 
introduced into a ferrocenyl-imidazolium salt by phosphorylation of a 1,3- 
dialkylimidazolium salt following the procedure of Brauer et al. [148]. Both 1- 
(methylferrocenyl)-3-ethylimidazolium iodide (81) andl-(methylferrocenyl)-3- 
butylimidazolium iodide (83) were employed (Scheme 5.12). This reaction failed, 
with no identifiable product being obtained and mostly starting material being 
recovered. Although in the reactions of Brauer, phosphorylation at the 2-position on 
the imidazolium ring was achieved, in our case neither phosphorylation of the 
ferrocene Cp nor the imidazolium ring occurred.
I i. n-BuLi 
' '  " n S n - R  j ii. PPh2CI
Fe ^  *“
DCM, -78°C, N2
_|
R = Et (81), Bt (83)
Scheme 5.12. Attempted phosphorylation o f  l-(methylferrocenyl)-3-alkylimidazolium 
iodide salts.
R = Et, Bt 
(198)
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5.3 Conclusion
The aim of this work was to introduce a second functionality into the 
ferrocenyl-azolium framework that had already been developed (Chapter 2). The 
chosen functionality was diphenylphosphine (-PPI12) due to its co-ordination 
properties. Thus, an alternative class of chelate ligand to biazolium-ferrocenyl salt 
compounds could be realised. The target compounds were based on 198 and 199, so 
that a 1,1'-disubstituted ferrocene and a 1,2-disubstituted ferrocene could be prepared 
and investigated. Although neither of these target compounds were prepared, some 
novel compounds were obtained during our investigations.
Regarding, the first class of target compounds -  1,1'-disubstituted ferrocenes, 1- 
diphenylphosphinosulphide-l'-(l-methylimidazole) ferrocene (205) and 1- 
diphenylphosphinosulphide-l'-(l-ethyl-3-methyl)imdazolium ferrocenyl iodide (207) 
were prepared. Unfortunately the last reaction, which was the removal of the sulphide 
protection group, in this multi-step synthesis proved problematic, and as only trace 
amounts of product 207 were available, the total preparation could not be finished. 
However, compounds 205 and 207 are very interesting. Sulphur is a good co­
ordinating group as well, so the sulphur in these compounds has replaced the 
phosphorus as the planned second co-ordinating functionality. Therefore, perhaps 
these ferrocenyl-sulphide-azolium systems could act as novel mixed 
sulphide/nitrogen or sulphide/carbene ligands.
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1,2-disubstituted ferrocenes, the synthesis of l-diphenylphopsphine-2-(l-alkyl-3 - 
methylazolium)ferrocenyl salts (199) did not yield any success. However, several 
novel compounds had been produced during the attempts to prepare 199 (210, 211, 
218 and 219). While phosphine functionalised imidazoles are known in the literature 
[140-152], they have not been investigated fully, and diphenylphosphine 
functionalised benzimidazoles have not really been prepared or studied at all apart 
from a couple of rare instances [205], These compounds have a lot of potential as 
mixed P,N donor ligands. Additionally, also the sulphide analogues were prepared as 
comparative compounds to the oxide (218) -  l-(methylferrocenyl)-2 -
(diphenylphosphinosulphide)imidazole (210) -  so that a full investigation of the co­
ordination properties o f these ligands could be carried out in future work.
In  the preparation o f the second class o f ferrocene-phosphine-azolium systems, the
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Chapter 6
Crystallographic Studies of 
Ferrocenyl-Imidazole-Diphenylphosphine
Compounds
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As full characterisation o f the two products of the phosphorylation reaction o f 148 -  
211 and 218 -  was not possible by NMR and IR spectroscopy and microanalysis, 
crystals were grown for X-ray structural characterisation. From a DCM/hexane 
solution, needle-like crystals that were suitable for crystallographic studies were 
grown. These X-ray ciystallographic studies were performed by Dr John Gallagher of 
the School of Chemical Sciences, Dublin City University. Figure 6.1 shows a 
perspective view o f 211 and 218 with the atomic numbering scheme assigned. All the 
pertinent crystallographic information is summarised in Table 6.1 for 211 and 218. 
Selected bond distances and angles of the non-hydrogen atoms are given in Table 6 .2 , 
with the full crystallographic analysis given in Appendix 1.
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Figure 6.1. ORTEP drawing o f  the crystal structures o f  l-(methylferrocenyl)-2- 
(diphenylphosphine)imidazole (211) and l-(methylferrocenyl)-2- 
(diphenylphosphineoxide)imidazole (218).
2 1 1 218
Identification code 3-04psi 2-04psi
Empirical formula C26H23FeN2P C26H23F eN2ÛP
Formula weight 450.28 466.28
Temperature (K) 294(2) 293(2)
Wavelength (A) 0.71073 0.71073
Unit cell dimensions
a (A) 15.9066(9) 11.3019(10)
6(A ) 7.9153(8) 7.9563(6)
c (  A) 17.9153(8) 24.449(2)
« (°) 90 90
p n 103.089(4) 99.572(6)
r n 90 90
Volume (A3) 2140.1(3) 2167.9(3)
Z 4 4
Calculated density (Mg 1.398 1.429
n f 3)
Absorption coefficient 0.795 0.791
(mm-1)
F(0 0 0 ) 936 968
Crystal size (mm) 0.52x0.45x0.35 0.42x0.38x0.25
Grange for data collection 2.40-28.06 1.88-45.45
(°)
Index ranges - 1 <A<2 1 , - 10 <£<1 , -\4< h< l,-l< k< \0 ,
-23</<22 -32</<32
Reflections collected 6508 6872
Independent reflections 5173 (i?im=0.1033) 5253 (£int=0.0261)
Completeness to 20=45.45 92.9% 27.4%
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Max./min. transmission 
Refinement method
Data/restraints/parameters 
Goodness-of-fit on F1 
Final R indices [I>2o(I)\
R indices (all data)
Largest diff. peak and hole 
(e-A-3)
0.7683 and 0.6827 
Full-matrix least-squares 
on F2
5173/0/271
1.046
#1=0.0345, wJ?2=0.0870 
#1=0.0451, h# 2=0.0934 
0.485 and -0.263
0.8268 and 0.7324 
Full-matrix least-squares 
on F2
5253/0/280
1.049
#1=0.0458, w#2=0.1080 
#1=0.0696, w#2=0. 1211
0,535 and -0.315
Table 6.1. Crystal data and structure refinement fo r  211 and 218.
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Parameter Compound
211 218
C(2)—C(11) (À) 1.498(2) 1.504(4)
N(2)-C(2) (A) 1.477(2) 1.478(3)
N(2)-C(2)-C(l 1) (°) 111.58(14) 111.8(2)
N (l)-C (l) (À) 1.325(2) 1.330(3)
N(2)-C(l) (Â) 1.370(2) 1.360(3)
N (l)-C (l)-N (2) O 110.56(16) 111.4(2)
P (l)-C (l) (A) 1.8257(18) 1.804(2)
P(1)-C(31)(A) 1.8302(18) 1.803(2)
P(1>-C(41)(A) 1.8364(17) 1.808(2)
P (l)-0 (1 ) (A) - 1.4825(19)
C (l)-P(l)-C (31) (°) 104.06(8) 104.90(11)
C(l)-P(l)-C (41) (°) 101.22(8) 102.95(11)
C(31)-P(l)-C(41)(0) 101.01(8) 108.82(11)
0(1)—P(l)—C(31) (°) - 112.20(11)
o ( i ) - p ( i ) - c ( i )  n - 113.90(11)
0(1)-P(1)-C(41) (°) - 113.34(12)
Table 6.2. Selected bond distances (Â) and bond angles (°) fo r  211 and 218.
For 211, the mean distance from the Fe atom to the carbons of the Cp rings is 2.03442 
Â, which compares well with other reported ferrocene-azole structures, such as 1- 
methylferrocenyl-2-ferrocenylbenzimidazole (88) [127]. The internal C-C bond 
lengths in the Cp ring are 1.410-1.429 (mean 1.405 Â) for the substituted ring and
181
1.386-1.407 (mean 1.3902) for the unsubstituted ring. Thus, the bond lengths are 
slightly longer in the substituted Cp ring than the unsubstituted ring.
The bond lengths and angles for the imidazole nucleus are in agreement with other 
reported values for imidazole compounds, such as [(l-methyl-2-para- 
phenyl)imidazole]diphenylphosphine (128) [150]: N (2)-C(l) is 1.320(2) and 
C (l)-N (l) is 1.325(2) A for 211 compared to 1.323(2) and 1.366(2) A for 128, 
respectively, and the N (2)-C (l)-N (l) bond angle is 110.56(16)° for 211 compared to 
110.6(2)° for 128.
For the methylene spacer the C (ll)-C (2) bond length is slightly longer at 1.498 A 
and the N(2)-C(2) bond length is 1.477 A. While the angle of the bond angle of N(2)- 
C (2)-C (ll) is 111.58(14)°, which is similar to reported values for 88 and 1- 
methylferrocenyl-2-(4-methoxyphenyl)benzimidazole 85 [126] of 112.4(4)° and 
112.15(16)°, respectively.
The diphenylphosphine substituent has C-P bond lengths typical of other 
trisubstituted phosphine compounds. P (l)-C (l) measures 1.8257(18), P(l)-C(31) is 
1.8302(18) and P(l)-C(41) is 1.8364(17) A, which compares well to normal 
P-C(phenyl) bond lengths of 1.835 A [206]. The C -P -C  bond angles of C (l)-P ( l) -  
C(31)=104.06(8), C (l)-P(l)-C (41)=101.22(8) and C(31)-P(l)-C(41)=101.01(8)0 
also compare well to the expected value for C(alkyl)-P-C(phenyl) bond angles of 
-101° [206],
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In compound 218, the mean Fe-C distance is 2.0323 A, which compares well with 
other ferrocene-azole structures and is very close to the value for 211 of 2.03442 A. 
Again, the substituted Cp ring has slightly longer internal C-C bond lengths of 
1.418-1.429 A (mean 1.4196 A) compared to 1.384-1.422 A (mean 1.3974 A) for the 
unsubstituted ring.
The imidazole bond distances are very similar to those in 211, being 1.360(3) and 
1.330(3) A for N (2)-C (l) and C (l)-N (l) A. The N (2)-C (l)-N (l) bond angle is 
slightly wider at 114.4° compared to 110.56°. For the methylene spacer, the 
C(11)-C(2) bond length is 1.504(4) A, making it slightly longer than in 211, while the 
N(2)-C(2) bond length at is very nearly the same at 1.478(3) A compared to 211. The 
bond angle of N (2)-C(2)-C(l 1) is 111.8(2) is again very close to the expected value.
In 218, the diphenylphosphine substituent has been oxidised. The C-P bond lengths 
are shorter than those of 211 and other aryl phosphine compounds, with the mean 
P (l)-C  bond distance measuring 1.805 A, compared to a mean distance of 1.8307 A 
for 211. The P (l)-0 (1 ) bond distance is 1.4825(19) A which compares well to other 
P=0 bond distances of approximately 1.489 A [207]. The C -P -C  bond angles are 
close to that of 211, for the C (l)-P(l)-C (31) and C (l)-P(l)-C (41) angles the values 
are very close [104.90(11) and 102.95(11)° for 218 vs. 104.06(8) and 101.22(8) for 
211]. However, for C(31)-P(l)-C(41) there is a larger change in the angle from 
101.01(8) in 211 to 108.82(11)° in 218. The mean C -P (l)-0 (1 ) bond angle is 
113.14°, which is slightly smaller than other reported values of 118.6(1)° for 
diphenyl(ieri. -butylamino) phosphine oxide [207].
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Chapter 7
Conclusion
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Azole and azolium salt moieties are currently being employed in a great many 
applications. Having previously prepared a series of monosubstituted 
ferrocenyl-azolium salt compounds [125,126], it was decided to extend this range so 
that bisazolium-ferrocenyl and macrocyclic salts could be realised and together with 
their application in some of these research areas.
In this work we prepared l-ferrocenylmethy-3-alkylimidazolium halides, 1- 
ferrocenylmethy-3-alkylbenzimidazolium halides, thus, completing the series of 1- 
ferrocenylmethyl-3-alkylazolium halide salts. These were prepared from 1- 
ferrocenylmethylazole precursor molecules (148 and 149) or 
(ferrocenylmethyl)trimethylammonium iodide (150).
In order to incorporate two azolium functionalities into the ferrocenyl-azolium 
system, two routes were chosen. The first involved coupling two monosubstituted 
ferrocene-azole salts using the 1-ferrocenylmethylazole (148/149) and 1,4- 
diiodobutane as the starting materials. In this way l-[(l-ferrocenylmethyl-3- 
butyl)imidazolium]-3-ferrocenylmethylimidazolium diiodide (164) and 1-[(1- 
ferrocenylmethyl-3-butyl)imidazolium]-3-ferrocenylmethylbenzimidazolium diiodide
(166) were prepared. The second route involved introducing two azolium moieties 
onto each Cp ring of the ferrocene functionality, preparing l,r-bisazolium-ferrocenyl 
salts. The salts l,r-bis(l-methyl-3-methylbenzimidazolium)ferrocenyl iodide (176) 
and l,r-bis(l-«-butyl-3-methylbenzimidazolium)ferrocenyl (177) were obtained. 
Ferrocene-r-diylbis-(methyltrimethylammonium iodide) (174) was converted into
l,r-bis-(l-methylbenzimidazole)ferrocene (175), which was alkylated to yield the
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corresponding benzimidazolium salt. Finally, a novel macrocyclic ferrocenyl-azolium 
salt system was prepared. From 175, using the same procedure as that used to 
generate the acyclic analogues 164 and 166, bis{l-[(l,l'-feiTocenylmethyl-3- 
butyl)benzimidazolium]-3-ferrocenylmethyl}benzimidazolium tetraiodide (186) was 
prepared. Thus, a series of compounds comprising of monosubstituted 
ferrocenyl-imidazolium, monosubstituted ferrocenyl-benzimidazolium,
bisimidazolium-bisferrocenyl, bisbenzimidazolium-bisferrocenyl, 1,1'-
bisbenzimidazolium-ferrocenyl and macrocyclic tetrabenzimidazolium-bisferrocenyl 
cyclophane halide salts had been prepared. This diversity of azolium-ferrocenyl salts 
allowed the catalytic, chemoreceptor and biological properties of these azolium salts 
to be investigated.
Imidazolium salts are becoming increasingly recognised as stable alternatives to 
triarylphosphines as auxiliary ligands in transition metal-mediated catalysis. So far 
though, while benzimidazolium salts have been employed as yV-heterocyclic carbene 
precursors their application to transition metal catalysis has not been employed. It was 
shown that the ferrocenyl-azolium salts were able to act as effective catalysts in the 
Heck reaction and that benzimidazolium salts are also able to act as auxiliary ligands 
in these reactions. It was concluded that imidazolium and benzimidazolium salts 
possibly aid the catalysis of the Heck reaction in different ways, with the imidazolium 
systems being more suited to less activated systems, while the benzimidazolium salts 
proved to be more effective at catalysing more activated systems. However, no 
significant difference in the effects of the chelates and the monosubstituted 
ferrocenyl-azolium salts was seen. As the monosubstituted salts are prepared in 
higher yields, it must be concluded that these would be preferred ligands for use in
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organometallic coupling reactions. For complete analysis of the comparative 
efficiencies of the benzimidazolium and imidazolium salts on the Heck reaction, 
another set of reactions should be carried out in future work using a considerably less 
activated substrate, such as 4-bromoanisole.
Also it was shown that at ambient temperature the ionic liquid 1,3-dialkylimidazolium 
salt -  ([BMIMJPF6) -  was able to act as a highly efficient solvent for the Heck 
reaction. It was demonstrated to be recyclable, as the palladium catalyst remained in 
the ionic liquid after the work-up procedure. Furthermore, the product could be 
obtained by distillation, allowing easy isolation of the product and repeated use of the 
solvent. Employment of ionic liquids as solvents for organometallic processes has 
been an important development for environmental chemistry, as they could 
substantially reduce the amount of VOCs currently employed in industrial processes.
Selected salts were then applied to chemoreceptor studies (164 and 177). As the 
previously prepared monosubstituted ferrocenyl-azolium salts had shown anion co­
ordination properties, it was thought that perhaps the acyclic bisazolium-ferrocenyl or 
macrocyclic tetraazolium-ferrocenyl systems may be able to confer a greater degree 
o f selective anion binding by chelate anion co-ordination. Compound 164 was 
observed to form a 1:1 complex with chloride, and thus it appears to bind by wrapping 
around the anion. However, compound 177 did not show any selective binding. This 
is a more sterically demanding system with the bulky benzimidazolium rings being in 
such close proximity, so perhaps the system is too constrained for anion co-ordination 
in the manner proposed. Thus, it can be concluded that the bisazolium-ferrocenyl
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systems do not appear to offer an increase in selectivity compared to the 
monosubstituted ferrocenyl-azolium salts.
Macrocycle 186 proved to be to be only soluble in DMSO-i/6, which was determined 
not to be a suitable solvent for anion binding studies when tested with other 
compounds. Therefore, potentiometric techniques, such as ion selective electrode 
analysis, are needed to evaluate the anion co-ordination abilities of this salt, which 
will be carried out in future work.
Antimicrobial studies were carried out on key ferrocenyl-azole/azolium compounds, 
where a selection of compounds was screened against P. aeruginosa and C. albicans. 
It was observed that compounds 161 and 166 had good antifungal properties against 
C. albicans, having LD50 values of 175 and 84 (j.g ml-1, although no significant 
activity against P. aeruginosa was seen by any compounds. No significant differences 
between the charged azolium salts or the azole compounds were found. It was 
observed that azolium compounds with two ferrocene units in their structure had good 
antifungal properties, from which it has been suggested that the redox behaviour of 
the ferrocenes may be involved in this activity. Future work here would require the 
structural modifications o f the bisferrocenyl-bisazolium compounds for a lead 
compound to be established.
As the imidazolium salts are well known to be excellent precursors to iV-heterocyclic 
carbene co-ordination complexes, it was thought to be a novel idea to introduce a 
second co-ordination functionality into the ferrocenyl-azolium system. Thus, the 
preparation of a 1 , 1 '-disubstituted ferrocenyl salt system with an imidazolium nucleus
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on one Cp ring and a diphenyl(sulphido)phosphine entity on the second Cp ring and a 
range of 1-ferrocenylmethylazole-diphenylphosphine functionalised compounds was 
carried out. l-Diphenylphosphinosulphide-r-(l-methylimidazole) ferrocene (205) 
and l-diphenylphosphinosulphide-r-(l-ethyl-3-methyl)imdazolium ferrocenyl iodide 
(209) and l-(methylferrocenyl)-2-(diphenylphosphineoxide)imidazole (210), 1- 
(methylferrocenyl)-2-(diphenylphosphine)imidazole (211), l-(methylferrocenyl)-2- 
(diphenylphosphineoxide)imidazole (218) and l-(methylferrocenyl)-2- 
(diphenylphosphine)benzimidazole (219) were prepared as compounds that show 
great potential as ligands. The structure of compounds 211 and 218 were fully 
elucidated by X-ray crystallography. The application of these compounds as ligands 
in co-ordination compounds is an area of promising future work.
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Chapter 8
Experimental
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'I!  and 13C NMR spectra were recorded using a Bruker Avance 400 MHz 
spectrometer. IR spectra were recorded on a Perkin Elmer Spectrum GX FT-IR 
System. Microanalysis was performed at University College Dublin. The reagents and 
chemicals were obtained from the Aldrich Chemical Company (UK) and were used as 
received unless otherwise stated. Diethyl ether and THF were dried over sodium, 
acetonitrile was dried over 4 A molecular sieves, chloroform washed with water then 
dried over calcium chloride and pyridine, dichloromethane was stored over potassium 
carbonate and TMEDA was dried over sodium hydroxide pellets. All reactions were 
performed under a nitrogen atmosphere unless otherwise stated.
Synthesis:
1-Ferrocenylmethylimidazole (148)
A solution of (ferrocenylmethyl)trimethylammonium iodide (150) (3.05 g, 7.79 
mmol), sodium imidazolium salt (0.77 g, 18.57 mmol) in dry acetonitrile (75 ml) was 
refluxed for 24 h. The cooled solution was poured into water (100 ml) and extracted 
with chloroform (3x75 ml). The extracts were washed with water (2x50 ml), dried 
over MgSC>4, filtered and evaporated in vaccu to give an orange oil, which was 
purified by column chromatography on silica gel using DCM-methanol (95:5) as the 
eluant (1.43 g, 72% yield), m.p. 78 -81°C.
'H NMR (CDC13): ppm 4.09 (s, 7 H, Cp H), 4.13 (s, 2 H, Cp H), 4.80 (s, 2 H, 
Fc-CH 2-), 6.85 (s, 1 H, 5-im H), 6.95 (s, 1 H, 4-im H), 7.42 (s, 1 H, 2-im H). 13C 
NMR (CDC13): ppm 44.72 (Fc-CH2-), 68.77 (Cp C-H), 82.5 (Cp Cips0), 120.29 (5-im 
C), 122.03 (4-im C), 122.79 (2- Im C). IR (KBr) v(cm _1) 3051, 2971, 1506, 1219, 
1110, 1076, 1036, 1007, 990, 818, 731. Ci4H]4N2Fe (266.13): calculated C 63.18, 
H5.3, N 20.99; found: C 62.88, H 5.39, N 20.81%.
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A solution o f 150 (10.03 g, 26.05 mmol), benzimidazole (3.23 g, 27.35 mmol) and 
potassium carbonate (3.96 g, 28.66 mmol) in dry acetonitrile (100 ml) was heated to 
reflux for 12 h. The cooled solution was poured into water (100 ml) and extracted 
with chloroform (3x75 ml). The extracts were washed with water (3x75 ml), dried 
over MgSC>4, filtered and evaporated in vaccu to give a brown oil, which was purified 
by column chromatography on silica gel using DCM-methanol (95:5) as the eluant 
(6.50 g, 81% yield), m.p. 115-119°C.
'H  NMR (CDC13): ppm 4.17 (s, 7 H, Cp H), 4.25 (s, 2 H, Cp H), 5.05 (s, 2 H, 
Fc-CH 2-), 7.27 (m, 2 H, J= 6 Hz, 6,7-bzim H), 7.43 (d, 1 H, 7=7.2 Hz, 5-bzim H), 
7.78 (d, 1 H, .7=7.2 Hz, 8 -bzim H), 7.86 (s, 1 H, 2-bzim H). 13C NMR (CDCI3): ppm
44.67 (Fc-CH2-), 68.75 (Cp C-H), 83.98 (Cp Cipso), 109.68 (6 -bzim C), 120.27 (5- 
bzim C), 122.10 (7-bzim C), 122.80 (8-bzim C), 133.71 (4-bzim C), 142.47 (9-bzim 
C), 143.70 (2-bzim C). IR (KBr) i / (c n f‘) 3077, 2927, 1489, 1456, 1443, 1348, 1283, 
1263, 1157, 1101, 1038, 1026, 1003, 739, 509, 488. Ci8Hi6N2Fe (316.19): calculated 
C 68.38, H 5.10, N 8 .8 6 ; found C 67.81, H 5.04, N 8.83%.
General procedure fo r  the synthesis o f  the 1-ferrocenylmethylimidazolium iodide 
salts (151)-(15 5)
Method (a):
1-Ferrocenylmethylimidazole (148) (1.67 g, 6.28 mmol) and «-butyl iodide (0.79 ml,
6.91 mmol) were dissolved in acetonitrile (20 ml) and heated to reflux for 2 h. The 
reaction mixture was cooled, poured into water (30 ml) and extracted with chloroform 
(3x20 ml). The organic extracts were dried over Mg2S0 4 , filtered and evaporated to
1 -Ferrocenylmethylbenzim idazole (149)
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afford a brown oil. The product was purified by column chromatograhy on silica gel 
using DCM/methanol (95:5) as the eluant, affording an orange oil (2.91 g, 98% yield).
Method (b):
To 1-ferrocenylmethylimidazole (148) (0.77g, 2.9 mmol) dissolved in dry acetonitrile 
(10 ml), benzyl chloride (0.4 ml, 3.5 mmol) was added and the reaction mixture left to 
stand at room temperature for 18 h. A large volume of diethyl ether was added very 
slowly to form a separate layer. After 48 h, crystals were collected by filtration. The 
filtrate was poured in water (10 ml) and extracted with DCM (3x10 ml). The organic 
extracts were washed with water (3x20 ml), dried over MgSC>4 and evaporated to 
afford a brown powder (0.937 g, 82% yield).
Method (c):
A solution of (ferrocenylmethyl)imidazolium iodide (150) (7.00 g, 18.2 mmol) and 
the appropriate 1-methylimidazole derivative (2.2 ml, 27.3 mmol) in dry acetonitrile 
(100 ml) was refluxed for 18 h. The cooled solution was poured into water (75 ml) 
and extracted with chloroform (3x50 ml). The extracts were washed with water (2x50 
ml), dried over MgS0 4  and evaporated to give an orange oil. The product was purified 
by column chromatograhy on silica gel using DCM/methanol (95:5) as the eluant, 
affording a yellow powder (5.27 g, 71% yield).
l-Ferrocenylmethyl-3-methylimidazolium iodide (151)
Method (a) 74%, method (b) 80%, method (c) 71%; yellow powder; m.p. 146-148°C. 
*H NMR (CDCI3): ppm 4.02 (s, 3H, CH3), 4.23 (m, 7H, Cp H), 4.49 (m, 2H, Cp H),
5.36 (s, 2H, Fc-CH2-) , 7.41 (s, 1H, 5-im H), 7.47 (s, 1H, 4-im H), 9.72 (s, 1H, 2-im
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H). I3C NMR (CDCI3): ppm 36.57 (NCHs), 49.34 (Fc-CH2-), 69.09-69.28 (Cp C), 
121.27 (4-im C), 123.0 (5-im C), 135.11 (2- Im C). IR (KBr) v (cm '')  2123, 2975, 
1560, 1319, 1097, 831, 756, 503, 497.
l-Ferrocenylmethyl-3-ethylimidazolium iodide (152)
Method (a) 8 6%, method (c) 67%; yellow powder; m.p. 60-62°C.
‘H NMR (CDCI3): ppm 1.41 (t, 7=7.4 Hz, 3 H, CH2CH3), 4.25 (s, 7 H, Cp H), 4.34 (q, 
7=7.4 Hz, 2 H, CH2CH3), 4.48 (t, 2 H, 7=1.5 Hz, Cp H), 5.38 (s, 2 H, Fc-CH2-), 7.28 
(s, 1 H, 5-im H), 7.34 (s, 1 H, 4-im H), 9.94 (s, 1 H, 2-im H). 13C NMR (CDCI3): ppm 
15.18 (NCH2CH3), 44.85 (NCHzCHj), 49.92 (Fc-CH2-), 68.68-71.81 (Cp C-H), 
121.31 (4-im C), 121.35 (5-im C), 134.44 (2- Im C). IR (KBr) v^cnT1) 3043, 1553, 
1441, 1237, 1156, 1106, 505, 480.
l-Ferrocenylmethyl-3-propylimidazolium iodide (153)
Method (c) 6 8 %, yellow powder; m.p. 102-104°C.
'H  NMR (CDCI3): ppm 0.98 (t, 7=7.4 Hz, 3 H, CH2CH2CH3), 1.95 (m, 7=7.4 Hz, 2 H, 
CH2CH2CH3), 4.24-4.27 (m, 9 H, Cp H and C lkC H ^H s), 4.49 (q, 2 H, 7=1.5 Hz, 
Cp H), 5.41 (s, 2 H, Fc-CH 2-), 7.28-7.29 (m, 2 H, 4- and 5-im H), 10.08 (s, 1 H, 2- 
im H). 13C NMR (CDC13): ppm 10.29 (NCH2CH2CH3), 23.06 (NCHjCHzCHb), 49.93 
(NCH2CH2CH3), 51.15 (Fc-CH2-), 68.66-71.80 (Cp C), 121.32 (4-im C), 121.71 (5- 
im C), 134.59 (2-im C). IR (KBr) ^ (c m '1) 3079, 1558, 1444, 1237, 1150, 500, 479.
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Method (a) 98%, method (c) 82%, an orange oil.
'H  NMR (CDC13): ppm 0.88 (t, 7=7.4 Hz, 3 H, CH2CH2CH2CH3), 1.27 (m, 2 H, 7= 4.4 
Hz, CH2CH2CH2CH3), 1.80 (m, 2 H, 7=7.2 Hz, C H ^ C H - C H ^ , 4.18-4.22 (m, 9 H, 
J=7.2 Hz, Cp H and ClfcCIfcafcCHs), 4.45 (t, 2 H, 7=1.2 Hz, Cp H), 5.33 (s, 2 H, 
Fc-CH2-) , 7.35 (d, 2 H, 7=10.4 Hz, 4- and 5-im H), 9.86 (s, 1 H, 2-im H). 13C NMR 
(CDC13): ppm 12.97 (NCH2CH2CH2CH,), 18.81 (NCH2CH2CH2CH3), 31.48 
(NCH2CH2CH2CH3), 46.59 (NCH2CH2CH2CH3), 49.03 (Fc-CH2-), 68.62-71.77 (Cp 
C), 121.34 (4-im C), 121.64 (5-im C), 134.51 (2-im C). IR (KBr) v (cm-1) 3072, 
1558, 1463, 1237, 1151,1105, 512, 499.
l-Ferrocenylmethyl-3-benzylimidazolium iodide (155)
Method (a) 82%; yellow powder; m.p. .
‘H NMR (CDC13): ppm 4.37 (s, 7 H, Cp H), 4.57 (s, 2 H, Cp a-H), 5.09 (s, 2 H, 
FC-CH2- )  5.26 (s, 2 H, CH2-Ph), 6.90 (s, 2 H, 4,5-im H), 7.16 (s, 3 H, m,p-Ph H), 
7.42 (s, 2 H, o-Ph H), 10.75 (s, 1 H, 2-im H). 13C NMR (CDC13): ppm 50.28 
(Fc-CH2-) , 53.73 (CH2-PI1), 69.54-70.12 (Cp C), 79.50 (Cp Cipso), 121.66 (4-im C),
121.80 (5-im C), 129.76-129.48 (o,/w,/?-Ph C), 133.56 (2-im C), 137.36 (Ph Cipso). IR 
(KBr) v (cm-1) 3161, 3038, 2668, 1560, 1445, 1155, 813, 711. C2iH2iN2FeCl 
(392.70): calculated C 64.23, H 5.39, N 7.13; found: C 63.53, H 5.78, N 6.91%.
l-Ferrocenylmethyl-3-n-butylimidazolium iodide (154)
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General procedure for the synthesis o f  the 1-ferrocenylmethylbenzimidazolium 
iodide salts (156)-(160)
l-Ferrocenylmethyl-3-methylbenzimidazolium iodide (156) 
1-Ferrocenylmethylbenzimidazole (33) (0.224 g, 0.70 mmol) and methyl iodide (1.2 
ml, 19.5 ml) were dissolved in acetonitrile (20 ml) and heated to reflux for 2 h until a 
yellow precipitate was formed. The reaction mixture was cooled, poured into water 
(30 ml) and extracted with chloroform (3x20 ml). The organic extracts were dried 
over Mg2S 04, filtered and evaporated to afford a fine yellow powder (0.306 g, 95% 
yield).
'H  NMR (CDC13): ppm 4.21 (s, 3 H, -C H 3), 4.33 (s, 7 H, Cp H), 4.63 (t, 2 H, 7=1.6 
Hz, Cp H), 5.64 (s, 2 H, Fc-CH2-), 7.63-7.69 (m, 3 H, 7=3.2 Hz, Bzim H), 7.79-7.82 
(m, 1 H, 7=2.8 Hz, 8-bzim H), 10.95 (s, 1 H, 2-bzim H). 13 C NMR (CDCI3): ppm
31.35 (-C H 3), 69.71-70.25 (Cp C), 48.08 (Fc-CH2-), 79.10 (Cp C,>JO) 113.14 (6 - 
bzim C), 113.72 (5-bzim C), 127.67 (7-bzim C), 131.18 (8-bzim C), 132.37 (4-bzim 
C), 142.08 (9-bzim C), 207.48 (2-bzim C). IR (KBr) i/(c n f ') 3489, 3436, 3135, 3082, 
3045, 2992, 1561, 1104, 763. Ci9Hi9N2FeI (458.13): calculated C 49.81, H 4.18, N 
6.11; found: C 47.41, H 4.19, 5.60%.
l-Ferrocenylmethyl-3-ethylbenzimidazolium iodide (157)
Yellow powder (0.48 g, 42% yield); m.p.,
'H  NMR (CDCI3): ppm 1.66 (t, 3 H, 7=7.2 Hz, -CHzCHs), 4.21 (s, 7 H, Cp H), 4.50 
(m, 2 H, 7=4.4 Hz, -C H 2CH3), 4.56 (s, 2 H, 7=2 Hz, Cp H), 5.63 (s, 2 H, Fc-CH2-), 
7.56 (m, 4 H, 7=2.8 Hz, Bzim H), 10.85 (s, 1 H, 2-bzim H). 13C NMR (CDC13): ppm
12.80 (-CH 2CH3), 41.00 (-CH 2CH3), 45.64 (Fc-CH2), 67.33 (Cp C-H), 77.01 (Cp 
C i p s o ) ,  110.97 (5-bzim C), 111.42 (5-bzim C), 111.60 (7-bzim C), 114.52 (8-bzim C),
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125.05 (4-bzim C), 128.96 (9-bzim C), 138.58 (2-bzim C). IR (KBr) v(cm  ') 3076, 
1497, 1266, 1232, 1160, 747.
l-Ferrocenylmethyl-3-propylbenzimidazolium iodide (158)
Yellow powder (51%); m.p. °C,
‘H NMR (CDCI3): ppm 0.98 (t, 3 H, 7=7.2 Hz, -C H 2CH2CH3), 2.03 (m, 2 H, > 7 .6  
Hz, -C H 2CH2CH3), 4.15 (s, 2 H, Cp H), 4.26 (5 H, Cp H), 4.42 (t, 2 H, 7=7.6 Hz, 
-C H 2CH2CH3), 5.64 (s, 2 H, Fc-CH2-), 7.55 (m, 2 H, 7=12 Hz, 6,7-bzim H), 7.60 
(m, 1 H, 7= 3.2 Hz, 8-bzim H), 7.40 (m, 1 H, 7= 2.8 Hz, 5-bzim H), 10.96 (s, 1 H, 2- 
bzim H). 13C NMR (CDCI3): 11.53 (-CH 2CH2CH3), 23.18 (-CH 2CH2CH3), 48.03 
(-CH 2CH2CH3), 49.49 (Fc-CH2~), 69.96 (Cp C-H), 79.45 (Cp Cipso), 113.35 (6 -bzim 
C), 113.96 (5-bzim C), 127.53 (7-bzim C), 127.5 (8-bzim C), 131.41 (4-bzim C),
131.67 (9-bzim C), 141.58 (2-bzim C). IR (KBr) v  (cm-1) 3118, 2965, 1559, 1406, 
761. C2iH23N2FeI (486.18): calculated C 51.88, H 4.77, N 5.76; found: C 51.84, H 
4.68, N  5.76%.
l-Ferrocenylmethyl-3-butylbenzimidazolium iodide (159)
Yellow powder (42% yield); m.p. °C.
'H  NMR (CDCI3): 0.98 (t, 3 H, 7=7.2 Hz, -C H 2CH2CH2CH3), 1.47 (m, 2  H, 7=4.4 
Hz, -C H 2CH2CH2CH3), 2.06 (m, 2 H, 7.2 Hz, -C H 2CH2CH2CH3), 4.22 (s, 2 H, Cp 
H), 4.33 (s, 5 H, Cp H), 4.54 (t, 2 H, 7=7.6 Hz, -C H 2CH2CH2CH3), 4.65 (s, 2 H, Cp 
H), 5.72 (s, 2 H, FC-CH2-) , 7.63 (m, 1 H, 7=2.8 Hz, 6,7-bzim H), 7.68 (m, 1 H, 7=6 
Hz, 8-bzim H), 7.82 (m, 1 H, 5-bzim H), 11.08 (s, 1 H, 2-bzim H). ,3C NMR (CDCI3): 
13.93 (-CH 2CH2CH2CH3), 20.26 (-CH 2CH2CH2CH3), 31.62 (-CH 2CH2CH2CH3),
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47.91 (-C H 2CH2CH2CH3), 48.04 (Fc-CHz-), 69.96 (Cp C-H), 7 9 .4 4  (Cp Cipso),
113.35 (6 -bzim C), 113.78 (5-bzim C), 113.99 (7-bzim C), 127.42 (8-bzim C), 127.54 
(4-bzim C), 131.41 (9-bzim C), 141.56 (2-bzim C). IR (KBr) v/(cm_1) 3117, 3104, 
2931, 1555, 1402, 759. C22H25N2FeI (500.21): calculated C 52.83, H 5.04, N 5.60; 
found: C 52.60, 4.84, 5.49%.
l-Ferrocenylmethyl-3-benzylbenzimidazolium chloride (160)
Yellow powder (0.173 g, 48%); m.p. °C.
*H NMR (DMSO-de): ppm 4.20 (s, 5 H, Cp H), 4.24 (s, 2 H, Cp H), 4.45 (s, 2 H, Cp 
H), 5.19 (-C H 2-Ph), 5.44 (Fc-CH2-), 7.40 (m, 7 H, 6 ,7-bzim H and phenyl H), 7.83 
(5,8-bzim H), 9.54 (2-bzim H). IR (KBr) v (cm-1) 3462, 3098, 3063, 1551, 1382, 
1105, 822,503.
l,3-Di(ferrocenylmethyl)imidazolium iodide (161)
A solution of 150 (5.00 g, 0.01 mol), imidazole (0.45 g, 0.01 mol) and potassium 
carbonate (1.35 g, 0.01 mol) in acetonitrile (100 ml) was heated to reflux for one 
week. The cooled solution was poured into water (100 ml) and extracted with 
chloroform (3x75 ml). The extracts were washed with water (2x50 ml), dried over 
MgS0 4  and evaporated to give an orange oil. The product was purified by column 
chromatography, using silica gel and methanol/DCM (5:95) as the eluant, yielding a 
yellow powder (2.6 g, 6 8 % yield), m.p. 170°C (decomp).
‘H NMR (CDCI3): ppm 4.22 (s, 14H, Cp H), 4.44 (s, 4H, Cp H), 5.31 (s, 4H, 
Fc-CH 2-) , 7.17 (s, 2 H, 4- and 5-m H), 9.92 (s, 1 H, 2-im H). 13C NMR (CDCI3): 
ppm 49.85 (Fc-CH2-), 68.75-69.66 (Cp C-H and C-C), 120.82 (4- and 5-im C), 
134.66 (2-im C). IR (KBr) v (cm-1): 3066, 2938, 1550, 1142, 1100, 826, 514, 498.
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C25H25N2Fe2l2 (718.99): calculated C 50.71, H, 4.25, 4.73; found: C 50.14, H 4.24, N 
4.95%.
l,3-Di(ferrocenylmethyl)benzimidazolium iodide (162) [126]
A solution o f 150 (6.17 g, 16 mmol) and 149 (5.0 g, 16 mmol) were heated to reflux 
in acetonitrile (150 ml) for 24 h. The reaction was cooled to room temperature, water 
was added and the suspension was extracted into chloroform. The organic layer was 
washed with water, dried over MgS0 4  and evaporated to leave an orange residue. 
This was treated with diethyl ether precipitating out an orange powder, which was 
collected by filtration ( 5.8 g, 57% yield), m.p. 121°C (decomp).
‘H NMR (CDC13): ppm 4.20 (s, 4 H, Cp fi-E), 4.25 (s, 10 H, Cp H), 4.45 (s, 4 H, Cp 
a-H), 5.41 (s, 4 H, Fc-CEb-), 7.55-7.57 (q, 2 H, 7=3.6 Hz, 6,7-bzim H), 7.69-7.71 
(m, 2 H, 7=3.2 Hz, 5,8-bzim H), 9.47 (s, 1 H, 2-bzim H). 13C (DMSO-i/e): ppm 46.36 
(Fc-CH2), 68.98 (Cp C-H), 69.51 (Fc Cp C-H), 80.23 (Cp Cipso), 114.02 (5,8-bzim 
C), 126.82 (6,7-bzim C), 130.71 (4,9-bzim H), 140.90 (2-bzim C). IR (KBr) v(cm_1): 
3064, 1615, 1559, 1495, 1265, 1171, 1106, 820, 750. C29H27N2FeI (642.15): 
calculated C 52.24, H 4.24, N 4.36; found C 52.15, H 4.00, N 4.07%.
l-(l-Ferrocenylmethyl)-3-(4-iodobutyl)imidazolium iodide (163) 
1-Ferrocenylmethylimidazole (148) (1.24 g, 4.65 mmol) and l,4diiodobutane (1.23 
ml, 9.30 mmol) were dissolved in dry acetonitrile (10 ml) and left to stand overnight. 
An orange separated out. The solvent was removed in vaccu and the product collected 
by column chromatography on silica gel using DCM-methanol (95:5) as the eluant, 
yielding a yellow solid (0.20 g, 74%).
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'H NMR (CDCI3): ppm 1.86 (m, 2 H, 7=7.6 Hz, -C H 2CH2CH2CH2I), 2.51 (m, 2 H, 
7=7.6 Hz, -C H 2CH2CH2CH2I), 4.24 (m, 9 H, 7=2.8 Hz, Cp H), 4.45 (t, 2 H, 7=1.6 Hz, 
-C H 2CH2CH2CH2I), 5.19 (s, 2  H, -CH 2CH2CH2CH2I), 5.75 (s, 2 H, 
-C H 2CH2CH2CH2I), 7.77 (s, 1 H, 4-im H), 7.80 (s, 1 H, 5-im H), 9.21 (s, 1 H, 2-im 
H). 13C NMR CDCI3): ppm 30.18 (-CH 2CH2CH2CH2I), 30.45 (-CH 2CH2CH2CH2I), 
46.98 (-CH 2CH2CH2CH2I), 48.25 (Fc-CH2-), 69.8-70.24 (Cp C), 79.70 (Cp Cipso),
127.68 (4-im C), 131.35 (5-im C), 141.42 (2-im C).
l-[(l-Ferrocenylmethyl-3-butyl)imidazolium]-3-ferrocenylmethylimidazolium 
diiodide (164)
1-Ferrocenylmethylimidazole (0.75 g, 1.88 mmol) and (163) were suspended in 
acetonitrile (30 ml) and heated to reflux overnight, with stirring and under nitrogen. A 
yellow precipitate was formed that was collected by filtration and washed with diethyl 
ether. The filtrate was poured into water (50 ml) and extracted with chloroform (3x40 
ml), the organic extracts were combined, dried over Mg4SC>4 and evaporated to afford 
a yellow powder (0.79 g, 50% yield).
*H NMR (CDCI3): ppm 2.13 (s, 4 H, -CHzCIfcC&CHz-), 4.202 (s, 14 H, Cp H and 4
H, -CH 2CH2CH2CH2-) , 4.38 (s, 4 H, Cp H), 5.20 (s, 2 H, 7=1.6 Hz, Fc-CH2-), 7.02 
(s, 1 H, 5-im H), 7.64 (s, 1 H, 5-im H), 9.74 (s, 1 H, 2-im H). 13C NMR (CDCI3):
27.02 (-CH 2CH2CH2CH2- ) , 49.51 (-CH 2CH2CH2CH2-), 50.68 (Fc-CH2-), 70.08 
(Cp C-H), 78.59 (Cp Cipso), 121.40 (4-im H), 123.41 (5-im C), 135.80 (2-im C). IR 
(KBr) v(cm-1): 3129, 3068, 1561, 1400, 1155, 1104, 924, 731. Q ^ e N ^ e z t  
(842.17): calculated C 45.64, H 4.31, N 6.65; found: C 44.66, H 4.16, N 6.30%.
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l-(l-Ferrocenylmethyl)-3-(4-iodobutyl)benzimidazolium iodide (165) 
1-Ferrocenylmethylbenzimidazole (3.0128 g, 9.53 mmol) and 1,4-diiodobutane were 
suspended in acetonitrile (1 0 0  ml) and heated to reflux with stirring under nitrogen 
until all the solid had dissolved. The reaction mixture was left to cool and a yellow 
solid precipitated. The solid was collected, and the filtrate was poured into water (100 
ml) and extracted with chloroform (3x50 ml). The organic layers were combined, 
washed with water, dried over Mg4S0 4 , filtered and evaporated to afford a yellow 
solid, which proved to be the same as the collected solid. Both solids were combined 
and washed with diethyl ether (4.7 g, 79%).
'H NMR (DMSO-rfe): ppm 1.95 (m, 2  H, 7=7.2 Hz, -C H 2CH2CH2CH2I), 2.24 (m, 2
H, 7=7.2 Hz, -C H 2CH2CH2CH2I), 4.22 (d, 2 H, 7=8.4 Hz, -C H 2CH2CH2CH2I), 
4.24-4.31 (m, 7 H, 7=2.0 Hz, Fc Cp H), 4.64 (m, 2 H, 7=2.0 Hz, -C H 2CH2CH2CH2I), 
4.62-4.66 (m, 2 H, -C H 2CH2CH2CH2I and 2 H Fc Cp), 7.63-7.66 (m, 2 H, 7=2.4 Hz,
6,7-bzim H), 7.76-7.83 (m, 1 H, 7=3.6 Hz, 5-bzim H), 7.84 (m, 1 H, 7=2.0 Hz, 8- 
bzim H), 11.01 (s, 1 H, 2-bzim H). 13C NMR (DMSO-í/6): ppm 29.78 
(-CH 2CH2CH2CH2I), 29.76 (-CH 2CH2CH2CH2I), 30.85 (-CH 2CH2CH2CH2I), 45.82 
(-CH 2CH2CH2CH2I), 46.56 (Fc-CH2-), 68.98-69.54 (Cp C), 113.82-114.10 (5,8- 
bzim C), 126.80 (6,7-bzim C), 130.98 (4-bzim C), 141.57 (9-bzim C), 207.01 (2-bzim 
C). IR (KBr) v (cm-1): 3103, 3010, 1555, 1426, 1238, 1002, 753, 499. C22H24N2FeI2 
(626.11): calculated C 42.20, H 3.86; found: C 41.71, H 3.69%.
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l-[(l-Ferrocenylmethyl-3-butyl)benzimidazolium]-3-ferrocenylmethyl 
benzintidazolium diiodide (166)
1-Ferrocenylmethylbenzimidazole (0.59 g, 1.88) and (165) were suspended in 
acetonitrile (30 ml) and heated to reflux overnight, with stirring and under nitrogen. A 
yellow precipitate was formed that was collected by filtration and washed with diethyl 
ether. The filtrate was poured into water (50 ml) and extracted with chloroform (3x40 
ml), the organic extracts were combined, dried over Mg4S0 4  and evaporated to afford 
a yellow powder (0.9761 g, 55% yield).
‘H NMR (DMSO-cfe): ppm 2.00 (d, 4 H, 7=19.6 Hz, -C H 2CH2CH2CH2-), 4.24 (s, 10
H, Cp H), 4.29 (s, 4 H, Cp H), 4.53 (m, 4 H, 7=2.8 Hz, Cp a-H), 4.56 (m, 4 H, 7=2.0 
Hz, -C H 2CH2CH2CH2-), 5.51 (t, 2 H, 7=7.6 Hz, Fc-CHa), 7.68 (m, 4 H, 7=2.0 Hz,
6,7-bzim H), 8.05 (m, 2 H, 4.8 Hz, 8-bzim H), 8.19 (m, 2 H, 7=1.6 Hz, 5-bzim H), 
9.72 (s, 2 H, 2-bzim H). I3C NMR (DMSO-4): ppm 31.5 (-CH 2CH2CH2CH2-), 
46.68 (-CH 2CH2CH2CH2-) , 46.80 (Fc-CH2-), 69.24 (Cp C-H), 69.89 (Cp C-H),
80.46 (Cp CipS0), 114.06 (8-bzim C), 114.33 (5-bzim C), 127.01 (6,7-bzim H), 130.98 
(4-bzim H) 141.75 (9-bzim H), 207.18 (2-bzim H). IR (KBr) v (cm-1): 3025, 2956, 
1556, 1379, 1238, 1171, 1104, 757, 484. C4oH4oN4Fe2I2 (942.29): calculated C 50.99, 
H 4.28, N 5.95; found: C 49.74, H 4.22, N 5.86%.
I,1 -Bis-(l-methylimidazole)ferrocene (170) -R oute (1):
1,1 -Ferrocenyldicarboxaldehyde (167)
To a stirred solution of TMEDA (20.00 ml, 13.5 mmols) and «-butyl lithium (2.5 M 
in hexanes; 54 ml, 13.5 mmols) in dry diethyl ether (200 ml), under an argon 
atmosphere ferrocene (10 g, 5.3 mmols) was added portionwise. After stirring 
overnight, the resulting red suspension was cooled to -78°C using a liquid
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nitrogen-methanol bath, anhydrous DMF (21 ml, 27 mmols) was added dropwise. 
The reaction mixture was stirred at -78°C for 3 h then left to return to room 
temperature. Water (200 ml) was added, the organic layer was separated and the 
aqueous layer extracted with DCM (3x100 ml). The combined organic portions were 
then washed with water (100 ml), dried over MgSC>4, filtered and evaporated in vaccu 
to dryness and the crude purple product was purified by column chromatography 
using diethyl ether as the eluant to yield red crystals (5.7 g, 45% yield).
‘H NMR (CDC13): ppm 4.67 (d, 4H, Cp H), 4.82 (d, 4H, Cp H), 9.94 (s, 2H, CHO).
1,1 -Ferrocenyldimethanol (168)
To solution o f 167 (2.39 g, 9.7 mmols) in methanol (100 ml), sodium borohydride 
(1.1 g, 29 mmols) was added portionwise and left at room temperature for 1 h. The 
brown reaction mixture was then poured into water (50 ml) and diethyl ether added 
(50 ml). The organic layer was separated and the aqueous layer was extracted with 
diethyl ether (3x50 ml). The combined organic layers were dried over MgSC>4, filtered 
and evaporated to dryness giving a yellow powder. The crude product was purified by 
column chromatography using 80:20 ethyl acetate:hexane as the eluant (or could be 
used crude for the next reaction) (2.87 g, 85%).
‘H NMR (CDCI3): ppm 4.18 (d, 4H, Cp H), 4.22 (d, 4H, Cp H), 4.39 (s, 2H, CH2).
l,l'-Bis-(l-methylimidazole)ferrocene (170) via (1,1 -ferrocenylmethyl)chloride
(169)
1,1'-Ferrocenyldimethanol (1.10 g, 4.47 mmols) was dissolved in dry THF (50 ml) 
and at -5°C, and pyridine (0.72 ml, 8.98 mmols) in dry THF (3 ml) was added 
dropwise with stirring. Phosphorus trichloride (0.8 ml, 8.98 mmols) in dry THF (5 ml)
203
was then added dropwise. An orange precipitate fell out of solution immediately. The 
reaction mixture was filtered under nitrogen and to the filtrate imidazole (0.61 g, 8.94 
mmols) and sodium carbonate (1.42 g, 13.41 mmols) were added. The reaction 
mixture was then evaporated to give an orange residue. Dry acetonitrile was replaced 
as the solvent and the suspension was heated to reflux overnight under a nitrogen 
atmosphere. After cooling, water was added and the product extracted with 
chloroform (3x50 ml), dried over MgSCU, filtered and evaporated in vaccu to yield an 
orange oil. After purification on silica gel, using diethyl ether/methanol (50:50) as the 
solvent, a yellow powder was recovered (0.05g, 3% yield).
‘H NMR (CDC13): ppm 4.10 (s, 8 H, Cp H), 4.73 (d, 4 H, J= 8 Hz, fc-CH 2), 6.84 (d, 2
H, J= 8 Hz, 5-im H), 6.97 (s, 2 H, 4-im H), 7.42 (s, 2 H, 2-im H). 13C NMR (CDC13): 
ppm 46.68 (Fc-CH2), 69.61 (Cp C), 70.04 (Cp C), 84.05 (Cp Cipso), 119.24 (4-im H), 
129.77 (5-im H), 137.07 (2-im H). C i s H i ^ e  (344.2) C 62.81, H 4.69, N; found: C 
62.02, H 5.21%.
(1,1 -Ferrocenylmethyl)-p-toluenesulphonate (171)
I,l'-Ferrocenedimethanol (0.10 g, 0.4 mmols), pyridine (0.13 ml, 1.6 mmols) andp- 
toluenesuphonyl chloride (0.23 g, 1.2 mmols) in purified ethanol (40 ml) (washed 
with water and dried over MgSCU, filtered and distilled from calcium chloride) were 
stirred together for 2 h. Water (10 ml) was poured into the reaction mixture and the 
organic layer separated. The aqueous layers were extracted with chloroform (3x10 
ml) and the organic extracts combined, dried over MgSC>4, filtered and evaporated in 
vaccu to yield a brown gum. After column chromatography using methanol as the 
eluant, a brown powder was obtained (0.18 g, 81% yield).
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lH NMR (DMSO-4): ppm 2.49 (s, 6H, Ar-CH3), 4.36 (d, 4H, Cp-H), 4.67 (d, 4H, 
Cp-H), 5.74 (s, 4H, Cp-CH 2-OTs), 7.10 (d, 4H, 2- and 6 -Ar), 7.66 (d, 4H, 3- and 5-
N,N-Dimethyl(methylene)ammonium chloride (172)
To a stirred solution of N,iV,./V',iV'-tetramethyldiaminomethane (5.4 ml, 39.1 mmol) in 
DCM (50 ml), cooled to 0°C, under a nitrogen atmosphere and with vigorous stirring, 
acetyl chloride (5.6 ml, 78.5 mmol) was added dropwise to keep the temperature 
below 5°C. A white precipitate was formed that was collected by filtration under 
nitrogen and was washed with dry DCM (50 ml) and dry THF (50 ml). The product is 
highly hydroscopic and so was placed in a dessicator under vaccum overnight before 
use. (3.57 g, 97% yield).
*H NMR (DMSO-i4): ppm 3.76 (6  H, N+(CH3)2), 8.32 (2 H, C H ^).
1,1 '-Bis-(N,N-dimethylaminomethyl)ferrocene (173)
To a stirred solution of ferrocene (2.5 g, 13.4 mmol) and TMEDA (4.9 ml, 32.2 
mmol) in hexane (80 ml), «-butyl lithium (13 ml, 2.5 M, 32.9 mmol) was added 
dropwise under an argon atmosphere and left to stir overnight. Diethyl ether (80 ml) 
was added and A^-dimethylmethyleneammonium chloride (2.59 g, 27.7 mmol) was 
added in one portion. The reaction mixture was stirred for a further 18 h, heated to 
reflux for 10 min and cooled. Water (30 ml) was added dropwise and stirring was 
continued for 15 min. Then more water was added (60 ml). The organic layer was 
separated and the aqueous layer extracted with 3x50 ml of diethyl ether. The 
combined organic layers were combined, dried over Mg2SC>4, filtered and evaporated 
to afford a red liquid as the crude product. The desired product was isolated using
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column chromatography on alumina. Pet. ether (40-60%) was used to elute unreacted 
ferrocene, 30% diethyl ether/pet. ether (40-60%) eluted the mono- 
dimethylaminomethyl derivative and 3% methanol/diethyl ether eluted the product as 
a orange/brown liquid (2.38 g, 65% yield).
'H NMR (CDC13): ppm 2.17 (s, 12 H, -NCH 3), 3.26 (s, 4 H, -C H H , 4.07 (m, 4 H, 
Fc Cp H), 4.11 (m, 4 H, Fc Cp H).
Ferrocene-1 '-diylbis-fmethyltrimethylammonium iodide) (174)
To 173 (0.26 g, 0.86 mmol) in methanol (2.5 ml), methyl iodide was added dropwise 
with stirring. The reaction mixture was heated to reflux for 15 min, and after cooling 
to room temperature, diethyl ether was added and the product precipitated out with 
some scratching of the glass. A pale yellow powder was collected by filtration and 
washed with diethyl ether (0.27 g, 53%).
'H NMR (CDCI3): ppm 3.09 (s, 18 H, (-CH3)3), 4.53 (s, 4 H, Cp H), 4.67 (s, 4 H, Cp 
H), 4.80 (s, 4 H, FC-CH2-). 13C NMR (CDC13): ppm 53.00 ((-CH3)3), 67.2 (-CH2-), 
72.9 (Cp C), 74.8 (Cp C), 75.6 (Cp Cipso).
1,1 -Bis(l-methylimidazole)ferrocene (170) via 174
Ferrocene-r-diylbis-(methyltrimethylammonium iodide) (174) (1.00 g, 1.7 mmol), 
imidazole (0.24 g, 3.5 mmol) and potassium carbonate (0.49 g, 3.57 mmol) were 
heated to reflux for 5 days in acetonitrile, with stirring, under nitrogen. The reaction 
mixture was cooled and poured into water (30 ml) and chloroform (30 ml). The 
organic layer was separated and the aqueous layer extracted with chloroform (3x20 
ml). The combined organic layers were combined, dried over Mg2SC>4, filtered and 
evaporated in vaccu to yield a brown oil. The crude product was purified by column
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chromatography using 50% methanol/diethyl ether, yielding a yellow powder (0.074 
g, 12% yield). Characterisation data as before.
1.1 -Bis(l-methylimidazole)ferrocene (170) via 168
l,l'-Ferrocenyldimethanol (168) (0.110 g, 0.45 mmol) and CDI (0.100 g, 0.59 mmol) 
were heated to reflux in dry acetonitrile (15 ml) for 5 h with sitrring. The solvent was 
removed in vaccu and the crude product purified by column chromatography on silica 
get using MeOH/DCM (50:50) to collect the product as a yellow solid (0.110 g, 71% 
yield). Characterisation data as before.
1.1 -Bis(l-methylbenzimidazole)ferrocene (175)
Compound 174 (6.5 g, 11.10 mmol), benzimidazole (2.96 g, 25.03 mmol) and 
potassium carbonate (3.83 g, 27.75 mmol) were heated to reflux for 6 days in 
acetonitrile (150 ml), with stirring, under nitrogen. The reaction mixture was cooled 
and poured into water (100 ml) and DCM (100 ml). The organic layer was separated 
and the the aqueous layer extracted with DCM (3x50 ml). The combined organic 
layers were combined, dried over Mg2SC>4, filtered and evaporated to yield a brown 
oil. The crude product was purified by column chromatography using ethyl acetate as 
the eluant, yielding a yellow powder (1.72 g, 20%).
‘H NMR (CDC13): ppm 4.13 (s, 4 H, Cp H), 4.18 (t, 4 H, .7=1.6 Hz, Cp H), 4.92 (d, 4
H, .7=1.6 Hz, fc-CH 2-) , 7.25 (q, .7=3.4 Hz, 4 H, 6,7-bzim H), 7.35 (d, .7=4.2 Hz, 2 H, 
5-bzim H), 7.73 (d, .7=6.8 Hz, 2 H, 8-bzim H), 7.80 (s, 2 H, 2-bzim H). 13C NMR 
(CDCI3): ppm 66.65 (fc-CH2-), 69.90 (Cp C), 70.03 (Cp C), 83.79 (Cp Cipso), 110.08 
(5,8-bzim H), 120.89 (9-bzim H), 122.68 (6,7-bzim H), 123.41 (4-bzim H), 142.85 (2- 
bzim H). IR (KBr) v(cnT'): 3090, 2932, 1497, 1264, 1238, 746, 434.
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1.1 -Bis(l-methyl-3-methylbenzimidazolium)ferrocenyl iodide (176)
Compound 175 (0.11 g, 0.25 mmol) was suspended in acetronitrile (15 ml) and heated 
to reflux with methyl iodide (2 ml) for 2 h with stirring, under nitrogen. A yellow 
precipitate formed and was collected by filtration, washed with diethyl ether. The 
filtration was poured into water ( 1 0  ml) and the product extracted with chloroform 
(3x20 ml). The organic extracts were dried over MgSCU, filtered, evaporated and 
purified by column chromatography on silica gel using DCM/methanol (95:5) as the 
eluant (0 .1 1  g, 60% yield).
*H NMR (CDC13): ppm 3.87 (s, 3 H, -C H 3), 4.18 (t, 4 H, 7= 1.6 Hz, Cp), 4.47 (s, 4 H, 
Cp), 5.40 (s, 4 H, fc-CH 2~), 7.51 (m, 7= 3.6 Hz, 4 H, 6,7-bzim H), 7.82 (m, .7=2.8 Hz, 
2 H, 5-bzim H), 8.05 (q, 7=2.4 Hz, 2 H, 8-bzim H), 9.64 (s, 2 H, 2-bzim H). 13C NMR 
(CDCI3): ppm 13 C NMR (CDCI3): ppm 31.89 (-CH3), 68.99-70.02 (Cp C), 47.96 
(FC-CH2- ) , 81.05 (Cp CipSo) 113.84 (6 -bzim C), 114.12 (5-bzim C), 128.17 (7-bzim 
C), 131.38 (8-bzim C), 133.01 (4-bzim C), 143.16 (9-bzim C), 208.16 (2-bzim C).
IR (KBr) 1/ (cm '1): 3511, 3445, 3125, 3063, 1561, 1400, 761, 498. C28H28N4l2Fe 
(730.22): calculated C 46.06, H 3.87, N 7.67; found: C 46.30, H 3.53, N 7.05%.
1.1 -Bis(l-methyl-3-n-buiylbenzimidazolium)ferrocenyl iodide (177)
The procedure was for as above (75% yield).
'H  NMR (CDCI3): 0.91 (t, 3 H, 7= 7.6 Hz, -C H 2CH2CH2CH3), 1.40 (m, 2 H, 7=7.6
Hz, -C H 2CH2CH2CH3), 1.96 (m, 2 H, .7=7.6 Hz, -C H 2CH2CH2CH3), 4.16 (t, 2 H,
7=2.0 Hz, Cp H), 4.26 (d, 4 H, 7=3.6 Hz, Cp H), 4.46 (t, 2 H, 7=7.6 Hz,
-C H 2CH2CH2CH3), 5.63 (fc-CH2), 7.57 (m, 3 H, 7=4.0 Hz, 6,7,8-bzim H), 7.72 (t, 1
H, 7=4.4 Hz, 5-bzim H), 11.03 (s, 1 H, 2-bzim H). I3C NMR (CDCI3): 19.82
(-CH 2CH2CH2CH3), 30.91 (-C H 2CH2CH2CH3), 31.18 (-CH 2CH2CH2CH3), 47.44
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(-CH 2CH2CH2CH3), 47.56 (Fc-CH2-), 69.51 (Cp C-H), 78.98 (Cp Cipso), 112.88 (6 - 
bzim H), 113.49 (5-bzim H), 127.07 (7-bzim H), 127.09 (8-bzim H), 130.97 (4-bzim 
H), 131.22 (9-bzim H), 141.16 (2-bzim H). IR (KBr) v (cm-1): 3118, 3015, 1560, 
1400, 1323, 760. C a^ o N tF ek  (814.38): calculated C 50.15, H 4.95, H 6 .8 8 ; found: C 
51.99, H 4.46, N 4.11%.
Bis[l-(1,1 -ferrocenylmethyl)-3-(4-iodobutyl)]benzitnidazolium iodide (185) 
Compound 175 (0.257 g, 0.58 mmol) and 1,4-diiodobutane (1 ml, 7.58 mmol) were 
suspended in acetonitrile (10 ml), heated to reflux for 4 h and let stand for 2 days at 
room temperature. A yellow precipitate was formed which was collected by filtration 
(0.141 g, 22% yield).
'H NMR (DMSO-i4): 1-8 6  (d, 4 H, 7=6.4 Hz, -C H 2CH2CH2CH2I), 1.97 (d, 4 H, 
7=8.0 Hz, -C H 2CH2CH2CH2I), 3.34 (m, 4 H, 7=5.6 Hz, -C H 2CH2CH2CH2l), 4.36 (t, 
4 H, 7=6.8 Hz, Cp H), 4.54 (t, 4 H, 7=8.4 Hz, Cp H), 4.69 36 (m, 4 H, 7=6.6 Hz, 
-C H 2CH2CH2CH2l), 7.73 (d, 4 H, 7=6.0 Hz, 6 ,7-bzim H), 8.11 (t, 2 H, 7=4.0 Hz, 8- 
bzim H), 8.25 (t, 2 H, 7=6.4 Hz, 5-bzim H), 9.82 (t, 2 H, 7=4.2 Hz, 2-bzim H). 13C 
NMR (DMSO-i/e): ppm 24.40 (-CH 2CH2CH2CH2I), 28.55 (-CH 2CH2CH2CH2I), 
29.52 (-CH 2CH2CH2CH2I), 44.53 (-CH 2CH2CH2CH2I), 45.02 (Fc-CH2-),
68.95-69.59 (Cp C), 79.52 (Cp Cipso), 112.61 (5-bzim C), 112.87 (8-bzim H), 125.43 
(6 -bzim C), 129.44 (7-bzim H), 129.85 (4-bzim C), 140.28 (9-bzim C), 205.39 (2- 
bzim C). IR (KBr) v(cm_1): 3134, 3015, 2949, 1559, 1236, 1171, 753, 489.
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Bis{l-[(1,1 -ferrocenylmethyl-3-butyl)benzimidazolium] 
-3-ferrocenylmethyljbenzimidazolium tetraiodide (186)
Compounds 185 and 175 were suspended in acetonitrile, heated to reflux for 4 h and 
let stand for 2 days at room temperature. A yellow precipitate formed, which was 
collected by filtration (0.055 g, 33% yield).
*H NMR (DMSO-*): 2.01 (s, 8 H, -C H 2CH2CH2CH2-) , 4.28 (d, 8 H, 7=20 Hz, 
-C H 2CH2CH2CH2-), 4.57 (s, 8 H, Cp H), 4.75 (d, 8 H, 7=14.8 Hz, Cp H), 5.77 (d, 8 
H, 7=10.8 Hz, fc-CH2-) , 7.71 (d, 8 H, 7=4.8 Hz, 6,7-bzim H), 8.26 (d, 4 H, 7=6.4 Hz, 
8-bzim H), 8.33 (d, 4 H, 7=5.2 Hz, 5-bzim H), 9.83 (d, 4 H, 7=5.2 Hz, 2-bzim H). 13C 
NMR (DMSO-i/e): ppm 31.05 (-CH 2CH2CH2CH2-) , 40.09 (-CH 2CH2CH2CH2- ) ,
46.50 (Fc-C H 2-), 70.47 (Cp C), 71.09 (Cp C), 85.25 (Cp Ci>i0), 109.92 (8-bzim C),
110.50 (5-bzim C), 125.65 (6-bzim H), 126.67 (7-bzim H), 127.01 (4-bzim H) 135.78 
(9-bzim H), 206.47 (2-bzim H). IR (KBr) v(cm_1) 3128, 1560, 1400, 1578, 753, 503. 
C6oH6oN8Fe2l4 (1512.51): calculated C 47.65, H 4.00, N 7.41; found: C 45.71, H 3.89, 
N 6.85%.
[BMIM]PF6 (185)
A stirred solution of 1-methylimidazole (11.61 g, 0.14 mols) and bromobutane (19.50 
g, 0.14 mols) in a round-bottomed flask fitted with a reflux condenser was heated at 
70°C for 48-72 h. The resulting viscous liquid was allowed to cool to room 
temperature and was then washed with ethyl acetate (3x200 ml). The solution was 
then placed under vacuum at 70°C overnight to remove the last of the ethyl acetate.
To the thus prepared 1-butyl-3-methylimidazolium bromide (12.73 g, 0.058 mols) in 
water (500 ml), hexafluorophosphoric acid (11.01 g, 0.078 mols) was added with 
vigorous stirring and the resulting reaction mixture left to stir for a further 12 h. The
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upper aqueous layer was decanted d the lower ionic liquid layer was washed with 
water (10x50 ml) until the washings were no longer acidic. The ionic liquid was then 
heated under vacuum (60°C) overnight to remove excess water (7.05 g, 43% yield). 
'H  NMR (acetone-^): ppm 0.96 (t, 3 H, -C H 2CH2CH2CH3), 1.37 (m, 2 H, 
-C H 2CH2CH2CH3), 1.96 (m, 2 H, -CH 2CH2CH2CH3), 4.16 (m, 3 H, -C H 3), 4.50 (t, 2 
H, -C H 2CH2CH2CH3), 8.01 (s, 1 H, 5-im H), 8.10 (s 1 H 4-im H), (10.17 s, 1 H, 2-im
General experimental procedure for the Heck reaction in [BM IM JPFsynthesis o f  
(191H 195)
To a solution of palladium acetate (0.011 g, 0.05 mmol, 0.10%) and 
triphenylphosphine (0.026 g, 0 .1 0  mmol, 0 .2 0 %) dissolved in anhydrous and 
degrgassed [BMIM] PFô (20 ml), 4-bromodanisole (0.990 g, 5 mmol), methyl acrylate 
(0.431 g, 5 mmol) and sodium acetate (0.450 g, 6.25 mmol) were added with stirring 
under argon. The reaction mixture was heated to 140°C for 17 h to ensure that the 
reaction had gone to completion. The mixture was extracted with diethyl ether (3x70 
ml), the extracts were dried over MgS0 4 , filtered and the solvent removed in vacuo to 
yield the crude product. After column chromatography on silica gel with DCM, the 
produce was obtained. Alternatively, after completion of the reaction, the ionic liquid 
was heated under vacuum and the product collected by distillation at 0.05 mmHg, 
70-72°C.
General experimental procedure for the Heck reaction in DMF)
As above, except that anhydrous DMF (20 ml) was employed as the solvent.
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1 '•(Diphenylphosphino)ferrocenecarboxaldehyde [Fe( if-C sH ^P hrff r f- 
CsH4CHO)J (201)
To a solution of ferrocenophane (4.17 g, 14.3 mmol) in diethyl ether (250 ml), a 
solution of phenyl lithium (14.5 ml. 1.8 M, 27.7 mmol) was added slowly at -78°C. 
The reaction mixture was stirred for 30 min at -78°C and for a further 30 min with 
the cooling bath removed. After cooling again to -78°C, DMF (2.8 ml, 16 mmol) was 
added dropwise and stirred for 15 min at -78°C, allowed to warm to room 
temperature and stirred for 24 h. Water (100 ml) was added, the organic phase 
separated, washed with water (3x100 ml), dried over magnesium sulphate and the 
solvent removed under vacuum. The residue was dissolved in small volume of ethyl 
acetate and the solution filtered through a plug of silica gel. On crystallization of the 
crude product from ethyl acetate/hexane, orange crystals were yielded (3.92 g, 69%, 
m.p. 148-150°C).
'H  NMR (CDC13): ppm 4.21 (q, 2 H, Cpp a-CH), 4.49 (t, 2 H, CpP fi-CR), 4.49 (t, 2 
H, Cpc /0-CH), 4.69 (t, 2 H, Cpc a-CB), 7.31-7.39 (m, 10 H, PPh2), 9.67 (s, 1 H, 
CHO). 13C NMR (CDC13): ppm 70.52 (Cpc J3-CH), 72.36 (d, CpP /3-CH), 74.16 (d,
CpP «-CH), 78.66 (d, Cpp Cipso), 79.69 (Cpc Cipso), 128.32 (d, PPh2 Cips0), 128.85 
(PPh2 /?-CH), 134.45 (d, PPh2 o-CH, 138.20 (d, PPh2 Cipso), 193.44 (-HO).
31P NMR (CDCI3): ppm -17.3 (s). IR (Nujol) i/(cnT‘) 1677 s, 1662 s; 1244 s, 1191 
m, 1161 m, 1092 w, 1068 w, 1036 m, 1027 m, 998 w, 849 w, 827 m, 754 s, 747 s, 699 
s, 534 w, 515 w, 507-493 m, 462 m, 458 m, 426 w. C23Hi9FeOP (398.2): calculated C 
69.37, H 4.82; found: C 69.44, H 5.13%.
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[1 '-(Diphenylphosphino)ferrocenyl]methanol [Fe( rf-CsHtPPhM rf-C 5H 4 CH2 OH)]
(202)
To a suspension o f (5) (1.99 g, 5.0 mmol) in dry methanol, sodium borohydride (1.13 
g, 30.0 mmol) was added portionwise over 90 min. The reaction mixture was then left 
to stir overnight at room temperature. Aqueous NaOH (100 ml, 1 M) was added and a 
yellow precipitate formed that was extracted into chloroform (2x100 ml). The organic 
extracts were then dried over magnesium sulphate and the solvent removed under 
pressure, yielding a brown oil (2.42 g).
Crystallisation could be induced by standing in cold temperatures for long periods, 
but it was found: that the oil produced was of sufficient purity to be used without the 
need for recrystallization.
‘H NMR (CDCI3): ppm 1.86 (q, 1 H, 7=6.0 Hz, CH2OH), 4.06 (d, 2 H, Cpc a-CH), 
4.10 (t, 2 H, Cpp a-CH), 4.16 (t, 2 H, Cpc J3-CH), 4.20 (s, 2H, 7=6.0 Hz, CH2OH),
4.37 (t, 2 H, CpP frCH), 7.31-7.37 (m, 10 H, PPh2). 13C NMR (CDCI3): ppm 60.42 
(CH2OH), 68.72 (Cpc P-CH), 69.31 (Cpc a-CH), 71.00 (CpP frCH), 73.09 (CpP a- 
CH), 76.26 (Cpp Cipso), 89.06 (Cpc Cipso), 128.18 (PPh2 m-CH), 128.62 (PPh2p-CH), 
134.45 (PPh2 o-CH), 138.63 (PPh2 Cipso). 31P NMR (CDC13): ppm -16.3 (s). IR 
(Nujol) v(cm_l): 3328 br s; 1667 w; 1310 m, 1235 m, 1160 m, 1028 m, 997 s, 987 s, 
926 m, 845 m, 807 m, 752 s, 743 s, 701 s, 698 s, 629 m, 503 s, 492 m, 458 m, 444 m. 
C23H2]FeOP (400.2): calculated C 69.02, H 5.29; found: C69.33, H 5.40%.
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[1 '-(Diphenylphosphinosulphide)ferrocenyl]methanol {Fe[rf-CsH.4P(S)Ph2](tjS- 
CsH4CH2OH)} (203)
A solution of the alcohol derivative (6 ) (3.65 g, 9.14 mmol) and sulphur (0.32 g,
10.06 mmol) in dry benzene (70 ml) were heated to reflux for 6 h. After cooling, the 
solvent was evaporated and a yellow/brown slurry obtained. The crude product was 
purified by column chromatography on alumina, using 1 : 1  ethyl acetate/hexane as the 
eluant, yielding a yellow powder (5.96 g, 65%).
'H NMR (CDC13): ppm 2.04 (s, 1 H, CH2OH), 3.98 (t, 2 H, J= 1.6 Hz, Cpc a-CH), 
4.28 (t, 2 H, J= 2.0 Hz, CpP a-CH), 4.28 (q, 2 H, .7=2.0 Hz, fc-CH2), 4.46 (q, 2 H, 
.7=1.6 Hz, Cpc ¡3-CH), 4.53 (q, 2 H, .7=2.0 Hz, Cpp J3-CH), 7.34-7.52 (m, 6 H, 0 - and 
p-H PPh2), 7.69-7.74 (m, 4H, m-H PPh2). 13C NMR (CDCI3): ppm 60.42 (CH2OH), 
69.67 (Cpc (3-CR), 72.53 (Cpc a-CH), 73.80 (Cpp /3-CR), 77.15 (Cpp a-CH), 77.47 
(Cpp Cipso), 77.79 (Cpc CipS0), 128.93 (PPh2 m-CH), 129.05 (PPh2 ^-CH), 132.12 
(PPh2 o-CH), 132.29 (PPh2 Cipso). 31P NMR (CDCI3): ppm +42.52 (s). IR (KBr) v 
(cm-1): 3467 br s; 2364 s; 1477 w; 1434 m; 1170 m; 1103 s; 1025 m; 1000 m; 837 m; 
821 m; 754 m; 716 s; 696 s; 653 s; 543 m; 502 m; 492 s; 448 m.
l-Diphenylphopsphine-l'-(l-methyltosyl) ferrocene (207)
Chloroform before use was washed with 2 aliquots of water, dried over MgSC>4 and 
distilled from CaCl2. The alcohol 203 (0.1691 g, 0.39 mmol), pyridine (0.062 g, 0.78 
mmol) and tosyl chloride (0.112 g, 0.58 mmol) were dissolved in chloroform (7 ml) 
and stirred at room temperature in a closed flask. The reaction mixture was poured 
into water ( 1 0  ml), the organic layer separated and the aqueous layer extracted with 
chloroform (2x10 ml). The combined organic layers were washed with water (2x10 
ml), dried over MgSC>4, filtered and the solvent removed to afford a brown oil. The
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crude product was purified by column chromatography on alumina using 10 0 % 
methanol as the eulant (brown oil, yield 0 .2 2 0 0  g, 130%).
‘H NMR: ppm 2.34 (s, 3 H, -C H 3), 4.11 (s, 2 H, Cpc, a-CH), 4.44 (s, 2 H, CpP, a- 
CH), 4.72 (s, 4 H, J3-Cpc and y3-Cpp), 5.82 (s, 2 H Cp-CH 2-OTs), 7.17-7.95 (m, 14 
H, Ph).
1-Diphenylphopsphine-l '-(1-methylimidazole) ferrocene {Fe[rf-CsH4P(S)Ph2](rf - 
C5H4CH2C3H3N2)} (208)
A solution of compound 203 (0.108 g, 0.25 mmol) and CDI (0.053 g, 0.33 mmol) 
were heated to reflux for 4 h in dry acetonitrile (20 ml), under nitrogen with stirring. 
The reaction mixture was cooled and diluted with water (20 ml) and chloroform (20 
ml). The organic layer was separated and the aqueous layer extracted with chloroform 
(2x10 ml). The combined organic layers were washed with water (4x10 ml), dried 
over magnesium sulphate and evaporated to afford a brown/black solid. The crude 
product was then purified by column chromatography using 1 0 % methanol/diethyl 
ether (0.074 g, 61% yield).
'H NMR (CDCI3): ppm 4.00 (t, 2 H, 7=2.0 Hz, Cpc a -C R ), 4.23 (t, 2 H, 7=1.6 Hz,
Cpp <z-CH), 4.35 (q, 2 H, 7=1.6 Hz, Cpc fi-C U ), 4.43 (q, 2 H, 7=1.6 Hz, CpP J3-CH), 
4.65 (s, 2 H, fc-CH 2-), 6.79 (s, 1 H, 5-im H), 6.94 (s, 1 H, 4-im H), 7.20 (s, 1 H, 2-im 
H) 7.35-7.43 (qd, 6 H, 7=2.0 Hz and 7=6.8 Hz, 0- andp -H PPh2), 7.63-7.68 (qd, 4 H, 
7=1.6  Hz and 7=4.0 Hz, 0- and m-H PPh2). 13C NMR (CDCI3): ppm 46.28 (CH2Im),
70.64 (Cpc /?-CH), 72.71 (Cpc a-CH), 72.75 (Cpp /?-CH), 74.18 (Cpp a-CH), 73.50 
(Cpp C lpso), 84.86 (Cpc C1>J0), 128.73 (PPh2 m-CH), 131.82 (PPh2 ;?-CH), 131.84 
(PPh2 o-CH), 131.97 (PPh2 C ipso), 132.07 (4-im C), 134.20 (5-im C), 134.20 (2-im H). 
31P NMR (CDCI3): ppm +42.41 (s). IR (KBr) i/(cnT‘): 3097 m; 3050 m; 1501 m;
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1434 s; 1171 m; 1103 s; 1021 m; 903 w; 843 w; 816 m; 715 s; 700 m; 692 m; 656 s; 
540 m; 492; 484 s; 466 m. C26H23N2PSFe (482.37): calculated C 64.74, H 4.81, N 
5.81; found: 63.99, H 4.65, N 5.88%.
1-Diphenylphopsphine-l '-(l-ethyl-3-methyl)imdazoliumferrocenyl iodide {Fefrj5- 
C5H4P(S)Ph2](Tf-CsH4CH2CiHiN2CH2C H i)f I  (209)
Compound (9) (0.0823 g, 0.17 mmol) was suspended in excess iodoethane (2 ml) and 
heated to reflux for 2 h, whereupon a yellow precipitate was formed. The reaction 
mixture was left to stir overnight and then the precipitate was collected and washed 
with diethyl ether (0.1020 g, 94% yield).
'H NMR (CDC13): ppm 1.52 (t, 3 H, 7=7.2 Hz, -C H 2CH3), 4.03 (t, 2 H, 7=2.0 Hz, 
Cpc a-CH), 4.27 (q, 2 H, 7=7.2 Hz, -C H 2CH3), 4.37 (t, 2 H, 7=2.0 Hz, Cpp a-CH),
4.64 (d, 4 H, 7=2.0 Hz, Cpc and Cpp fi-CH), 5.26 (s, 2 H, fc-CH 2-im ), 7.19 (s, 1 H, 
5-im H), 7.20 (s, 1 H, 4-im H), 7.37-7.47 (m, 6 H, o- andp -H PPh2), 7.61-7.68 (m, 4 
H, m-H PPh2), 10.05 (s, 1 H, 2-im H). ,3C NMR (CDC13): ppm 15.85 (-CH 2CH3), 
45.89 (-CH 2CH3), 49.50 (fc-CH 2-im), 71.54 (Cpc p-CH), 72.49 (Cpc a-CH), 12.15 
(CpP /3-CH.), 73.64 (CpP a-CH), 74.50 (CpP Cipso), 76.01 (Cpp Cipso), 80.80 (Cpc Cipso), 
121.90 (PPh2 m-CH), 128.80 (PPh2 /?-CH), 131.99 (PPh2 o-CH), 133.83 (PPh2 Cipso),
134.69 (4-im C), 136.08 (5-im c), 207.48 (2-im C). 31P NMR (CDC13): ppm +42.66 
(s). IR(KBr): v / c m 3006 s; 2363m; 1558 m; 1434 m; 1169 m; 1153 m; 1102 s; 1027 
m; 762 m; 752 m; 718 s; 702 s; 657 s; 542 m; 500 m; 487 m; 463 w. C28H2gN2PSFeI 
(638.34): calculated C 52.69, H 4.42, N 4.39; found: C 52.15, H 4.25, N 4.41%.
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Compound 212 (0.20 g, 0.47 mmol) was suspended in distilled acetic anhydride (2.5 
ml) in a sealed glass container and heated at 90 -110°C for 1 h. On cooling to room 
temperature organe crystals formed, which were collected by filtration (0.094 g, 
45%).
'H  NMR (CDC13): ppm 1.60 (s, 3 H, -C H 3), 3.77 (t, 1 H, 7=0.4 Hz, Cp H,), 4.08 (s, 5 
H, Cp H), 4.32 (t, 1 H, 7=0.8 Hz, Cp H), 4.53 (q, 1 H, 7=0.4 Hz, Cp H), 5.14 (d, 2 H, 
7=1.2 Hz, Fc-CH2-), 7.21-77.55 (m, 10 H, PPh2 H). ,3C NMR (CDCI3): ppm 20.34 
(-C H 3), 61.20 (Fc-CH2-), 70.03 (Cp C-H), 86.89 (Cp Cipso), 128.61 (PPh2 m-CYL),
128.80 (PPh2 jp-CH), 133.34 (PPh2 o-CH), 135.81 (PPh2 Cips0). XP NMR (CDCI3): 
ppm -22.72 (s).
l-(Methylferrocenyl)-2-(diphenylphosphinesulphido) imidazole (210)
Sulphur (0.035 g, 1.09 mmol) was added to a solution of compound 211 (0.432 g, 
0.99 mmol) in toluene (15 ml). The reaction mixture was heated to reflux overnight, 
cooled to room temperature and then the solvent removed to afford a yellow powder 
(0.391 g, 84% yield).
lH NMR (CDCb): ppm 3.94 (d, 2 H, 7=1.6 Hz, Cp H), 4.00 (m, 7 H, 7=1.6 Hz, Cp 
H), 5.23 (d, 2 H, Fc-CH2-), 6.93 (m, 1 H, 5-im H), 7.04 (d, 1 H, Hz, 4-im H), 7.19 (s, 
1 H, 2-im H), 7.42 (m, 4 H, o-H PPh2), 7.45 (m, 2 H ,p-H PPh2), 7.65 (m, 4 H, m-H 
PPh2). 13C NMR (CDCI3): ppm 47.92 (CH2), 69.09 (Cpc f3-Cti), 69.21 (Cpc a-CH), 
69.79 (Cp), 81.70 (Cpc Cipso), 124.33 (4-im C), 128.88 (PPh2 m-CH), 129.01 (PPh2p- 
CH), 130.28 (PPh2 o-CH), 134.44 (PPh2 CI>i0) 131.98 (5-im C), 132.36 (2-im C). 3,P 
NMR (CDCI3): ppm +30.72 (s). IR (KBr) v/(cm“‘): 3107, 3048, 2365, 1437, 1261,
l,2-Bis(diphenylphosphino)ferrocene methyl acetate (213)
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1096, 771, 653. C26H23N2PFeS (482.37): calculated C 64.74, H 4.81, N 5.81; found C 
63.31, H 4.67, N 5.51%.
l-(Methylferrocenyl)-2-(diphenylphosphine)imidazole [Fe{ rf- 
CsH4[C3H 2N 2 (PPh2)J}(Tjs-C5Hs)] (211) and l-(methylferrocenyl)-2- 
(diphenylphosphineoxide)imidazole [Fe{7]5-CsH4(C3H2N2(P(0)Ph2))}(Tj5-CsHs)] 
(218)
To a solution of (l-methylferrocenyl)imidazole (4.06 g, 19.3 mmol) in diethyl ether 
(125 ml), at -78°C, «-butyl lithium (8.1 ml, 2.5 M in hexane, 20.3 mmol) was added 
dropwise under nitrogen, with stirring. The reaction mixture was stirred for 45 min at 
-78°C, then chlorodiphenylphosphine (3.6 ml, 20.3 mmol) was added dropwise. 
Stirring was continued for a further hour at -78°C, allowed to warm to room 
temperature and stirred overnight. Saturated potassium hydrogencarbonate solution 
was added and the reaction mixture was stirred for 2 h at room temperature. DCM (50 
ml) was added, the organic layer separated and the aqueous layer extracted with (2x30 
ml) of DCM. The combined organic layers washed with (2x30 ml) of water, dried 
over magnesium sulphate, filtered and the solvent removed under vacuum, affording 
an orange oil. The crude product was purified by column chromatography.
Compound 211 was collected using 1:1 petroleum ether/diethyl ether as the eluant, 
yielding an orange powder, 2.71 g, 31%.
'H NMR (CDC13): ppm 4.01 (t, 2 H, 7=2.0 Hz, Cpc a-CH), 4.02 (d, 2 H, Cpc /?-CH),
4.06 (, 5 H, Cp CH), 5.03 (d, 2 H, 7=0.8 Hz, CH2), 6.95 (s, 1 H, 7=1.2 Hz, 5-im H), 
7.13 (s, 1 H, 4-im H), 7.26-7.28 (m, 6 H, o- andp -H PPh2), 7.36-7.41 (m, 4 H, m-H 
PPh2). 13C NMR (CDCI3): ppm 47.05 (CH2), 66.27 (Cpc /?-CH), 68.96 (Cpc a-CH),
69.15 (Cp), 83.28 (Cpc Cipso), 122.06 (4-C Im), 128.94 (PPh2 m-CH), 128.95 (PPh2p- 
CH), 131.61 (PPh2 o-CH), 134.20 (PPh2 Cipso) 135.62 (5-C Im), 145.20 (4-C Im). 31P 
NMR (CDCI3): ppm -31.53 (s). IR (KBr): y(cm_1): 3448 br; 3053; 2365; 1477; 1432; 
1252; 1102; 1026; 809; 746; 740; 692; 515; 498; 466; 423. C26H23N2PFe (450.31): 
calculated C 69.3, H 5.15, N 6.22; found: C 69.24, C 5.18, N 6.98%.
Compound 218 was collected using 100% diethyl ether as the eluant, yielding an 
orange powder, 2 .0 0  g, 2 2 %.
*H NMR (CDCI3): ppm 4.08 (s, 2 H, Cpc a-CH), 4.13 (s, 8 H, Cpc fi-CK), 5.41 (s, 2 
H, Cg-), 7.05 (s, 1 H, 5-im H), 7.28 (s, 1 H, 4-im H), 7.50-7.57 (m, 6 H, o- andp -H 
PPh2), 7.80-7.85 (m, 4 H, m-H PPh2). 13C NMR (CDCI3): ppm 47.42 (CH2), 69.05 
(Cpc J3-CH), 69.20 (Cpc a-CH), 69.61 (Cp CH), 82.73 (Cpc Cjpso), 123.75 (4-C Im), 
128.92 (PPh2 m-CH), 130.97 (PPh2 p-CH), 131.14 (PPh2 o-CH), 134.20 (PPh2 Cipso) 
135.62 (5-C Im), 145.20 (2-C Im). 31P NMR (CDCI3): ppm +20.93 (s). IR (KBr): 
vycm“ 1 3448 br; 3096; 1435; 1195; 1185; 1122; 1105; 823; 817; 794; 748; 730; 700; 
692; 565; 535. 499; 481; 457; 420. C26H23N2PFeO (466.31): calculated C 66.97, H 
4.97, N 6.00; C 66.80, H 4.98, N 6.25%.
l-(Methylferrocenyl)-2-(diphenylphosphine)benzimidazole
[Fe{rf-CsH4[CiH2N2(PPh2)]}(Tf-C$Hs)](219)
To a solution of (l-methylferrocenyl)benzimidazole (0.25 g, 0.79 mmol) in diethyl 
ether (125 ml), at -78°C, «-butyl lithium (0.33 ml, 2.5 M in hexanes, 0.825 mmol) 
was added dropwise under nitrogen, with stirring. The reaction mixture was stirred for 
45 min at -78°C, then chlorodiphenylphosphine (0.15 ml, 0.825 mmol) was added 
dropwise. Stirring was continued for a further hour at -78°C, allowed to warm to
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room temperature and stirred overnight. Saturated potassium hydrogencarbonate 
solution was added and the reaction mixture was stirred for 2  h at room temperature. 
DCM (50 ml) was added, the organic layer separated and the aqueous layer extracted 
with (2x30 ml) of DCM. The combined organic layers washed with (2x30 ml) of 
water, dried over magnesium sulphate, filtered and the solvent removed under 
vacuum, affording an orange oil. The crude product was purified by column 
chromatography using diethyl ether/hexane ( 1 :1 ) as the eluant obtaining 
orange/brown crystals (0.135 g, 36% yield).
‘H NMR (CDCI3): ppm 4.04 (d, 2 H, 7=1.6 Hz, Cpc a-CH), 4.19 (d, 5 H, 7=1.6 Hz, 
Cp CH), 4.23 (t, 2 H, 7=1.6 Hz, Cpc /?-), 5.42 (d, 2 H, 7=2.4 Hz, fc-CH2-), 7.26 (m, 2 
H, 7=1.6 Hz, 6,7-im H), 7.39-7.41 (m, 7 H, o- andp -H PPh2 and 8-bzim H), 7.56 (m, 
4 H, m-H PPh2), 7.85 (d, 4 H, 7=1.6 Hz, 5-bzim H). 13C NMR (CDCI3): ppm 45.05 
(CH2), 6 8 .6 8  (Cpc P-CR), 69.19 (Cpc a-CH), 69.71 (Cp CH), 83.22 (Cpc Cipso), 
110.73 (6 -bzim C), 121.00 (5-bzim C), 122.45 (7-bzim C), 123.37 (8-bzim C), 129.06 
(PPh2 m-CH), 129.83 (PPh2 p-CH), 134.59 (PPh2 o-CH), 136.14 (PPh2 Cipso), 144.86 
(4-bzim C), 144.89 (9-bzim C), 153.68 (2-bzim C). 3IP NMR (CDCI3): ppm -27.38 
(s). IR (KBr) (v  cm-1) 3448, 2363, 2343, 1478, 1436, 1322, 1156, 1103, 824, 806, 
743, 697, 504. C26H26N2PFe (502.38): calculated C 71.72, H 5.42, N 5.58; found C 
71.79, H 5.05, N 5.75%.
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Table 1. Bond lengths (A) and angles (°) fo r  211.
Fe( 1 )-C(21) 2.011(2) C(15)—H( 15) 0.9300
Fe(l)-C(l 1) 2.0223(17) C(21)-C(22) 1.401(4)
Fe(l)-C(25) 2.025(2) C(21)-C(25) 1.407(4)
Fe(l)-C(22) 2.030(2) C(22)-C(23) 1.386(4)
Fe(l)-C(15) 2.0333(19) C(22>-H(22) 0.9300
Fe(l)-C(12) 2.0354(18) C(23)-C(24) 1.373(3)
Fe(l)-C(23) 2.043(2) C(23)-H(23) 0.9300
Fe(l)-C(24) 2.045(2) C(24)-C(25) 1.384(4)
Fe(l)-C(14) 2.0489(18) C(24)-H(24) 0.9300
Fe( 1)—C( 13) 2.0506(18) C(25)-H(25) 0.9300
P( 1)—C( 1) 1.8257(18) C(31)-C(36) 1.388(3)
P( 1)—C(31) 1.8302(18) C(31)-C(32) 1.391(3)
P( I)—C(41) 1.8364(17) C(32)-C(33) 1.385(3)
N (l)-C (l) 1.325(2) C(32)-H(32) 0.9300
N( 1 )-C(4) 1.363(3) C(33)-C(34) 1.379(3)
N(2)-C(3) 1.364(2) C(33)-H(33) 0.9300
N(2)-C(l) 1.370(2) C(34)-C(35) 1.369(3)
N(2)-C(2) 1.477(2) C(34)-H(34) 0.9300
C(2)-C(l 1) 1.498(2) C(35)-C(36) 1.387(3)
C(2)-H( 1 A) 0.9700 C(35>—H(35) 0.9300
C(2)-H(1B) 0.9700 C(36}-H(36) 0.9300
C(3)-C(4) 1.355(3) C(41)-C(46) 1.381(3)
C(3)-H(3) 0.9300 C(41)-C(42) 1.391(3)
C(4)-H(4) 0.9300 C(42)-C(43) 1.387(3)
C( 11)—C( 15) 1.422(2) C(42)-H(42) 0.9300
C(11)—C( 12) 1.429(3) C(43)-C(44) 1.369(3)
C(12)-C(13) 1.418(3) C(43)-H(43) 0.9300
C( 12)—H( 12) 0.9300 C(44)-C(45) 1.374(3)
C( 13)—C( 14) 1.410(3) C(44>-H(44) 0.9300
C( 13)—H( 13) 0.9300 C(45)-C(46) 1.393(3)
C(14)-C(15) 1.420(3) C(45)-H(45) 0.9300
C(14)-H(14) 0.9300 C(46>-H(46) 0.9300
C(21)—H(21) 0.9300
C(21)-Fe(l)-C(l 1) 106.11(9) C(14)-C(13}-H(13) 125.9
C(21)-Fe(l)-C(25) 40.80(13) C(12)-C(13)-H(13) 125.9
C(l 1)-Fe(l)-C(25) 122.45(10) Fe( 1>—C( 13)—H( 13) 126.8
C(21 )-Fe( 1 )-C(22) 40.55(13) C(13)-C(14)-C(15) 108.22(16)
C(11)-Fe(l)-C(22) 121.89(9) C(13)-C(14)-Fe(l) 69.95(11)
C(25)-Fe( 1 >-C(22) 67.98(12) C(15)-C(14)-Fe(l) 69.05(10)
C(21 )-Fe( 1 }-C( 15) 122.60(11) C( 13)-C( 14)-H( 14) 125.9
C(11)—Fe( 1)—C( 15) 41.05(7) C( 15)-C( 14)-H( 14) 125.9
C(25)-Fe(l)-C(15) 108.01(10) Fe( 1 >-C( 14)-H( 14) 126.7
C(22)-Fe(l >-C( 15) 158.57(10) C(14)-C(15)-C(l 1) 108.09(16)
C(21)-Fe(l)-C(12) 121.82(12) C(14)-C(15)-Fe(l) 70.23(11)
C(11)-Fe(l)-C(12) 41.24(7) C(11)-C(15)-Fe(l) 69.06(10)
C(25)-Fe( 1 >-C( 12) 158.63(12) C(14)-C(15)-H(15) 126.0
C(22)-Fe( 1 )-C( 12) 106.85(9) C(11)-C(15)-H(15) 126.0
C(15)-Fe(l)-C(12) 68.79(8) Fe(l)-C(15)-H(15) 126.3
C(21)-Fe(l)-C(23) 67.14(11) C(22)-C(21)-C(25) 107.7(2)
C(11)-Fe(l)-C(23) 158.54(9) C(22)-C(21)-Fe(l) 70.47(14)
C(25)-Fe( 1 }-C(23) 66.71(10) C(25)-C(21 )-Fe( 1) 70.17(14)
C(22)-Fe(l)-C(23) 39.79(10) C(22)-C(21 )-H (21) 126.1
C(15)-Fe(l)-C(23) 159.83(9) C(25)-C(21)-H(2l) 126.1
C( 12)-Fe( 1 )-C(23) 123.45(9) Fe( 1 >-C(21 }-H(21) 124.8
C(21 )-F e( 1 )-C(24) 67.40(11) C(23)-C(22)-C(21) 107.1(2)
C (ll)-Fe(l)-C (24) 159.11(9) C(23)-C(22>-Fe( 1) 70.58(13)
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C(25)-Fe( 1 )-C(24) 39.75(12) C(21)-C(22)-Fe(l) 68.97(14)
C(22)-Fe(l)-C(24) 67.00(10) C(23)-C(22)-H(22) 126.4
C(l5)-Fe(l)-C(24) 124.29(9) C(21 )-C(22)-H(22) 126.4
C( 12)-Fe( 1 }-C(24) 159.20(9) Fe(l)-C(22)-H(22) 125.6
C(23)-Fe(l)-C(24) 39.25(9) C(24)-C(23)-C(22) 109.2(2)
C(21 )-Fe( 1 )-C( 14) 159.52(14) C(24)-C(23)-Fe( 1 ) 70.48(12)
C(11 )—Fe( 1 )—C( 14) 68.81(7) C(22)-C(23)-Fe(l) 69.63(13)
C(25)-Fe( 1 )-C( 14) 123.98(12) C(24)-C(23)-H(23) 125.4
C(22)-Fe(l)-C(14) 158.98(12) C(22)-C(23)-H(23) 125.4
C(15)-Fe(l)-C(14) 40.71(7) Fe(l)-C(23)-H(23) 126.1
C( 12>-Fe( 1 )-C( 14) 68.26(8) C(23)-C(24)-C(25) 108.4(2)
C(23)-Fe(l)-C(14) 124.59(9) C(23)-C(24)-Fe( 1 ) 70.26(12)
C(24)-Fe( 1 )-C( 14) 109.89(9) C(25)-C(24)-Fe( 1 ) 69.35(13)
C(21 )-Fe( 1 )-C( 13) 158.28(14) C(23)-C(24)-H(24) 125.8
C(11 )—Fe( I )—C( 13) 68.85(7) C(25)-C(24)-H(24) 125.8
C(25)-Fe(l)-C(13) 159.62(13) Fe(l)-C(24)-H(24) 126.2
C(22)-Fe(l)-C(13) 122.88( 11) C(24)-C(25)-C(21 ) 107.5(2)
C( 15)—Fe( 1 )—C( 13) 68.31(8) C(24)-C(25)-Fe( 1 ) 70.90(13)
C( 12)—Fe( 1 )—C( 13) 40.60(7) C(21)-C(25)-Fe(l) 69.03(14)
C(23)-Fe( 1 )-C( 13 ) 109.41(9) C(24)-C(25)-H(25) 126.3
C(24)-Fe(l)-C(13) 124.54(9) C(21 )-C(25)-H(25) 126.3
C(14)-Fe(l)-C(13) 40.23(8) Fe( 1 )-C(25)-H(25) 125.4
C( 1 )—P(l)—C(31 ) 104.06(8) C(36)-C(31)-C(32) 118.36(18)
C( I )—P( 1 )—C(41 ) 101.22(8) C(36)-C(3 l)-P (l) 117.87(14)
C(31)-P(1)-C(41) 101.01(8) C(32)-C(31)—P( 1 ) 123.67(14)
C(l)-N(l)-C(4) 106.94(15) C(3 3)-C(3 2)-C(31 ) 120.4(2)
C(3)-N(2)-C(2) 124.97(15) C(33)-C(32)-H(32) 119.8
C(l)-N(2)-C(2) 128.01(14) C(31)-C(32)-H(32) 119.8
N(l)-C(l)-N (2) 110.56(16) C(34)-C(33)-C(32) 120.3(2)
N( 1)—C( 1 )—P( 1) 127.80(14) C(34)-C(33)-H(33) 119.8
N (2)—C( 1 )—P( 1 ) 121.63(12) C(32)-C(33)-H(33) 119.8
N(2)-C(2)-C(l 1) 111.58(14) C(35)-C(34)-C(33) 120.0(2)
N(2)-C(2)-H(1A) 109.3 C(35)-C(34)-H(34) 120.0
C(11)-C(2)-H(1 A) 109.3 C(33)-C(34)-H(34) 120.0
N (2)-C(2)-H( 1B) 109.3 C(34)-C(35)-C(36) 120.1(2 )
C(11)-C(2)-H(1B) 109.3 C(34)-C(35)-H(35) 120.0
H(1A)-C(2)-H(1B) 108.0 C(36)-C(35)-H(35) 120.0
C(4)-C(3)-N(2) 106.25(16) C(3 5)-C(3 6)-C(31 ) 120.90(19)
C(4)-C(3)-H(3) 126.9 C(35>-C(36)-H(36) 119.6
N(2)-C(3)-H(3) 126.9 C(31)-C(36)-H(36) 119.6
C(3)-C(4)-N(l) 110.53(17) C(46)-C(41 )-C(42) 118.08(17)
C(3)-C(4)-H(4) 124.7 C(46)-C(41)-P(l) 123.73(14)
N(l)-C(4)-H(4) 124.7 C(42)-C(41)-P(l) 117.85(13)
C(15)-C(11)-C(12) 107.46(15) C(43)-C(42)-C(41 ) 121.11(19)
C(15)-C(ll)-C(2) 126.66(17) C(43)-C(42)-H(42) 119.4
C(12)-C(11)—C(2) 125.88(17) C(41 )-C(42)-H(42) 119.4
C(15)-C(l l)-Fe(l) 69.89(10) C(44)-C(43)-C(42) 119.9(2)
C(12)-C(l 1 )—Fe( 1 ) 69.88(10) C(44)-C(43)-H(43) 120.1
C(2)-C(l l)-Fe(l) 125.31(12) C(42)-C(43)-H(43) 120.1
C( 13)—C( 12)—C( 11) 107.96(16) C(43)-C(44)-C(45) 120.0(2)
C( 13)-C( 12>-Fe( 1 ) 70.27(10) C(43)-C(44)-H(44) 120.0
C(11 )—C( 12)—Fe( 1) 68.89(10) C(45)-C(44)-H(44) 120.0
C( 13)—C( 12)—H( 12) 126.0 C(44)-C(45)-C(46) 120.0(2 )
C(11)—C( 12>—H( 12) 126.0 C(44)-C(45)-H(45) 120.0
Fe( l>—C( 12)—H( 12) 126.4 C(46)-C(45)-H(45) 120.0
C( 14)-C( 13)—C( 12) 108.27(16) C(41 )-C(46)-C(45) 120.8(2)
C(14)-C(13)-Fe(l) 69.82(11) C(41)-C(46)-H(46) 119.6
C(12)-C(13)-Fe(l) 69.13(10) C(45)-C(46)-H(46) 119.6
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Table 2. Bond lengths (Â) and angles (°) fo r  218.
Fe(l)-C(25) 2.019(3) C(15)-H(15) 0.9300
Fe(l)-C(14) 2.027(3) C(21)-C(25) 1.382(6)
Fe(l)-C(21) 2.028(3) C(21)-C(22) 1.389(5)
Fe(l)-C(15) 2.028(3) C(21)-H(21) 0.9300
Fe( 1 )—C( 11) 2.028(2) C(22)-C(23) 1.394(5)
Fe(l)-C(24) 2.030(3) C(22)-H(22) 0.9300
Fe(l)-C(23) 2.034(3) C(23)-C(24) 1.400(6)
Fe(l)-C(22) 2.036(3) C(23)-H(23) 0.9300
Fe( I)—C( 13) 2.042(3) C(24)-C(25) 1.422(6)
Fe(l)-C(12) 2.051(3) C(24)-H(24) 0.9300
P(l)-0(1) 1.4825(19) C(25)-H(25) 0.9300
P(l)-C(31) 1.803(2) C(31)-C(36) 1.385(3)
P(l)-C(l) 1.804(2) C(31)-C(32) 1.388(4)
P(l)-C(4l) 1.808(2) C(32)-C(33) 1.386(4)
N (l)-C (l) 1.330(3) C(32)-H(32) 0.9300
N(I)-C(4) 1.367(4) C(33)-C(34) 1.383(5)
N(2)-C(l) 1.360(3) C(33)-H(33) 0.9300
N(2)—C(3) 1.364(3) C(34)-C(35) 1.369(5)
N(2)-C(2) 1.478(3) C(34)-H(34) 0.9300
C(2)-C(l 1) 1.504(4) C(35)-C(36) 1.387(4)
C(2)-H(2A) 0.9700 C(35)-H(35) 0.9300
C(2)-H(2B) 0.9700 C(36)-H(36) 0.9300
C(3)-C(4) 1.359(4) C(41)-C(42) 1.385(4)
C(3)-H(3) 0.9300 C(41)-C(46) 1.390(4)
C(4)-H(4) 0.9300 C(42)-C(43) 1.394(4)
C(11)—C(15) 1.422(4) C(42)-H(42) 0.9300
C(11)-C(12) 1.424(4) C(43)-C(44) 1.367(4)
C(12)-C(13) 1.418(4) C(43)-H(43) 0.9300
C(12)-H(12) 0.9300 C(44>-C(45) 1.372(5)
C(13>-C(14) 1.416(4) C(44)-H(44) 0.9300
C(13)-H(13) 0.9300 C(45)-C(46) 1.385(4)
C(14>—C( 15) 1.418(4) C(45)-H(45) 0.9300
C(14)-H(14) 0.9300 C(46)-H(46) 0.9300
C(25)-Fe(l)-C(14) 115.96(15)
C(25)-Fe(l)-C(21) 39.95(16)
C(14)-Fe(l)-C(21) 147.39(15)
C(25)-Fe(l)-C(15) 108.04(15)
C(14)-Fe(l)-C(15) 40.93(12)
C(21)-Fe(l)-C(15) 115.14(13)
C(25)-Fe(l)-C(l 1) 130.58(16)
C(14)-Fe(l)-C(l 1) 68.82(12)
C (21)-Fe(l)-C (ll) 108.34(13)
C(25)-Fe( I )-C(24) 41.12(18)
C( 14)-Fe( 1 )-C(24) 109.50(15)
C(21 )-Fe( 1 )-C(24) 67.80(17)
C( 15)-F e( 1 )-C(24) 131.83(17)
C(1 l)-Fe(l)—C(24) 170.66(18)
C(25)-Fe(l)-C(23) 68.38(17)
C( 14}-Fe( 1 )-C(23) 132.41(14)
C(21 )-Fe( 1 )-C(23 ) 67.75(14)
C(15)-Fe(l)-C(23) 171.15(15)
C (ll)-Fe(l)-C (23) 147.37(15)
C( 12)-C( 13)-H( 13) 126.0
Fe(l)-C(13)-H(13) 126.5
C(13)-C(14)-C(15) 108.4(3)
C(13)-C(14)-Fe(l) 70.20(17)
C(15)-C(14)-Fe(l) 69.57(17)
C(13)-C(14)-H(14) 125.8
C(15)-C(14)-H(14) 125.8
Fe( 1 )-C( 14)-H( 14) 126.0
C(14)-C(15)-C(l 1) 107.6(2)
C(14)-C(15)-Fe(l) 69.50(16)
C(ll)-C(15)-Fe(l) 69.49(14)
C(14)-C(15)-H(15) 126.2
C(11)-C(15)-H(15) 126.2
Fe(l)-C(15)-H(15) 126.4
C(25)-C(21)-C(22) 108.4(3)
C(25)-C(21)-Fe(l) 69.7(2)
C(22)-C(21 )-F e( 1 ) 70.34(19)
C(25)-C(21 )-H (21 ) 125.8
C(22)-C(21)-H(21) 125.8
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C( 12)—C( 13)—Fe( 1 ) 70.06(16)
C(14)-C(13)-H(13) 126.0
C(41 )-C(46)-H(46) 120.0
Table 3. Atomic coordinates (xlO4)  and equivalent isotropic displacement parameters
(A2 xlO3) fo r  211 a
Atom X y z U'q
Fe(l) 9125(1) 7798(1) 2465(1) 31(1)
P(l) 7337(1) 2780(1) -82(1) 33(1)
N(l) 9017(1) 1514(2) -36(1) 46(1)
N(2) 8999(1) 3847(2) 661(1) 36(1)
C(l) 8513(1) 2658(2) 187(1) 35(1)
C(2) 8696(1) 5367(3) 1010(1) 45(1)
C(3) 9844(1) 3424(3) 725(1) 44(1)
C(4) 9841(1) 1993(3) 299(1) 46(1)
C(11) 9304(1) 5860(2) 1764(1) 35(1)
C(12) 9997(1) 7044(2) 1842(1) 39(1)
C(13) 10405(1) 7162(3) 2652(1) 42(1)
C(14) 9978(1) 6064(3) 3074(1) 42(1)
C(15) 9299(1) 5252(2) 2529(1) 39(1)
C(21) 7995(2) 8867(4) 1940(2) 88(1)
C(22) 8657(2) 10066(3) 2019(2) 71(1)
C(23) 9017(2) 10234(3) 2816(2) 56(1)
C(24) 8597(2) 9176(3) 3230(1) 58(1)
C(25) 7962(2) 8317(3) 2699(2) 79(1)
C(31) 6987(1) 582(2) -53(1) 34(1)
C(32) 7297(1) -733(3) —440(1) 45(1)
C(33) 6969(2) -2350(3) -425(1) 54(1)
C(34) 6331(2) -2673(3) -26(1) 56(1)
C(35) 6018(1) -1392(3) 356(1) 55(1)
C(36) 6342(1) 232(3) 343(1) 43(1)
C(4l) 7144(1) 3132(2) -1148(1) 32(1)
C(42) 6328(1) 2766(3) -1603(1) 46(1)
C(43) 6104(1) 3180(4) -2396(1) 59(1)
C(44) 6688(2) 3980(3) -2739(1) 61(1)
C(45) 7503(2) 4329(3) -2304(1) 62(1)
C(46) 7732(1) 3897(3) -1510(1) 50(1)
“Ucq is defined as one third of the trace of the orthogonalized.
Table 4. Atomic coordinates (xlO3)  and eqiuvalent isotropic displacement parameters
(A2-xlO3) fo r  218."
Atom X y z U' q
Fe(l) 5448(1) 6690(1) 1849(1) 38(1)
P(l) 1111(1) 3225(1) 1193(1) 31(1)
0 (1) 1554(2) 2326(2) 1718(1) 45(1)
N(l) -215(2) 6157(3) 1035(1) 43(1)
N(2) 1534(2) 6536(3) 1588(1) 36(1)
C(l) 786(2) 5417(3) 1285(1) 33(1)
C(2) 2729(2) 6195(4) 1917(1) 45(1)
C(3) 977(2) 8062(3) 1528(1) 46(1)
C(4) -87(2) 7808(3) 1187(1) 49(1)
C (ll) 3682(2) 7297(3) 1744(1) 38(1)
C(12) 4361(2) 8520(3) 2087(1) 43(1)
C(13) 5202(3) 9229(4) 1783(1) 52(1)
C(14) 5035(3) 8464(4) 1253(1) 53(1)
C(15) 4094(2) 7273(4) 1225(1) 45(1)
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C(21) 5619(3) 4210(4) 2037(2) 68(1
C(22) 6048(3) 5162(4) 2505(1) 60(1
C(23) 6978(3) 6183(5) 2390(2) 68(1
C(24) 7140(3) 5838(6) 1846(2) 90(2
C(25) 6275(4) 4611(5) 1626(2) 80(1
0(31) 2191(2) 3214(3) 727(1) 33(1
C(32) 2025(2) 4176(4) 246(1) 47(1
C(33) 2898(3) 4194(4) -91(1) 60(1
0(34) 3942(3) 3280(4) 62(2) 60(1
0(35) 4104(3) 2319(4) 533(2) 58(1
0(36) 3228(2) 2273(4) 868(1) 43(1
0(41) -299(2) 2417(3) 830(1) 35(1
0(42) -486(2) 1917(3) 280(1) 44(1
0(43) -1586(3) 1225(4) 44(1) 55(1
0(44) -2474(3) 1037(4) 357(2) 58(1
0(45) -2296(3) 1514(4) 903(2) 55(1
0(46) -1214(2) 2225(4) 1141(1) 45(1
*£/«, is defined as one third of the trace of the orthogonalized.
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Appendix 2
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